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ABSTRACT 
Melvin G. Dodson 
Loyola University of Chicago 
ISOLATION AND CHARACTERIZATION OF A VULVAR CARCINOMA 
IN TISSUE CULTURE: STUDIES OF THE 
TUMOR BIOLOGY AND TUMOR-HOST INTERACTION 
LT-2, a squamous cell carcinoma, represents the third 
vulvar cancer isolated in tissue culture. 
Immunological evaluation of the host revealed markedly 
decreased absolute numbers, percentages of peripheral blood 
lymphocytes, T-cell, active T-cell, and B-cell. A response 
was noted to only one of five bacterial recall skin test 
antigens, which subsequently became negative when re-tested 
6 weeks later. No response was noted to primary immuniza-
tion with DNCB, but the patient became PPD positive follow-
ing intralesional BCG therapy. The patient became anergic 
even to PPD within 2 months. No clinical response was noted 
to BCG treatment, although a "bone marrow" sparing effect 
with an increase in lymphocytes occurred. No response oc-
curred to immunization with an autologous tumor extract. 
Lymphoblast responses to PHA were markedly depressed and no 
lymphoblast response occurred to autologous tumor extracts. 
ix 
cytotoxicity studies using autologous lymphocyte and tumor 
cells revealed no specific cytotoxicity and non-specific 
cytotoxicity of patient lymphocytes to an unrelated tumor 
were depressed. A significant increase in both specific cy-
totoxicity and non-specific cytotoxicity was noted following 
a blood transfusion. 
LT-2 has continued to grow in vitro through 70 plus· 
subcultivations during a 4 year period. It grows as a 
strict monolayer with no piling up of cells and a plating 
efficiency of about 40%. The doubling time of 34 hours and 
the saturation density of 1 x 105 cells/cm2. LT-2 requires 
serum for growth. In time-lapse cinematography, LT-2 is 
motile and small colonies are noted to move together with no 
contact inhibition of cell movement (topoinhibition}, al-
though strong lateral cell to cell adhesions were noted. 
Cell divisions were also noted in the center of large cell 
colonies of LT-2 demonstrating a lack of contact inhibition 
of cell division despite monolayer growth. LT-2 produces 
the -chain of hCG and CEA in tissue culture and was agglu-
tinated by lectins. It retained its ABH antigens, but ex-
pressed a heterophile antigen and was agglutinated by normal 
rabbit serum. This heterophile antigen was different from 
the heterophile antigen expressed in infectious mononucleo-
sus infections. 
Karyotyping of LT-2 demonstrated aneuploidy with marker 
chromosomes and considerable variation in chromosome num-
bers. 
X 
LT-2 was noted to divide in soft agar increasing the 
number of cells in agar cultures by about 60%, but no 
clones were produced. Experiments were performed to deter-
mine if a soluble stimulant or inhibition of anchorage in-
dependent growth could be detected. Co-cultivation of an 
anchorage independent cervical carcinoma cell line with LT-
2 resulted in stimulation of cell growth with increased 
cloning efficiency. No "feeder effect" was often noted 
after 2 weeks. Mitomycin C treated AU-471 and WI-38 were 
also capable of "feeding" AU-471. The "feeder effect" was 
transferable with conditioned media and was generally dose 
dependent. 
Co-cultivation of LT-2 with mitomycin C or protein ex-
tracts of AU-471 did not stimulate anchorage independent 
growth of LT-2. 
Anchorage independence could not be stimulated by en-
zyme treatment with carbohydrates, neuraminidase, culturing 
in agarose or with DEAE or dibutyrl cyclic GMP. 
Fibronectin markedly increased cloning efficiency of 
AU-471, but not LT-2 or "normal" cell strains like M.S. or 
WI-38, that do not clone in soft agar. BHK-21 soft agar 
cloning was stimulated by fibronectin. Antifibronectin in-
hibited cloning efficiency of AU-471, but not BHK-21. In-
jecting LT-2 in nude mice resulted in tumor formation. Tu-
mor nodules were relatively well differentiated epithelium 
with keratin formation toward the center of tumor nodules. 
xi 
chromosomal analysis of in vitro cultivated nodule cells in-
dicated marked aneuploidy. Soft agar cultures of LT-2 nude 
mouse nodule cells did not produce anchorage independent 
growth. No metastases were noted. 
xii 
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CHAPTER I 
INTRODUCTION 
Many approaches have been undertaken in research di-
rected towards uderstanding and treating cancer. Some 
studies have investigated one cancer characteristic, or 
used one assay in many different cancer types, while others 
have intensely studied one protein or one phenotype or cha-
racteristic associated with cancer. This dissertation has 
by both necessity and design used a large number of clinical 
and experimental assays to bet~er appreciate the complex in-
teraction between the tumor and the tumor host. From an in 
depth study of a tumor cell, new insights into the behavior 
and characteristics of the cancer cell might be achieved. 
The cancer cell model studied was an epithelial carcinoma 
originating from the vulva which clinically progressed to 
the death of the patient, confirming its biological poten-
tial. 
Tumor immunology has generated considerable enthusiasm 
as a potential method for the treatment of cancer. Evi-
dence of immune responses to tumor cells have come from a 
wide range of clinical and experimental observations in re-
search. The pariicipation of the immune response in con-
trolling tumors can be discussed under the general concept 
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of "immune surveillance". In order to have an immune re-
sponse, tumor cells must contain a "tumor antigen". The 
host must be "immunocompetent" and c~pable of responding to 
such an antigen. In order to bring the question of immune 
responses from the clinical bedside to the laboratory for 
closer scrutiny, in vitro "cytotoxicity" studies have been 
developed using host lymphocytes and tumor cells in culture. 
Chapter 2, Section A. will summarize pertinent aspects of 
these "four topics" under the appropriate headings. 
A study of tumor immunobiology cannot divorce itself 
from a basic understanding of tumor cell physiology. Al-
though, on a clinical level, cancer is relatively easy to 
define by its biological behavior, the exact criteria of 
tumorigenicity on a cellular level in vitro are much more 
difficult. Considerable advancements have been made in 
culturing tumor cells in vitro, and a number of cell pheno-
types have been found to be associated with tumorigenicity. 
A brief review of these cancer phenotypes as pertinent to 
this discussion appears in Chapter 2, Section B. 
Reported here is the establishment and characterization 
of a squamous cell carcinoma of the vulva in tissue culture 
(designated LT-2), including evaluation of its malignant 
potential, cytomorphology, growth properties, secretory 
Products, antigens, in vitro behavior, and immunological 
stu~ies of the host, clinical course, therapy, and some as-
Pects of the tumor-host relationship. 
The following briefly reviews the findings and clini-
cal course of the patient from which the tumor LT-2 was 
isolated. 
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A 60-year-old white woman was seen in June of 1975 with 
a two-week history of vulvovaginal itching, swelling, and 
discharge. Extensive induration of the external genitalia 
with ulcerative lesions involving the introitus and ante-
rior vaginal wall was noted. Groin nodes on both sides were 
enlarged. Biopsy revealed squamous cell carcinoma. Chest 
x-ray, intravenous pyelogram (IVP), and liver and bone scans 
were normal. The patient refused surgery and was treated 
with radiotherapy consisting of 6,000 rads in 30 fractions 
over 56 days through a single perineal port. Additional 
therapy to the inguinal nodes consisted of 4,550 rads in 26 
fractions over 36 days. Some regression of the vulvar le-
sions was noted. The inguinal nodes remained enlarged and 
were treated with an additional 1,050 rads in six frac-
tions. She did well until December, 1975, when she noted 
increasing pelvic discomfort and pain. By January, 1976, 
the inguinal nodes had ruptured through the skin, producing 
a fungating lesion. She was started on dactinomycin, 0.8 
mg intravenously, daily for five days and bleomycin, 20 
units intravenously every other day for three days. She 
experienced considerable nausea and vomiting and refused 
further chemotherapy. She received two units of blood one 
month later because of anemia. Adjuvant immunotherapy con-
sisting of 2 x 106 Bacillus Calmette-Guerin (BCG) organisms 
~as administered intralesionally. She was started on Cy-
toxan, 50 mg four times daily, depending on the leukocyte 
count, and received three additional BCG immunizations dur-
ing breaks in chemotherapy. In vivo tests of immunocompe-
tence consisted of skin testing with bacterial recall skiQ 
test antigens, dinitrochlorobenzene (DNCB), and autologous 
tumor extracts. In vitro tests of immunocompetence in-
4 
eluded total and per cent peripheral blood T-cells, active 
T-cells, B-cells and phytohemagglutinin (PHA) stimulation of 
lymphocytes. The tumor-host r~lationship was evaluated by 
autologous lymphocyte-tumor cytotoxic reactivity as meas-
ured by a chromium release assay, and lymphoblast transfor-
mation in the presence of tumor extracts and mitomycin C-
treated tumor cells as described in the text. The patient 
died in September, 1976. 
CHAPTER II 
REVIEW OF RELATED LITERATURE 
TUMOR IMMUNOBIOLOGY 
1. IMMUNE SURVEILLANCE 
In a general discussion of delayed hypersensitivity, 
Thomas suggested in 1959, that it is a "universal 
requirement of multicellular organisms to preserve 
uniformity o.f cell type and to prevent mutant cells from 
colonizing and flourishing," and that "the phenomenon of 
homograft rejection will turn out to represent a primary 
mechanism for natural defense against neoplasia'' (1). This 
concept was expanded by F.M. Burnet into the concept of 
immunological surveillance which suggests that neoplasms 
frequently occur and contain new tumor antigens and 
subsequently are re~ected by the immune system (2). 
According to this concept, it is the immune system that 
prevents the host from developing cancer. 
Observations that have been used to support the concept 
II 
of immune surveillance according to Moller et al (3), 
include the following: a) The incidence of neoplasia in 
the elderly is increased simultaneously with a decrease in 
the efficiency of immune responses. Old mice cannot reject 
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small numbers of sarcoma cells that can be readily rejected 
bY younger mice. Old mice die and young mice are 1mmunized. 
b) The incidence of malignancies diagnosed histologically 
is much higher than the known clinical incidence; for 
example, autopsied infants have 50 times greater 
neuroblastomas diagnosed histologically than the known 
clinical incidence. Similarily, the incidence of 
histologically malignant thyroid nodules noted in autopsy 
specimens is 2%, but the clinical incidence of thyroid 
cancer is only 6 per 1x106 individuals. It has been 
suggested that the immune system accounts for these 
differences. c) The increased incidence of tumors in some 
genetic immunodeficiency disorders like Ataxia 
Telangiectasia (i.e., 14 tumors in 200 reported cases), 
Chediak-Higashi (11/50) and Wiskott-Aldrich (11/90) has also 
been used to support the concept of immune surveillance. 
Gatti (4) has reported that the incidence of malignancy in 
patients with primary immunodeficiencies is 10,000 times 
that of the general age-matched population. d) The 
increased incidence of tumors in immunosuppressed 
individuals, for example in patients receiving kidney 
transplants, also confirms the role of the immune systems 
in tumors. In 4,000 renal allograft recipients, 37 
developed tumors,· which is estimated to be SOx the expected 
incidence. Israel Penn (5) collected data on 47 kidney 
transplant recipients who received organs from donors with 
cancer; 36% developed cancers histologically identical to 
that present in the donor. Immunosuppressive therapy was 
discontinued in 3 patients with known metastasis, and the 
tumors regressed and disappeared. In 432 kidney 
recipients, reviewed by Penn, 24 developed neoplasms, an 
incidence of 5.6%, which is approximately 100x greater than 
the incidence in the general population in the same age 
range. Penn also reported on 48 patients receiving 
immunosuppressive therapy for a number of medical problems 
like psoriasis, systemic lupus erythematosus, rheumatoid 
arthritis and ulcerative colitis, suggesting a possible 
increased incidence of cancers in such patients. 
The occasional clinical observations of tumor 
regression have also been used to support the concept of 
immune surveillance. Everson and Cole reviewed 176 
examples of spontaneous tumor regression between 1900 and 
1964 (6). The implication was that the tumor regressed 
because of the immune system. 
We might add to these observations the occasional 
report of dramatic tumor regression using immunotherapy 
like BCG and C. Parvum. In addition to these arguments 
supporting the concept of immune surveillance, there have 
been extensive animal experimental data implicating the 
immune system as an important participant in tumor 
Progression. 
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prehn has summarizd the data against immune 
surveillance, and feels that the case for immunological 
surveillance has been "exaggerated" (7). 
Prehn first notes that some "classes of tumors have 
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many members with little or no detectable immunogenicity". 
ThiS lack of tumor antigens would preclude any immunological 
surveillance mechanism. If immunoselection was responsible 
for the lack of tumor antigens in spontaneous neoplasia, 
then neoplasms arising in immuno-deficient environments 
should be highly antigenic. Prehn tested this hypothesis by 
growing tumors in intraperitoneal diffusion chambers, and 
found relatively little immunogenicity. Also mouse embryo 
cells, grown in tissue culture and treated with chemical 
carcinogens yield tumors showing relatively little 
immunogenicity. Very small inocula of immunogenic tumor 
cells sometimes survive and kill the host (a phenomenon 
first described by Humphreys et al, and is termed "Sneak 
Through" (8), even though large inocula result in effective 
immunization and inhibition of tumor growth. This "sneak 
through" phenomenon suggests the immune system is sometimes 
ineffective even with immunogenic tumors (9). " Moller and 
II 
Moller have also pointed out that in several diseases with 
pronounced immunosuppression there is no increased tumor 
incidence (Leprosy, Sarcoidosis}, and that immunodeficient 
patients develop a very restricted range of neoplasms, 
generallY of lympnoid origin, rather than the common tumors 
seen clinically (10). 
Further negative data come from animal stud1es. Nude 
mice which lack T-cells and cannot reject foreign grafts, 
have a very low spontaneous rate of tumor development. 
Rygaard and Povlsen reported on 11,000 nude mice without a 
single example of a tumor developing (11). Simpson and 
Nehlsen used antilymphocyte sera to suppress the immune 
system in CBA mice and also found no increase in the 
" " incidence of spontaneous tumors (12). Moller and Moller 
also point out that immune surveillance should produce a 
high incidence of tumors· in immune privileged sites like 
the anterior chamber of the eye, cheek pouch of the hamster 
and brain. Yet, these are not common sites of spontaneous 
malignancy. 
The data implicating the potential for involvement of 
the immune system in cancer are impressive, particularly if 
the experimental animal data are accepted as a valid 
comparison to human cancers. From a pragmatic point of 
view, the question remains one of degree. How important is 
the immune system in the prevention of tumors, not 
theoretically but practically? 
Experimental systems must be viewed with caution since 
many such tumors ·are induced by viruses or strong chemical 
ca · rc1nogens (mutagens) which have repeatedly been 
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demonstrated to express viral or highly antigenic 
mutational antigens. Therefore, immunological reJection of 
such tumors may only reflect the involvement of the 1mmune 
system in tissue graft rejection or the killing of virus 
infected cells. Klein and Klein have suggested that immune 
surveillance may, in fact, be mainly involved in the 
prevention of viral tumors (13). Prehn's note of caution 
regarding tumor antigens would appear to be central to the 
controversy (14). 
2. TUMOR ANTIGENS 
The first convincing evidence that malignant cells 
have antigens not present in the normal precursor cell came 
from studies using tumor transplants by Gross (15) in 1943 
with syngeneic mice and chemically induced tumors. Prior to 
that time, most reports of tumor antigens were thought to 
have resulted from transplantation or histocompatibility 
antigens. Prehn and Main (16) confirmed these findings in 
1957 when they showed that skin grafts from tumor donors 
were accepted while the tumor itself was rejected, 
indicating the presence of antigens on the surface of tumor 
cells which are absent on the normal skin of the tumor 
donor. These new antigens, which were responsible for tumor 
rejection in the syngeneic host, were originally termed 
tumor-specific transplantation antigens, since they were 
demonstrated by rejection of a grafted tumor. Results of 
further studies by Prehn (17) revealed that two such 
1 1 
chemically induced tumors arising at different sites on the 
same mouse had different tumor-specific antigens. Most 
chemically induced tumors have tumor neoantigens. New 
antigens may also arise from spontaneous mutation~ 
occurring in any dividing cell population. 
Some viruses also induce malignant growth. The first 
virus-induced tumors were demonstrated by Ellermann and 
Bang (18) in 1908 and by Rous (19) in 1911. The presence of 
virus-specific tumor rejection antigens was described by 
n 
Sjogren and associates (20) and independently by Habel (21) 
in polyoma virus-induced mouse tumors. 
A different type of tumor antigen was demonstrated in 
1965 when Gold and Freedman (22) reported an antigen which 
was associated with human carcinoma of the colon, and was 
also present in fetal tissues. This antigen, termed 
carcinoembryonic antigen, was later found to be associated 
with many different types of human tumors and some 
non-malignant diseases, as well as normal fetal tissues. 
The initial enthusiasm for carcinoembryonic antigen as a 
diagnostic test for carcinoma of the colon waned because of 
its lack of specificity and its inconsistency of expression 
in tumors. Since these limitations have been appreciated, 
carcinoembryonic antigen has becon1e a useful screening tool 
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in suspected instances of malignant disease, and is used to 
monitor therapy in some patients with cancer (23). 
The presence of fetal antigens .in malignant tumors was 
n 
suggested in 1906 by Schone (24), but the significance of 
" these antigens was not fully appreciated. Schone immunized 
mice with extracts of fetal tissue and noted resistance to 
transplantation of a sarcoma, suggesting the presence of 
fetal antigens in the sarcoma. 
In addition to recognition of antigens resulting from 
chemical or viral transformation or expression of repressed 
fetal antigens in tumors, there is now a better 
appreciation of the large number of antigens expressed by a 
normal cell. The closer normal cell antigens are observed, 
the more complex and varied are the antigenic determinants 
noted. For example, there have been over 379 recognized 
normal red cell antigens reported (25). An increase or 
decrease in the number of normal cell antigens may occur 
following malignant transformation (26, 27), and some 
normal antigens initially have been confused with 
tumor-associated antigens (28, 29). 
New antigens in tumor cells may also result from 
enzymatic change or synthesis. Such structurally altered 
antigens have been noted in studies of both the ABH and MN 
blood group system. 
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Not all antigens expressed on a tumor cell can be 
explained by a single mechanism of formation. Any given 
transformed cell may express a variety of new antigens, 
including those arising from mutation, modulation of normal 
cell macromolecules, derepression of fetal genes or 
recessive alleles and faulty macromolecular biosynthesis. 
3. IMMUNOCOMPETENCY 
Host immunocompetency can be assessed both by in vivo 
and in vitro testing. In vitro methods of evaluation of 
immunocompetence in tumor patients include total lymphocyte 
counts, T and active T cell subpopulations, lymphocyte 
response to mitogen stimulation and specific lymphocyte 
response to tumor cells or tumor extracts. Stefani and 
colleagues (30, 31) and Kerman and associates (32), have 
shown depression of total T cells, active T cells, and 
mitogen stimulation in patients with certain solid tumors. 
In vivo host immunocompetence is frequently evaluated 
by delayed hypersensitivity skin test responses -
specifically to tumor antigens prepared from autologous or 
allogeneic tumors or nonspecifically through recall 
(secondary) responses to microbial skin test antigens and 
response to primary sensitization with dinitrochlorobenzene 
(DNCB). It has been found that 90 to 100 per cent of normal 
individuals will respond to at least one of a series of 
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five ubiquitous microbial skin test antigens and 96.5 per 
cent will respond to primary sensitization with DNCB 
(33,34,35). Patients with a wide variety of tumors have 
shown depressed responses to both recall antigens and 
primary immunization. Nalick and co-workers demonstrated 
depressed responses by both parameters in cervical, 
uterine, ovarian, and vulvar cancers (36). Eilber and 
Morton reported a correlation of DNCB responsiveness to 
prognosis (37). Ninety-six per cent (50 of 52) of patients 
who were DNCB non-reactive were either inoperable or 
developed recurrent cancer within 6 months. 
In some tumors, imm~nocompetence may correlate with 
prolonged survival and/or stage of disease (38). However, 
reports vary considerably as to the prognostic value and 
dependability of different immune parameters. Even when a 
correlation exists for a tumor of a given histologic type 
between immunocompetence evaluations and state of disease 
or prognosis, it cannot be easily extrapolated to other 
types of tumors. In addition, even in studies showing 
statistical correlation between immunocompetence and 
prolonged survival, any individual patient may show good 
immune response in the face of tumor progression, 
deteriorating clinical condition, and death or poor immune 
response and prolonged survival. Eilber and Morton noted 
two patients who were DNCB positive despite widespread 
metastasis and they remained positive until their death 
( 39). 
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Attempts have been made to use immune stimulation for 
tumor therapy. Bacillus Calmette-Guerin (BCG) has been 
used extensively as the primary mode of immunotherapy. 
Generally, limited success has been noted, although 
occasional good responses have been reported in individual 
cases. The rationale for BCG immunotherapy includes 
stimulation of cellular immunity, possibly resulting in 
enhanced sensitization and consequent immune response to 
tumor antigens leading to tumor regression. A bone marrow 
- sparing effect has been reported with BCG, increasing the 
number of peripheral blood lymphocytes giving the potential 
for delivery of increased doses of chemotherapeutic agents 
that produce leukopenia (40). 
Of even more interest is the response of cancer 
patients to extracts of their own tumor. Herberman (41) 
noted that skin tests for delayed hypersensitivity to tumor 
extracts have two principal objectives: a) a means of 
detecting antigens on tumor cells, and b) as a mechanism for 
assaying host cellular mediated immune responses to 
neoplastic disease, and correlation of such responses to 
resistance to tumor g~owth, clini~al status, prognosis, and 
for monitoring patients during therapy. 
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Delayed-type hypersensitivity reactions (DTH) have 
been reported in 72% of patients to extracts of leuKemias 
and lymphomas (42). Fass noted positive DTH in 61% (8/13) 
of patients with Burkitt's Lymphoma, and noted a correlation 
with clinical status (43}. Stewart found specific DTH 
responses to autologous tumor extracts in 26% of a group of 
134 patients with lung cancer (44}. Fass, et al, also 
reported positive skin reactivity to autologous tumor 
extracts in 3 patients with malignant melanoma with 
localized disease, and an absence of reactivity in 5 
patients with advanced disease (45}. 
Herberman suggested· that in vivo skin testing to 
autologous tumor extracts had several advantages over in 
vitro testing of host cellular mediated immunity: its 
simplicity, elimination of the need for tissue cultures, 
availability of better controls using normal tissues which 
are more difficult to grow in vitro, and a better reflection 
of results of in vivo skin testing with the immune status 
of the patient. The disadvantages of in vivo skin testing 
are the difficulty of precise quantitation, the necessity of 
patient cooperation, and the fact that such testing involves 
the use of tumor tissue (extracts} in human subjects. 
Care must be used in interpretation of autologous tumor 
DTH, since skin t·est reactivity to extracts of normal 
tissue has been reported. Bacterial contamination may also 
be responsible for false positive skin test (46,47). 
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4. CYTOTOXICITY 
Cytotoxicity may result from a wide variety of 
biological, physical and chemical agents. Three general 
"types" of immunological cytotoxicity are recognized: a) 
complement mediated antibody dependent cytotoxicity (CMAD), 
b) antibody dependent cell mediated cytotoxicity (ADCC), 
and c) cell mediated cytotoxicity (CMC). 
a. COMPLEMENT MEDIATED ANTIBODY DEPENDENT 
CYTOTOXICITY (CMAD) 
Kalfayan and Kidd (48) in 1953 noted tumor cell 
swelling in the presence of antibody and complement, and 
Gorer and O'Gorman (49) noted tumor cell killing in vitro in 
1957 as judged by vital dye exclusion (trypan blue) after 
incubation with isoantibodies and complement. Green, et al 
reported cellular leakage of radioactive molecules from 
ascites cells in the presence of antibody and complement, 
and suggested that ~omplement induced "holes" in the cell 
membrane (50). These "holes" when visualized by electron 
microscopy, are uniform, stable structures 100 A0 in 
diameter; and result from insertion of complement 
components into the cell membrane, forming a doughnut-like 
hole (51). Although IgM, IgG1, IgG2 and IgG3 antibodies 
can "fix" complement with resulting cytolysis, IgM is 800 
times more effective than IgG (52). 
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Despite the undeniable fact that antibody and 
complement can result in cytotoxicity, the role of such 
humoral immunity to tumors remains quite controversial. 
Tumor cells very considerably in their susceptibility to 
cell lysis by CMAD (53), and evidence has even been 
presented suggesting that antibodies might "protect" tumors 
from cell-mediated cytotoxicity resulting in tumor 
enhancement (54). 
The existence of antibodies to tumor-associated 
antigens has variably been reported, but in the opinion of 
Herberman, not adequately proven (55). Multiple reports 
have probably adequately confirmed the existence of 
anti-tumor antibodies in patients with at least three 
different types of tumors: 1) Burkitt's Lymphoma, 2) 
malignant melanoma, and 3) sarcomas. Theofilopoulos in 
1977 reported immune complexes in about half of patients 
with melanoma, colon carcinoma, and osteogenic sarcomas 
(56). Hoffken et il 1978, noted circulating immune 
complexes in the initial stages of chemically induced 
carcinomas (3-methylcholanthrene) that returned to normal 
with tumor excision and also decreased in concentration with 
continued tumor progression (57). Antibody responses also 
occurred in viral induced tumors (Mammary Tumor Virus in 
BALB/cfC3H female mice), with specificities against not 
only viral antigens, but also against a wide variety of 
unique specificities (58). 
19 
Hellstrom reported an' enhancement of tumor growth by 
hyper-immune serum (59). This effect was initially thought 
to result from blocking antibodies (60). The effect of 
serum in tumor growth enhancement was found to be specific. 
others have also reported tumor cell enhancement (61,62). 
The tumor growth enhancement could be removed by absorption 
with specific tumors (Moloney sarcoma), but not with control 
cells (63). The serum effect was initially thought to be 
due to antibodies that "blocked" cell-mediated 
cytotoxicities (CMC). Such CMC blocking was confirmed by 
" Sjogren et al (64) and by Baldwin (65}. The concept of 
"blocking antibodies" was based on the observation that: 1) 
blocking activity could be removed by absorption with 
specific tumor cells, and 2) blocking occurred if target 
cells were incubated with serum, but not if lymphocytes 
were incubated with serum. The concept of "blocking 
antibodies" had to be modified when the blocking effect was 
noted to disappear shortly after tumor regression or 
surgical removal of tumors. Sera from such tumor-free 
animals was found to be "unblocking" and the blocking 
activity was then felt to result from antibody-antigen 
complexes, and unblocking from antibodies (66). The 
blocking effect is reported to occur at either the target 
cell or effector cell level by antigen-antibody complexes. 
Free antigen blocked at the effector cell level. These 
observations were partially substantiated by Baldwin using 
papain solubilized tumor antigens (67). Neither antigens 
nor antibodies to the same antigens blocked CMC, but 
complexes in the right proportion were capable of blocking 
at the level of the target cell, and both complexes and 
free antigens were found to be capable of blocking at the 
level of the effector cell. CMC reactivity using patient 
lymphocytes against histologically similar tumor cells was 
also used as evidence of histological type specific 
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reactivity, and suggested similar antigens in patients with 
histologically similar type tumors (68). 
The importance of the observation in vitro is suggested 
by the correlation between blocking factors against CMC and 
melanoma growth. Hellstrom noted a correlation between 
blocking factors against CMC and melanoma growth (69). 
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Bansal and Sjorgen confirmed these findings in vivo using a 
polyoma viral induced tumor in rats (70). Murray reported 
a 15,000 dalton blocking factor that bound both to Con A 
and to melanoma antibodies, and which was also found in the 
supernatants and membranes of melanoma cells in tissue 
culture ( 71 ) . 
How these observations integrate with more recent 
observations regarding ADCC is not clear. The lack of 
normal reactivity (spontaneous cell mediated immunity, SCMC 
or natural cytotoxicity) in these studies is very 
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questionable (72). The histologic type-specific reactivity 
haS also been seriously questioned (73). Takasugi, Mickey 
and Terasaki reported on cytotoxicity reactions involving 
peripheral blood lymphocytes in a variety of cancer patients 
using 45 different human tumor cell lines with 9294 
different lymphocyte-tumor combinations and found no 
correlation between CMC and "histologic types" of cancers 
(74). 
b. ANTIBODY DEPENDENT CELL MEDIATED CYTOTOXICITY 
(ADCC) 
Like CMAD, ADCC requires antibody; however, in ADCC, 
lysis results from the interaction of an effector cell with 
antibody coated target cells rather than complement. 
Therefore, ADCC is complement independent. ADCC has been 
thought to be exclusively a function of IgG (all 
subclasses), although one report has indicated that IgM may 
also be capable of initiating ADCC (75). Effector cells 
bind to the Fe portion of the antibody, and do not have to 
be previously sensitized. The specificity of ADCC resides 
in the antibody. Effector-target cell interaction is 
required. Effector cells must be viable in order to 
participate in ADCC, although DNA synthesis is not required. 
A wide variety of cells has been capable of participating as 
effector cells in ADCC including polymorphs, macrophages, 
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mononuclear cells, K cells, and even fetal liver cells 
( 7 6) • 
c. CELL-MEDIATED CYTOTOXICITY 
Kidd and Toolan in 1950 noted that tumors or tumor 
cells mixed with lymph node cells when inJected into 
recipient animals resulted in tumor growth and eventually 
host death, but tumor cells mixed with specifically 
sensitized lymphocytes resulted in tumor prevention or at 
least retardation of tumor growth (77). In 1955, using 
allografts, Mitchison noted that in vitro cells could 
mediate cytotoxicity (78). Graft rejection could be 
adoptively transferred with lymphocytes, but not with 
serum. Winn in 1960, noted reduction of allogeneic tumors 
when specifically sensitized lymphocytes were injected along 
with the tumor cells (79). Govaerts reported in vitro 
cytotoxicity using dog cell monolayers following in vitro 
incubation with specifically sensitized lymphocytes (80). 
Following these early observations, a large number of 
experiments has been performed to evaluate in vitro 
cell-mediated cytotoxicity against tumors. 
In vitro CMC studies involve the use of an effector 
cell responsible for the cytotoxic action, a target cell, 
and a mechanism of measuring the cytotoxic effect. A wide 
variety of effector cells has been used in the past 
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including monocytes, macrophages, polymorphonuclear 
leukocytes and lymphoid cells from lymph nodes, spleen, 
thymus or peripheral blood. Likewise, a wide variety of 
normal and tumorigenic target cells has been used. 
Frequently, allogeneic tumor cells of the same histological 
type as the lymphocyte donor have been used in assessing 
tumor patient cytotoxicity. Occasionally syngeneic or 
autochthonous tumor lymphocyte combinations have been used. 
More recently, cytotoxic effects of non-immunized 
mononuclear cells against normal and even self tissue have 
been recognized (81). A wide range of techniques has been 
used to measure and quantitate the effector-target 
cytotoxic interaction including: early experimental 
observations of cytopathic changes in monolayer plaques; 
exclusion of supravital dyes by target cells; cell counting; 
colony inhibition or colony formation in soft agar; release 
of radiolabeled proteins, amino acids, 32p or 51chromium 
(82). The effector target interaction may occur in 
allogeneic or autologous serum, and length and condition of 
incubation vary as well as manipulations in the processing 
of effector and target cells. 
The mechanism of cytotoxicity is not known, although 
Ferluga et al reported cytotoxicity resulting from plasma 
membranes of peripheral blood lymphocytes (83). 
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CMC is antibody and complement independent and may be 
specific (directed against target cells expressing specific 
antigens) or non-specific (resulting from release of 
cytotoxic soluble substances or from the action of 
nonsensitized but activated effector cells). As noted 
above, a variety of effector cells can produce cytotoxic 
reactions including macrophages, T-lymphocytes, 
a-lymphocytes, and natural killer (NK) cells. 
Two general types of macrophage cytotoxicity have been 
described. One type, resulting from "Activated" macrophages 
is not immunplogically specific, the other is 
immunologically specific, and is a function of "armed" 
macrophages. 
Armed macrophages demonstrate immunological 
specificity. The mechanism of "arming" is not known. Armed 
macrophages may be generated in vitro or in vivo by exposure 
of immunized lymphoid cells to antigen. Evans reported a 
specific T-cell proauct (specific macrophage arming factor 
(SMAF) that armed macrophages (84). The possibility of 
cytophilic antibodies has also been suggested as "the arming 
agent", since treatment of macrophages with trypsin or heat 
inactivation of serum at 56oc for 30 minutes results in loss 
of specific cytotoxicity which could be restored by immune 
serum. Armed macrophages (specific reactivity to a 
Particular antigen like SRBC) can be activated (with non-
immune inhibition of tumor cell growth) by exposure to 
specific antigen (SRBC) (85). 
Macrophages may be activated by factors from T cells 
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or by substances like endotoxin, peptone, starch, glycogen, 
acG, double-stranded RNA, or exposure to intracellular 
pathogens like toxoplasma (86). Activated macrophages may 
also be obtained by exposing "armed" macrophages to specific 
antigens. The cytotoxic action is non-specific, but 
reportedly only abnormally growing cells are killed (87). 
The recognition mechanism is nonimmune and not based on H-2 
foreign target cell antigens. Instead, the cytotoxic 
action is based on recognition of cell properties associated 
with abnormal growth characteristics. Contact-inhibited 
nontumor 3T3 fibroblasts are spared, but transformed 
(SV-40) 3T3 fibroblasts which have lost contact inhibition 
are killed (88). 
The mechanism which macrophages use to distinguish 
cancer from a normal cell is not known. Inhibitors of 
protein synthesis (puromycin, cycloheximide), DNA synthesis 
(mitomycin C, actinomycin D) or inhibitors of phagocytosis 
(cytochalasin B) have no effect on the cytotoxic 
capabilities of activated macrophages. The mechanism of 
killing is thought to result from."secretion" of lysosomal 
enzymes into the target cells (89), because it is inhibited 
by hydrocortisone (which also inhibits lysosomal 
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exocytosis), and trypan blue (inhibits lysosomal enzyme ac-
tion). No cytotoxic factor(s) is/are noted in cultured me-
dia of activated macrophages suggesting that cell-cell con-
tact is needed for the cytotoxic effect (90). 
d. SPONTANEOUS CELL MEDIA·rED CYTOTOXICI'rY ( SC_MC) 
More recently, cytotoxicity of non-sensitized effector 
cells has been recognized and termed spontaneous or natural 
cytotoxicity. The effector cells have been called the nat-
ural killer or NK cell. Early reports suggested a non-T, 
Fe+, C3+ cell as the responsible effector cell (91). The NK 
cell has been characteri~ied by Eremin as aT-neg. (non-
thymus cell), Fe+, C3-, Ig+ cell in peripheral blood (92), 
similar or identical to the K cell of ADCC (a B-cell, but 
not requiring antibody for cytotoxic effect). In contrast, 
the NK cell in tonsils and lymphnodes was found to be an 
Ig-, Fe-, c3-, T+ cell. Vessella reported data suggesting 
that cells mediating SCMC were a heterogenous population 
composed of Fe+ lymphocytes both with and without C3 rec2p-
tors (93). Vessella also suggested that the cells responsi-
ble for ADCC and SCMC are identical although the mechanisms 
are different. Hersey has suggested that an "activated" T-
cell is responsible for SCMC (94). Removal of the Fe bear-
ing cell decreased responsiveness, although depletion of 
phagocytic cells did not affect SCMC activity. Oehler noted 
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an increase 1n NK cytotoxicity following intraperitoneal 
injection of ~~~~Y-~~, Poly I:C (Polyinosinic-Polycytidylic 
Acid), LCMV (lymphocytic choriomeningitis virus) and KRV 
(Kilharn rat virus) (95). Treatment with hydrocortisone, X-
irradiatioil or cyclophosphamide suppresseJ SCMC in vivo, 
but Poly I:C following such treatment restored cytotoxic-
ity. Silica also reduced SCMC which could not subsequently 
be restored with Poly I:C. Thymectomy had no effect on 
SCMC. Oehler used these observations to suggest that pha-
gocytosis plays a role in SCMC, although T-cells do not, and 
implicates interferon as possibly playing an important role 
in SCMC (96). Menon et al have demonstrated a decrease in 
SCMC in tumor patients, and noted a correlation between PHA 
responsiveness and SCMC (97). PHA is a non-specific stimu-
lator of T-cells. 
28 
a. TUMOR CELL PHYSIOLOGY 
1. TISSUE CULTURE 
HeLa was the first human carcinoma cell line to be 
established in vitro. It was isolated by Gey (98) from a 
squamous cell carcinoma of the cervix in 1951, and since 
then has been maintained in continuous culture. 
Established gynecolojic tumor cell lines include carcinomas 
of the cervix, ovary, uterine endometrium and chorion. No 
exact record of the number of gynecologic tumor cell lines 
is available. Fogh and Trempe {99), Gall (100), Pattillo 
(101), Nelson-Rees (102)., DiSaia {103), and the American 
Type Culture Collection {104), collectively have listed 15 
cervical, 13 ovarian, and three uterine tumor cell lines, 
but not all of these have been characterized. Other such 
lines may also now exist. The in vitro cultivation of 
vulvar carcinoma cell lines has been reported by Giard and 
associates (105), in 1973 and Fogh and co-workers (106} in 
1977. 
Ironically, the proliferation of established human 
carcinoma cell lines may not be as abundant as previously 
believed, since many cell lines have been found to be 
contaminated with HeLa or even animal cells (107,108). 
Other cell lines ·used in various studies have not been 
well-characterized, and even the origin of some lines is 
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vague. When a tumor is cu1tured in vitro, it is important 
to determine that the cells that establish themselves are 
in tact malignant. The capability of continual 
subcultivation in vitro, abnormal karyotype, growth in soft 
agar suspension, ana the ability to grow and form tumors in 
immuno-suppressed or immunodeficient animals are frequently 
used criteria of malignancy (109-114). 
A number of continuous malignant cell lines have been 
used in studies involving the biochemical, biological, 
genetic, and ultra-structural properties of cancer cells. 
In addition to studies of tumor cells per se, cultured cells 
have been used to evaluate the host's immune response 
(immunocompetence) to the tumor. 
2. CONTACT INHIBITION: SATURATION DENSITY 
The behavior of cancer cells and normal cells has been 
compared in tissue culture and correlated with the in vitro 
potential for tumor' growth. Normal cells grow in strict 
monolayers, but cancer cells pile up often forming multiple 
layers. Abercrombie and Heaysman initially explained the 
tendency of fibroblasts to remain as monolayers on the 
substratum as contact inhibition (115). Middleton notes 
that although monolayering is commonly used to designate 
contact inhibition, there are other potential explanations 
for monolayer growth (116). Steinberg has emphasized the 
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point that con tact ini1 ib it ion can be used to designate 
several phenomena: contact inhibition of cell movement 
implying cessation of cell movement secondary to cell-cell 
contact; contact inhibition of growth implying inhibition 
of cell growth and division with cell-cell contact. The 
term may indicate the behavior of one cell when it collides 
with another cell in which there is a cessation of 
locomotion in the direction that brought about the 
collision; or the term may even be applied to the behavior 
of whole populations of cells and imply monolayer growth 
(117). Monolayer growth resulting from contact inhibition 
can readily be appreciated in vitro on inspection of 
confluent cell cultures. The phenomenon can be quantitated 
by measuring the cell density of confluent cell cultures 
and is termed saturation density. Pollack et al, reported 
a correlation between contact inhibition by saturation 
density, and in vitro tumorigenicity (118). 
Although the mechanism of conta~t inhibition is not 
known, Abercrombie (119) has suggested that it might result 
from: the inability of the dorsal surface of one cell to 
provide a substratum for locomotion for another cell, or 
the development upon cell-cell contact of strong lateral 
adhesions such that further movement in the direction of 
the adhesions is impossible. studies by Middelton 
demonstrated that epithelial cells, layered over a 
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confluent monolayer of the same cell type failed to spread, 
suggesting that the dorsal surface of the normal cell does 
not provide an adequate substratum for attachment and 
locomotion for another cell of the same type (120). 
Also, Steinberg has noted cell movement in time-lapse 
studies from confluent 1nonolayer cultures with cells in 
mutual contact on all sides (121). Steinberg concluded that 
the avoidance of overlapping rather than the inhibition of 
locrnnotion was responsible for monolayer growth. 
3. SERUM DEPENDENCE 
Almost all normal cells require serum for growth in 
vitro. Tumors have been noted to have a reduced 
requirement for serum factors (122). This has been 
demonstrated by Holley using SV-40 transfocmed 3T3 cells 
(123). Holley noted that the active material in the serum 
is a 100,000 dalton, non-dialyzable factor which is 
destroyed by pronase treatment. Smith and Temin have 
suggested that tumor cells might adopt a serum free culture 
condition by producing their own growth factor (124). The 
growth factor in serum must be produced by some cells within 
the body, and since cells of the same origin all have the 
same genetic material, this would be conceivable. Smith and 
Temin, have in fact, isolated such a growth promoting 
factor from conditioned media from a cell line that is serum 
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independent. Gospodarowicz et al have reviewed the mitogen 
and growth factors found in serum and plasma, and note that 
tnere is a complex mixture of substances including epidermal 
growth factor (EGF), fibroblast 3rowth factor (FGF), nerve 
growth factor (NGF), insulin, nonsuppressible insulin-like 
activity (NSILA), colony-stimulating factor (CSF), 
somatomedins (125). More recently, Guinivan et al, using 
normal rat kidney (NRK) and Kirsten sarcoma virus 
transformed NRK cells (Ki-NRK) reported that cells were 
stimulated by EGF ann expressed high concentrations of EGF 
receptors. Ki-NRK cells were unresponsive to EGF and no 
receptors were detected •. Cross feeding experiments 
demonstrated the production of a heat-stable substance from 
Ki-NRK cells that stimulated DNA synthesis in NRK cells, 
independently of the presence of serum or epidermal EGF 
(126). 
Despite the good correlation of in vitro serum 
independence of cells with in vivo tumor formation, Shin 
has noted that serum independence can be disassociated from 
in vivo tumorigenicity (127). 
Interestin~ly 1 Stanbridge et al (128) were able to 
disassociate anchorage independent and nude mouse growth as 
separate genetic phenotypes using HeLa and normal 
fibroblast fusion hybrids. Their findings suggest that the 
properties of serum independence, anchorage independence, 
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loss of contact inhibition (density dependent limitation of 
growth) and lectin agglutination do not by themselves or in 
concert endow a cell with tumorigenic potential. 
stanbridge suggested that the in vitro transformation 
phenotypes are dominant traits whereas malignant behavior 
in vivo is a recessive trait. 
4. LOCOMOTION 
Both normal cells and tumor cells have been reported 
to show locomotion in tissue culture. In normal cells, 
contact inhibition is important in controlling cell 
movement in vitro (129).· Collisions between cells lead to 
the development of stable adhesions (130). Not all tumor 
cells show motility in vitro. Hosaka et al, studied the 
motility of four strains of rat ascites tumor cells and 
noted no locomotion in two of these strains (131). Tickle 
et al, tried to correlate cell movement and invasiveness 
using a variety of tumor cells implanted into developing 
chicken wing buds. The results suggest that cell movement 
may not be a common factor in all invasive tumors (132). 
Trophoblasts, sarcoma 180, and cultured hamster fibroblasts 
did invade the mesenchyme, but appeared to do so by 
different mechanisms. Trophoblasts dest~oyed adjacent host 
tissue. Even cells that showed contact inhibition were 
capable of movement and tissue invasion. 
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5. KARYOTYPE · 
Aneuploidy is a common finding in cancer cells; it has 
almost become an integral part of any definition of cancer -
a cellular criterion of malignancy. Boveri in 1941 noted 
that malignant cells are cells with genetically unbalanced 
chromosomal complements (133). Boveri's intuition 
regarding chromosomes and cancer was confirmed in 1952 by 
Makino (134). Atkin has reviewed the subject, and has 
noted that data fail to disclose any simple chromosomal 
change common to all cancers, and that considerable 
variations occur in different cancers (135). 
Spriggs has posed a particularly pertinent question: 
Do chromosomal changes occur before or after malignant 
changes? (136). If chromosomal changes are seldom or 
inconsistently present in precancerous stages of tumors, 
then they can be dismissed as inessential features, but if 
chromosomal changes are regularly found in lesions 
preceding cancer bi many years, then these changes may play 
an integral part in the carcinogenic process. Not enough 
precancerous lesions have been studied to confidently 
answer this question to date, but Spriggs' review of 
cervical dysplasia and carcinoma in situ would suggest that 
many of these lesions do in fact have abnormalities in 
chromosomal numbers and/or abnormal marker chromosomes long 
before invasion and metastasis occur. Indeed, this 
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supports the suggestion that aneuploidy does play a central 
role in the development of cancer. 
Most carcinogens, includin0 viral, chemical or 
radiation are known to produce chromosomal breaks, and a 
number of inherited disorders known to be associated with 
cnromosomal breaks like Bloom's Syndrome and Fanconi's 
Anemia are also associated with an increased incidence of 
cancer { 137}. 
Katayama and Woodruff have noted aneuploidy in both 
carcinoma in situ and invasive carcinoma of the vulva 
{ 1 38 } • 
6. HISTOLOGY 
~torpholog ical changes in cells have in the past been 
the most widely used criteria of malignancy, and have 
served clinical medicine well as a means of distinguishing 
normal tissue from its malignant counterparts. Despite the 
developments in oncogenic pathology and cytology, exceptions 
do occur, as well recognized in the difficulty in 
distinguishing between benign and malignant thyroid tissue. 
The criteria and morphological hallmarks of malignancy 
sometimes vary in different tissue types. Morpnological 
criteria for spontaneous chemically induced tumors have 
also been studied in experimental animal systems. 
Morphological changes which have been reported to correlate 
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with neoplastic transformation include: pleomorphism in 
cell and/or nuclear size and shape; increased 
nuclear-cytoplasmic ratio; prominent enlarged or numerous 
nucleoli; basophilic cytoplasm; abnormal mitosis; reduced 
intercellular cohesiveness with piling up of cells; and 
reduced cytoplasmic spreading. The cytoplasmic criterion 
which Montesano et al noted to correlate best with 
tumorigenicity was increased nuclear cytoplasmic ratio, and 
basophilic cytoplasm (139). Cytodiagnosis was reliable in 
94% of 18 cultured rat liver tumor cell lines. 
Electron microscopic studies of multiple tumor systems 
have not shown any specific or universal patterns in 
cancers (140). Mao, Nalcao and Angrist studying grade 1 
adenocarcinomas could not distinguish malignant from normal 
or hyperplastic tissues (141). Ultra structure differences 
are generally quantitative rather than qualitative. 
7. ANCHORAGE INDEPENDENT GROWrH 
The physiological and biochemical alterations which 
result in anchorage independent growth of tumor cells are 
not known. Tucker et al, noted that decreased cytoplasmic 
spreading resulted in increased growth in suspension, and 
also noted variation in cloning efficiency from cell line 
to cell line by a 200 fold range (142). Variations in 
cloning efficiency at different inoculum sizes were also 
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noted. A decrease from 105 to 104 cells in soft agar 
resulted in an increase in cloning efficiency of from 6 to 
1000 fold .. Kimball et al, also reported that increasing 
concentrations tlf cells decreased soft agar cloning 
efficiency (143). Mavligit et al, reported that a large 
percentage of non-viable cells could inhibit in vitro growth 
in soft agar (144). MacPherson and Bryden noted an 
increase in cloning efficiency if responder cells were 
co-cultured in soft agar with x-ray or UV-radiated or 
mitomycin C treated "feeder" cells (145). A 4 fold 
increase in cloning efficiency was noted in the range of .5 
- 1.0 x 105 feeder cells, but a 38% reduction in cloning 
when feeder cells were reduced to .1 x 105 cells. No 
feeder effect was noted when as few as 0.05 x 105 feeder 
cells were used. Dextran sulfate and heparin have been 
reported to decrease soft agar cloning reportedly because of 
their strong negative charges. Conditioned media, collagen, 
increased serum, insulin, DEAE-dextr~n and a variety of 
viruses have all been reported to increase soft agar growth 
(146). Cells grown in agar which form colonies may be 
subcultured on conventional culture plates by removing 
colonies from the agar with finely drawn pipettes producing 
a colony of cells derived from a single cell. Such cells 
when grown as monolayer cultures in vitro and replated in 
soft agar show a high plating efficiency between 40% and 
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70%. Even cells that do not form coloni~~s re1na in viable in 
soft agar suspension as manifest by their ability to absorb 
neutral red after 10 days (147). Salmon and Buick have 
described a methodology for fixing colonies in soft agars 
and drying them onto microscopic slides for permanent 
preservation and staining (148). 
Normal cells do not multiply in liquid or semi-solid 
suspension cultures. Cancer cells and some cell lines 
derived from normal tissue but carried through many 
generations will grow in suspension. Also, some virus 
"transformed" cells will grow in semi-solid suspensions 
(149). MacPherson, in 1964, first used this property of 
growth in suspension as an in vitro test of malignancy by 
culturing cells in soft agar (150). Since that time, many 
investigators have reported a good correlation between 
biological potential of malignancy as manifested by growth 
and tumor formation in an appropriate animal host and 
anchorage independent gcowth and colony formation in soft 
agar. Colburn et al, studied transformation in BALB/C mouse 
epidermal cells following treatment with chemical 
carcinogens, and reported a strong correlation between 
anchorage independent growth and tumor formation in 
syngeneic mice (151). Montesano et al compared cytology, 
production of plasminogen activator and soft agar growth of 
22 tumors and non-tumorigenic rat liver epithelial cultures 
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(152). There was a poor correlation of tumorigenicity with 
plasminogen activator production, but a good correlation 
with anchorage independent growth, although Marshall et al, 
reported two tumors derived from human bladder carcinoma 
that were nontumorigenic in nude mice, but which grew in 
soft agar, and one cell line that grew in the nude mouse, 
but would not clone in soft agar (153). Dexter et al, 
reported a complete loss of soft agar growth when cells were 
plated in the presence of polar solvents 
(N,N-Dimethyl-formamide) (154). No tumors were produced in 
nude mice inoculated with treated cells. Removal of polar 
solvents from the culture media resulted in appearance of 
anchorage independent growth. Courtenay et al attempted to 
culture 40 fresh human tumors from a variety of tissues in 
soft agar. Colonies were noted in 22 soft agar cultures 
with a plating efficiency varying from 0.02 to 15% (155). 
More recently, Salmon et al has used soft agar growth as a 
mechanism of quantitation of differential sensitivity of 
human tumor cells to anticancer drugs (156). 
8. FIBRONECTIN 
In 1948 Morrison et al isolated a cold-insoluble 
globulin (CIG) from h·uman plasma .. Since that time, CIG has 
been noted to have a wide variety of blological activities, 
and it has acquired a considerable number of synonyms 
including cell surface protein, large external 
transformation sensitive protein (LETS), and fibronectin, 
which is derived fr-om the Latin "fibra" meaning tn l)ind or 
tie, and which characterizes its biofunctional properti~s 
{157). 
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?ibronectin is a major cell sur-face glycoprotein with a 
molecular weight of 220,000 daltons (158), and exists as? 
dimer cross-linked by a disulfide bridge. It constitutes 
about 3% of the total cell protein (159). The plasma and 
cell forms differ slightly. Fibronectin is found in the 
human plasma at a concentration of 0.3 mg/ml. 
The carbohydrate portion of the molecule consists of 
4-6 oligo-saccharides with terminal galactose, sialic acid 
and fucose linked by N-glycosidic bonds to asparagine. It 
is not necessary for synthesis, processing or secretion, but 
appears to protect the molecule from rapid degradation. The 
half life of fibronectin is 36 hours, and cell 
concentration is highest in the G phase of the cell cycle, 
and lowest during mitosis. The diffusion constant for 
fibronectin is 5x1s-12 cm2/sec., indicating a relatively 
immobile molecule on the cell surface (160). 
Fibronectin is an integral part of adhesion plaques 
forming an interface between the cell and the substratum 
(161), and its secretion by the cell is both time and 
temperature dependent. 
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Fibronectin is responsible for cell-cell and 
cell-substrate interaction, for maintenance of normal cell 
morphology (162). It will also agglutinate sheep 
erythrocytes in vitro. Agglutinating activity is destroyed 
by proteases, chelating agents or boiling. Tumorigenicity 
of cells transplanted into nude mice also correlates witn 
decreased fibronectin (163). 
There is a decrease in m-RNA for fibronectin, and 
therefore a decreased biosynthesis in transformed cells, 
although Yamada and Olden reported no decrease in 
fibronectin .in 12 of 89 transformed cell lines (164). 
Transformed cell lines and permanent (immortal) cell lines 
required plasma fibronectin for substratum adhesion, but 
cell strains attacheJ and spread in the absence of 
exogenous fibronectin (165). Addition of fibronectin 
restores cell spreading and normal morphology to 
transformed cells. This restoration of more normal 
cellular behavior and morphology is prevented by the 
presence of anti-fibronectin (166). 
9. IN VIVO GROWTH IN THE NUDE MOUSE 
In addition to the progress made in in vitro 
propagation of human tumors, progress has also been made in 
the in vivo establishment and propagation of such tumors. 
Several in vivo methodologies have been explored, including 
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the use of thymectomized and cadiated mice oc the tceatment 
of cecipient animals with antilymphocyte secum. A 
particularly useful mechanism was described in 1969 by 
Rygaard and Povlsen using a congenitally athymic mutant 
"nude" mouse {167). Since their original description, 
numerous reports have appeared using the nude mouse as a 
mechanism for establishing or serially passing human or 
animal tumors. Shimosato et al, histologically confirmed 
an initial transplant "take" in 22 of 91 human tumors, and 
successfully serially transplanted 14 {168). Fogh et al 
reported growth of 127 cultured.human tumors in the nude 
mouse (169). Stiles noted that every tumor cell line that 
was tumorigenic in some other animal host or of neoplastic 
origin was also tumorigenic in the nude mouse. Some human 
tumors that have been particularly difficult to establish in 
tissue culture have been established in the nude mouse 
(170). Bastert reported growth in the nude mouse of 85% of 
44 human breast cancers (171 ). 
Morphology of the original tumor is generally 
maintained, {172), although scirrhous tumors such as 
stomach and breast tend to become medullary with a deccease 
in the amount of tumor stroma. Some tumocs may exhibit a 
higher degree of differentiation Jn the nude mouse than in 
the original tumor {173). Production of tumor products such 
as mucin in gastric carcinomas or melanin in malignant 
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melanomas as well as ectopic hormone production 
(adcenocorticotropin) is maintaine<l in the nude mouse 
tcansplants (174). Tumor anti~enicity and karyotype are 
also 1naintained (175). Altnough normal tissue (skin, etc.) 
can readily be transplanted onto the nude mouse, normal 
cells or grafts do not produce tumors (176). Stiles 
suggests that this is a response to host mediated 
growth-regulatory signals (177). Tne "Nu" gene has been 
successfully bre<i into a number of different genetic 
backgrounds including BALB/C, C3H and C57/BL with a similar 
effect in the acceptance of heterotransplants (178). 
The nude mouse is apparently not without some defense 
in terms of tumor metastasis, despite its T-cell and 
humoral immunodeficiency. Despite the growth of heterotrans-
planted tumors in the nude mouse, metastases are uncommon 
(179). Shimosato (180) noted metastases in only one of 22 
transplanted human tumors, and Kullander (181) noted no 
metastases in 10 tumors in nude mice. Graham noted 
metastases following injection of human T-cells into nude 
mice with human malignant transitional bladder carcinomas 
or prostatic adenocarcinoma (182). Control animals not 
receiving T-cells did not develop metastasis. warner 
reported a radiation sensitive non-T-cell surveillance 
system against lymphoid tumors in the nude mouse (183). 
Rygaard noted a considerable cytotoxic antibody response to 
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heterograft stimulus, but not to allografts. Yet, 
heterografts were more readily accepted than allografts 
(l84). Cheers reported an augmented macrophage response in 
the nude mouse (185). 
Another interesting apparent paradox of the nude mouse 
is the relative sparsity of spontaneous neoplasms. Machado 
noted one spontaneous neoplasm in over 1000 nude mice, in an 
animal that had received a neonatal thymus transplant, and 
Rygaard noted no neoplasms in over 11,000 nude mice (186). 
This lack of malignant neoplasms in an animal lacking a 
T-cell mediated immunologic system has been used as a 
strong argument against the immunosurveillance theory as 
proposed by Thomas. 
C-type particles that have been repeatedly noted in 
other mice strains are also present in the nude mouse. 
Tralka reported a spontaneous lymphosarcoma in a nude mouse 
with no C-type particles visualized in the primary tumor by 
electron microscopy, but abundant C-type particles were 
present in the in vitro cultured cells (187). Tumors 
developed in nude mice injected with tumor, but again no 
C-type particles were noted in the transplanted tumo~ 
suggesting some type of in vitro suppression or control of 
virus expression in vivo. Suzuki•reported the presence of 
C-type particles in 6 of 9 human tumors transplanted into 
the nude mouse. Other human tumors could be readily 
infected by co-cultivation (188). 
Growth of tumor in the nude mouse or other 
immunodeficient or syngenic (to the tumor) animals is 
unquestionably the most stringent criterion of 
tumorigenicity for in vitro cultured cells. The 
development of the nude mouse is a significant advancement 
in tumor biology. 
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CHAPTER III 
MATERIALS AND METHODS 
A. CELL CULTURES 
1. PREPARATION OF PRIMARY CULTURES 
Finely minced pieces of tissue, obtained from a biopsy 
of a metastatic lesion in the right inguinal lymph node were 
placed in complete medium, CM, (RPMI 1640, KC Biological; 
Lenexa, KS; o~ Grand Island Biological Co. supplemented with 
15% fetal calf serum, 2 mM 1-glutamine (GIPCO), 100 U 
Penicillin/ml (GIPCO), 100 g streptomycin/m1 (GIPCO), 
and/or 100 g kanamycin/ml), and incubated at 37oc in 5% 
C02. 95% air. Fibroblast growth was antagonized by periodic 
scraping of the flask under microscopic visualization with a 
sterile cotton-tipped Pasteur pipette. Repeated mechanical 
removal of fibroblasts eventually allowed the development 
of a confluent epithelial monolayer. Cells were cultured in 
25 cm2 (T-30) and 75 cm2 (T-250), Corning tissue culture 
flasks (Corning Glass, Corning, N.Y.). Feeding consisted 
of CM (15 ml for 75 cm2, 5 ml for 25 cm2), when cultures 
became acidic as indicated by a color change in the media 
{phenophthaline) - generally every three days. The 
epithelial cell monolayer isolated was designated LT-2. 
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2. SUBCULTIVATION 
Media was removed; the monolayers wash·~~ with 5 ml of 
ca++ and Mg++ free PBS; followed by 3 ml of 0.02% EDTA 
(Mallincrodt); followed by incubation for 20 to 30 minutes 
with 2 ml of 0.02% EDTA and 2 ml of 0.25% trypsin (GIPCO, 
Grand Island, N.Y.). Once the cells became detached 5 ml of 
CM were added and the cells were centrifuged at 1200 rpm 
for 10 minutes (400 x g.Model TJ-6, Beckman Instruments, 
Fullerton, CA), resuspended in CM and placed in culture 
flasks. The flasks were labeled, dated, and the passage 
number recorded. A confluent 75 cm2 monolayer generally 
yielded between 5-14 x 106 LT-2 cells. During 
subcultivation these cells were generally split into two 
flasks with 15 ml CM each. 
3. CELL COUNT AND VIABILITY 
Washed cells were obtained as above, suspended in 5 to 
10 ml of complete media, and a 0.05 ml aliquot mixed with 
0.05 ml of 0.4% trypan blue in normal saline (Matheson, 
Coleman and Bell; Norwood, OH) and placed in a 
hemocytometer counting chamber (Scientific Products; McGraw 
Park, IL). The viable (non-staining cells) were counted, 
and the number of ce1ls/ml calculated as follows: No. 
cells counted/mm2 (at least 100) x 104 x dilution factor = 
No. cells/ml. 
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4. FREEZING AND TrlAWING 
Cells from confluent flasks (75 cm2) were collected as 
above, washed with ta++ and Mg++ free PBS, and resuspended 
in 1 ml of CM with 10% DMSO (Fisher Scientific Co.; 
Fairlawn, NJ). Cells were placed in 1 ml vials (Wheaton 
scientific, Millville, NJ) and sealed using a propane torch. 
The cells were then slowly frozen (about 1°C/min.) in the 
freezer core in the vapor phase (BF-5 biological freezer 
assembly) of a LD-30 Linde liquid nitrogen container (Union 
carbide Co., Linde Products, Indianapolis, IN) and stored in 
the liquid nitrogen tank at -7ooc. 
Cells were thawed by placing frozen vials in a water 
bath at 37°C with shaking until melting occurred. The 
glass vial neck was cleansed with alcohol, broken and the 
contents placed in 10 ml of pre-warmed (37oC) CM, 
centrifuged (1200 RPM x 10 min.) and the pellet resuspended 
in 10 ml of CM and placed in culture flasks. Viability was 
generally about 80%. 
5. PLATING EFFICIENCY 
Monolayer cultures of LT-2 were harvested (T/E), 
washed in CM, centrifuged, resuspended in CM and plated at 6 
x 105 V. cells in 5 ml CM per flask in 25 cm2 tissue culture 
flasks. Cells were harvested at 2, 4 and 6 hour intervals 
after washing x 2 with PBS without ca++ and Mg++, 2 ml 
49 
versene followed by 2 ml Versene with 2 ml trypsin, incu-
bated for 60 minutes at 37oc, neutralized with CM, centri-
fuged and an aliquot diluted 1:1 with trypan blue and 
counted on a hemocytometer. The procedure was repeated at 
2, 4 and 6 hours. A repeat experiment plated 4.25 x 106 v. 
LT-2 cells per flask, processed as described abov~, except 
that cells were incubated for 30 minutes at 37°C with or 
without 100 mg/ml mitomycin C per flask; were harvested at 
2, 4, 6 and 24 hours and counted. 
6. ACETO-ORCEIN STAINING OF CELLS 
LT-2 cultures were tested for the presence of Myco-
plasma by evaluation of aceto-orcein (GIPCO) staining of 
Leighton tube (Wheaton Scientific, Millville, NJ) monolayers 
subjected to hypotonic treatment as described by Fogh (189). 
7. OTHER CELL LINES AND STRAINS 
Other cell lines and strains used in studies include: 
AU-471, a human cervical carcinoma cell line obtained from 
Doctor Walter Nelson-Rees, Naval Biomedical Research Labora-
tory, Oakland, CA; WI-38, a near diploid "normal" lung fi-
broblast cell strain obtained from The American Type Culture 
Collection, Rockville·, MD; AT-264; a lung carcinoma cell 
line kindly provided by Doctor Mira Menon, Hines 
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veteran Administration Hospital, Chicago, IL; MS, a diploid 
fetal fibroblast cell line cultured from an abortion ctt 
Loyola University, Stritch School of Medicine, Chicago, IL; 
sHK-21, a baby hamster kidney cell line kindly provided by 
ooctor Eugene Major, Loyola University, Stritch School of 
Medicine, Chicago, IL; LT-4, a normal human cell strain 
isolated at Loyola University, Stritch School of Medicine, 
Chicago, IL. Cell numbers in all experiments represent 
viable cells determined by trypan blue exclusion. 
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TUMOH-HOST INTERACTIONS: IN VITRO 
1. ISOLATION OF LYMPrlOCYTES 
Peripheral blood was collected by venipuncture into 
heparin containing tubes which were immediately mixed. 
Five (5) ml of blood were gently laye~ed on top of 3 ml of 
Ficoll-Hypaque (Lymphoprep, Nyegaard Ans. Co.r Oslo, Norway) 
in sterile tubes and centrifuged at 400 x g. (1400 rpm) for 
20 minutes (190). The supernatant plasma was removed and 
frozen, and the interface layer of lymphocytes was removed 
with a Pasteur pipette. The lymphocytes were washed with 
ca++ and Mg++ free PBS, and re-centrifuged 1200 x g. for 5 
minutes. The cell pellet was resuspended in 5 ml of PBS 
and an aliquot counted in a hemocytometer. 
2. DETERMINATION OF T AND 8 CELL POPULATIONS 
Sheep red blood cells (SRBC) were stored at 40°C in 
Alsevar's Solution (1:1), and used within 7 to 10 days of 
delivery. Before use, the cells were washed x3 and 
adjusted to a 0.5% suspension in PBS. Two populations of 
T-RFC were measured: the first termed the total T-RFC, 
representing all T-cells in the peripheral blood; the second 
called the active T-RFC, representing a subpopulation of the 
total T-cells that 1) may have an active surveillance 
function, and/or 2) be an index of cellular immunity (191). 
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'1' cells were evaluated by the formation of spontaneous 
rosettes by mononuclear peripheral blood lymphocytes (PBL) 
with unsensitized SRHC. As a measure of the total T-RFC 
population, 0.25 ml (5 x 105) PJHJ WPr"i~ ~'1iX·2d with 0.25 I'll 1>f. 
o.5% unsensitized SRBC (a final SRBC: PBL ratio of 40:1) and 
centrifuged at room temperature for five minutes at 200 x g, 
and then incubated in an ice-water bath at 4-8°C for 60 
minutes. After the cell pellet was gently resuspended, a 
drop of suspension was placed onto a hemocytometer and the 
number of rosettes (3 or more SRBC surrounding a 
lymphocyte) were counted. All tests were performed in 
duplicate and 200 or more lymp~ocytes were counted to 
determine the percentage of total T-RFC. 
To measure the active T-RFC, a modification of the 
procedure of Wybran et al (192), was used: 0.25 ml (5 x 105 
PBL) was mixed with 0.25 ml of 0.5% unsensitized SRBC and 
centrifuged immediately at room temperature for five 
minutes at 200 x g. The cell pellet was gently resuspended 
and a drop of the suspension was placed onto a hemocytometer 
and the number of active T-RFC counted. 
B-cells were determined by an 
erythrocyte-antibody-complement (EAC) rosetting technique. 
Five ml of a 5% solution of washed unsensitized SRBC was 
incubated for 30 'minutes at 37oc with 5 ml of rabbit 
anti-SRBC sera diluted 1/2500 in PBS. The cells were 
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~ashed three times, and resuspended in 5 ml of PBS. Five 
ml of a 1/10 dilution of mouse sera was added, and the 
suspension was incubated for 30 minutes in a 37°C ~ater 
bath. The sensitized SRBC were washed, and adjusted to a 
o.5% final concentration in PBS containing 0.01 M Na3HEDTA. 
For the B-RFC assay, 0.25 ml (5 x 105) PBL was ~ixed 
~ith 0.25 ml of 0.5% sensitized SRBC, centrifuged at 200 ~ 
g. for two minutes at room temperature, and then incubated 
for 30 minutes in a 37°C water bath. The cell pellet was 
resuspended by vigorous mixing, and the B-RFC were counted 
as described before. When unsensitized SRBC were tested as 
controls, no or few rosettes w~re formed. 
3. LYMPHOCYTE-MEDIATED CYTOTOXICITY (LMC) 
LMC of patient and control lymphocytes versus cultured 
tumor cells was determined by the chromium release assay 
(CRA) described by Brunner, et al (193). 
Briefly, 5 x 105 patient or control lymphocytes in 0.5 
ml HEPES buffered complete medium with 15% fetal calf 
serum, patient plasma or control plasma were incubated with 
104 51cr-labeled tumor cells in 0.5 ml complete medium with 
the corresponding serum or plasma (50:1 effector/target) 5 
to 7 hours at 37°C in a C~2 incubator. Total count and 
blank tubes contained labeled tumor cells in a 1 ml complete 
medium with the appropriate seru1n or plasma without 
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lymphocytes: 0.1 ml 10% Triton X-100 was added to each total 
count tube.- All determinations were made in triplicate or 
quadruplicate. 
After incubation, tubes were centrifuged at 400 x g. 
for 10 minutes and an aliquot of the supernatant was assayed 
for radioactivity in an automated gamma spectrophotometer. 
Lymphocyte-mediated cytotoxicity of samples was determined 
by the expression: 
CPM Sample - CPM blank 
-------· .. -·.- --------
%LMC = X 100. 
CPM total count - CPM blank 
4. DETERMINATION OF LYMPHOBLAST 'rRANSFORMATION 
Lymphocytes were obtained from heparinized blood as 
described above and 5 x 105 of these cells were incubated 
in complete medium with 15% fetal calf serum, patient 
. 
plasma or control plasma with 0.1 ml PBS, phytohemagglutinin 
(PHA-P, Difco Labs; full-strength or 1:10 dilution), a cell 
KCl extract (100 meg or 1 meg), or 104 mitomycin C-treated 
LT-2 cells at 37°C in a C02 incubator. 
After 48 hours incubation 1~Ci 3H-thymidine (2 Ci/mM, 
New England Nuclear Corp.) was added to each tube. After an 
additional 24 hours incubation, the reaction was stopped by 
transferring the tubes to a refrigerator, DNA was 
55 
~recipitated with trichloroacetic acid (TCA), the 
precipitate was washed with PBS, centrifuged, and 
resuspended in NCS solubil izer ( Amer.;3ha;n/Searle Corp., 
Arlington Heights, IL) and the resultant solution was 
transferred to scintillation vials in 10 ml Bray's solution 
with Triton X-100. Radioactivity in the vials was assayed 
in a Packard Tri-Carb automatic refrigerated liquid 
scintillation counter. 
Lymphoblast transformation was ascertained from the 
relative 3H-thymidine uptake by lymphocytes, represented by 
a stimulation index calculated from the ratio of CPM in 
sample vials to CPM in PBS control vials. Quench was found 
to be invariable among samples with 5%. Samples were 
assayed in triplicate or quadruplicate. 
c. TUMOR-HOST IN'rERATIONS: IU VIVO 
• > •• - •• - • ---
1. SKIN TESTS 
General and specific delayed type hypersensitivity of 
the patient was determined by intradermal injection on the 
flexar aspect of the forearms of the patient with 0.1 ml 
streptokinase/streptodornase (50 units with respect to 
streptokinase in 0.1 ml (Lederle Lab., Pearl River, NY), 
dermatophytin (0.1 ml of a 1/30 dilution, Hollister-Stier 
Lab., Spokane, WA), dermatophytin-0 (0.1 ml of a 1/100 
dilution, Hollister-Stier Lab.), PPD (0.1 ml intermediate 
strength, Parke Davis, Detroit, MI), mumps (0.1 ml, Eli 
Lilly, Indianapolis, IN), and 0.1 ml LT-2 KC1 extract 
(sterilized by filtration; 
100 ,;cg and lAg protein/0.1 ml). DNCB (2000 and SO_)A..g in 
acetone, Eastman Organic Chemical Co., Rochester, NY) 
challenge was accomplished by allowing test samples to 
evaporate on a 25 to 30 mm3 area of skin on the forearm. 
At least 10 mm of induration at 48 hours after challenge 
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with microbial antigens was considered a positive skin test 
response. For DNCB the reaction was evaluated by retest at 
14 days. A flare at both the 2000~g and 50Mg sites was 
scored as a 4+ reactivity; at only the 2000 ~g site as 3+; 
a positive flare to only a repeat application of SO~g on 
the opposite forearm evaluated at 48 was scored 2+. In 
practice, a 3+ or 4+ reactive score is considered normal 
(positive DNC3 reaction). 
2. PREPARA'riON Of KC 1 EXTHAC'rS 
L'l'-2 monolayers consistinlJ vf i>~~tween 6 to 14 x 106 
cells were harvested using either 3M KCl or 0.081% EDTA in 
25 mm HEPES buffer, followed by centrifugation and 
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resuspension in 3M KCl. The KCl suspensions were rocked at 
4oc overnight and then centrifuged at 163,000 x g. for 60 
minutes at 4°C in a Beckman Ultra-centrifuge. The 
supernatants· were filtered, concentrated (PM-10 membranes), 
dialyzed against three changes of 200 volumes of normal 
saline at 4°C for 24 hours, centrifuged at 1,500 x g. for 20 
minutes at 4°C, lyophilized and reconstituted in 2 ml of PRS 
and the protein concentration measured by the Lowrey method. 
The extract was filtered through 0.2 ~pore size Gelman 
filters and stored in glass vials at -75°C. Skin testing 
consisted of the intradermal injection of 0.1 ml of the 
above preparation, and 0.1 ml of PBS on the volar skin of 
the forearm. The autologous tumor skin test was read at 48 
and 72 hours. 
3. BCG IMMUNOTHERAPY 
The patient received four BCG immunizations over a five 
month period, commencing 46 days after the lesion in the 
right inguinal lymph node was biopsied. For the first 
immunization, 3 to 5 x 108 lyophilized viable Chicago 
strain organisms were reconstituted with 0.5 ml sterile 
saline and 0.2 ml (1.2-2.0 x 106 viable organisms} was 
injected into one site of the lesion. 
Three additional immunizations were given, 
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administered at one month intervals following the first 
injection. For the second and third immunizations, the 
contents of one ampule were reconstituted with 1 ml sterile 
water followed by a 100-fold dilution; 0.2 ml (0.6-1.0 x 106 
viable organisms} was injected intralesionally, in six 
sites for the second immunization and in one site for the 
third immunization. For the final immunization, one ampule 
was reconstituted with 0.5 ml sterile water and this 
suspension was spread over an area of the anterior right 
thigh: 72 puncture wounds were made in this area by 
applying a 36-tine instrument to two adjacent sites. 
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o. CELL CHARACTERIZATION AND TUNOR PROPERTIES 
1. ELECTRON MICROSCOPY 
A portion of a nude mouse nodule (see below) and cells 
harvested from monolayer cultures were fixed in 2.5% 
glutaraldehyde in PBS at 4ooc overnight and post-fixed in 
osmic acid one hour at room temperature. The fixed 
specimens were then carried through graded alcohol 
dehydration and embedding in Araldite. Electron microscopy 
procedures were performed by Doctor Emilio Orfei, 
Department of Pathology, .Loyola University Medical Center, 
Chicago, IL. 
2. KARYOTYPING 
Karyotyping was done by a modification of the method 
of Hsu (194). Briefly, colchicine 1o-6M (BBL) in CM was 
added to an LT-2 monolayer and incubated for five hours at 
37°C. An EDTA-HEPES-harvested single-cell suspension was 
counted, centrifuged at 300 x g. for 10 minutes and 
resuspended in hypotonic KCl (71mM) at a concentration of 
104 cells/ml. Following a 20 minute incubation at 37oc the 
cells were again centrifuged and resuspended in a 10 ml 
freshly prepared absolute methanol-glacial acetic acid 
(3:1). The cells were centrifuged, the supernatant 
decanted, the pellet left overnight at 4oc, and resuspended 
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in a 2 ml methanol-acetic acid fixative. The cell 
suspension was dropped onto slides, framed, allowed to dry, 
and stained with Giemsa (for 7 to 9 minutes). Mitotic 
figures were observed and photographed through a Zeiss 
microscope at 1000 x magnification. 
3. DETERMINATION OF GENERATION TIME 
Two confluent 75 cm2 culture flasks (approximately 
17.6 x 106 cells, 96% V.) were harvested, washed and 
resuspended in CM and distributed equally among twenty 25 
cm2 culture flasks (8.5 x 10S cells per flask). Adherent 
cells were harvested from quadruplicate flasks after 27 
hours, 46.5 hours, 72 hours, 97 hours and 118 hours. The 
single-cell suspension was centrifuged at 300 x g. for ten 
minutes and the pellet was resuspended in 0.5 ml phosphate 
buffered saline (PBS), diluted with an equal volume of 0.4% 
trypan blue stain in normal saline and counted in a 
hemocytometer. The log of the number of viable cells (N) 
was plotted against time in hours. Based on the relation 
log N= 0 -~~ 1 t +log No. The doubling time (to) during the 
logarithmic growth phase of the cells was determined from 
the slope (0.301/to) of the linear growth curve. 
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4. TIME-LAPSE"CINEMATOGRAPHY 
Time-lapse cinematography was done using a Nikon model 
M inverted phase co~trast microscope with Matthias 
time-lapse control unit and Bolex camera and incubation 
chamber with heater and a Precision Scientific air/C02 
blender. This equipment was used courtesy of Doctor George 
Willbanks, Chairman, Department of Obstetrics and 
Gynecology, Presbyterian-St. Lukes Medical School, Chicago, 
IL). Kodak Plus-X reversal film 7276 (400ft., 16mm-B 
wind) was exposed for one second at two frames per minute 
at 200 x magnification, (about 40.18 frames/ft.). Two 
separate filmings of LT-2 and one of AU-471 were done. 
5. SATURATION DENSITY 
L'f-2, AU-471 and WI-38 monolayer cultures were 
harvested; washed and resuspended each in 5 ml PBS; the 
cells counted, centrifuged, and adjusted to a concentration 
of 5 x 105 cells/ml' in RPMI-1640 with 15% FCS; and plated in 
24 well cluster dishes, Costar, (0.1 ml/well with 5 x 104 
viable cells). Only the inner eight wells of each 24 cell 
cluster plate were used for culture. The outer wells were 
filled with sterile H20. Each well has a 16 mm diameter or 
an area of 2.011 cm2/well. Three cultures (24 total wells) 
were used for each cell type. Cultures were fed 
periodically with CM (1 ml/well). One well from each of 
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three plates was harvested serially, and the cells counted, 
and scored for viability. The cell density was expressed 
as the number of cells per cm2. 
6. DENSITY DEPENDENT INHIBITION OF CELL DIVISION OF 
L:r_-:_2, AU-471 and WI-38_ CELL LINES 
Eighteen Leighton tubes with cover slips (Wheaton 
scientific, Millville, NJ) were autoclaved. Three groups 
of six tubes each were seeded with 5 x 104 viable cells per 
tube with LT-2, AU-471 and WI-38. When the cover slips were 
noted to be partially confluent, two tubes from each set 
were harvested, fixed in acetone for five minutes, stained 
with aceto-orcein for five minutes and counterstained with 
Giemsa for five minutes. The remaining four cultures were 
then refed with colchicine 10-6 M in CM, and two tubes 
harvested at 24 and 48 hours, fixed and stained as above. 
Photographs were taken of appropriate areas to locate the 
position of dividing cells in moderate sized colonies. 
7. SURFACE ANTIGENS: ABH 
LT-2 was harvested (Pas. 30, 92% V.), washed, counted 
and resuspended at 5 x 106 cells/ml. Twenty-five ~1 
aliquots were mixed with 0.025 ml of an agglutinogen 
consisting of: Anti-Rho, Anti-RhC, Anti-A, Anti-B, Anti-H 
substance. Tne antiseras and cells were incubated at both 
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2soc and 32°C for ten minutes. Controls with LT-2 and 0.025 
ml of PBS were also used to assay for "spontaneous" aggluti-
nation. 
8. HETEROPHILE ANTIGEN 
LT-2 monolayers were washed with PBS without Mg++ and 
ca++ and x3 with 5 ml of Versene. They were incubated with 
versene until cells became detached or harvested in a rou-
tine manner (as described above) using trypsin and EDTA. 
They were washed with PBS, centrifuged and resuspended at 5 
x 106 cells/ml in PBS with Mg++ and ca++. AU-471 was pro-
cessed similarly. 
Infectious mononucleosis positive and negative human 
serum was obtained (courtesy of Doctor Ken Thompson, Loyola 
University Clinical Microbiology Laboratory, Chicago, IL), 
and normal rabbit serum were mixed (0.025 ml). Each were 
incubated at 7oc for 1 and 2 hours, and evaluated for ag-
glutination. 
9. ASSAY FOR CEA AND hCG 
Two days after nutrient media changes, spent media from 
LT-2 cultures (subsequently harvested with 0.01% 
Na2EDTA/0.125% trypsin for counting of single cells) was 
filtered through 0.2 micron pore size Nalgene disposable 
filter units. Most of this filtered spent media was con-
centrated to approximately 1/Tth or 1/4th of its original 
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volume through a PM-10 membrane in an Amicon ultrafiltration 
unit. An equal quantity of unused complete media was 
treated in an identical fashion. Sa~ples of spent media, 
7-times concentrated spent media, 14-times concentrated 
spent media, and corresponding samples of unused complete 
media were assayed for CEA, hCG, and/.1-hCG-subunit. 
Carcinoembryonic antigen (CEA) in the above samples 
was determined by the Foster G. McGaw Hospital Nuclear 
Medicine Department, Chicago, IL, under the direction of 
Doctor Robert Henkin, using the CEA-Roche test kit (Roche 
Diagnostics, Nutley, NJ). Radioimmuno-assay for hCG/LH 
and/.1-hCG-subunit was performed by the John I. Brewer, Cho-
riocarcinoma Research and Treatment Center, Northwestern 
University Cancer Center, Northwestern University Medical 
Center, Chicago, IL. The rate, r, of ~-hCG or CEA produc-
tion (ng/106 cells/day) by LT-2 was approximated as 
(ng/ml assayed}(concentration factor) x 10 ml/flask 
r = (3 x 106 cells/flask average) x 2 days 
10. SERUM DEPENDENCE 
Serum dependence was evaluated for LT-2, AU-471 and WI-
38. Two separate experiments were performed. In the 
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first experiment LT-2, AU-471 and WI-38 were plated in 10%, 
1%, 0.01% and 0% FCS at 1.5 x 105 viable cells per well in 
24 cluster plates (Costar, Cambridge, MA) in triplicate. 
only the inner eight wells of any given 24 well plate were 
used. Duplicate plates with each cell type were plated in 
15% FCS, incubated overnight, and the media aspirated. 
culture wells were washed once and then refed with CM with 
the varying concentration of FCS as noted above. Plates 
were harvested (T/E) four days later, and cells counted 
using a Coulter counter (Coulter Electronics Inc., Elk Grove 
Village, IL). 
A similar experiment was repeated using triplicate 
cultures plated in the appropriate serum concentration 
using AU-471 and LT-2 with cultures harvested six days 
after plating and then counted on a hemocytometer. 
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GROWrH IN SOFT AGAR: ANCHORAGE INDEPENDENT GRO~~H 
-·------------
1. EPIGENETIC FACTORS 
Tumor cell growth in soft agar is a commonly used test 
for in vitro malignancy. It is based on the observation 
that nonmalignant epithelial cells do not grow in soft agar 
or in suspension, but require attachment to a surface 
before cell division will occur. Therefore, growth in soft 
agar (anchorage independence for cell division) is an 
"abnormal" property for a cell, and suggests a malignant 
biological potential. 
Soft agar assays were adopted from protocols of 
MacPherson and Montagnier (195) and also from Major and di 
Mayorca (196). Briefly, a "feeder agar" consisting of 0.5% 
Difco Bacto agar in RPMI-1640 with 10% tryptosephosphate 
broth (GIPCO), and antibiotics (consisting of either 
penicillin, 100 units/ml and streptomycin 100~/ml or 
kanamycin 100~g/ml or gentamycin 100~g/ml) was poured 
into 60 mm x 15 mm petri dishes (Flacon No. 1007) and 
allowed to solidify. Over this "hard" or "feeder agar" was 
poured 1.5 ml of 0.33% "soft agar" (prepared as for 0.5% 
agar above, but with less agar). Test cells were suspended 
in the soft agar. The cultures were maintained at 37°C in 
an atmosphere of ·5% C02, 95% air for 3 to 4 weeks, until 
visible colonies were scored and the test terminated. 
67 
2. SOLUBLE STIMULANTS OR INHIBITORS 
Anchorage independent growth in soft agar suspension is 
a frequently used i~ vitro criterion for malignancy as 
noted above. Yet, under usual conditions LT-2 would not 
clone in soft agar, but did fulfill most other criteria for 
malignancy including: continued growth in culture, growtn 
and tumor formation in nude mice, abnormal karyotype, (see 
below). Experiments were performed to determine whether 
LT-2 produced a soluble inhibitor that would prevent the 
growth of other tumors in soft agar culture, and conversely 
determine if. growth in soft agar could be stimulated by a 
soluble substance from tumor cells that grow well in soft 
agar as manifest by a high soft agar cloning efficiency. 
LT-2, AU-471 and WI-38 were used in these experiments. 
3. THE EFFECT OF LT-2 ON THE SOFT AGAR GROWTH AND 
CLONING OF AU-471 
In four experi~ents, viable LT-2 cells were treated 
with mitomycin C (100~g/ml CM), and incubated for 40 min-
utes at 37°C with shaking, washed 2 times with PBS and re-
suspended in CM. These mitomycin C treated LT-2 cells 
served as 11 feeder cells" to test for the presence of soluble 
factors that might stimulate or inhibit cloning in soft 
agar. Mitomycin C is an antibiotic produced by Streptomyces 
Verticillatus and is converted in a cell by reductive acti-
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vation to an alkylating agent that selectively inhibits DNA 
synth~sis (197). AU-471 served as test cells, and were 
plated at 5 x 102 or 2 x 103 cells per plate in soft agar 
in different experiments and mixed with increasing concen-
trations of LT-2 "feeder" cells (1 x 104 to 1 x 105 LT-2). 
AU-471 controls were plated at the appropriate concen-
tration without "feeder" cells to serve as a standard con-
trol, and LT-2 mitomycin C or nonmitomycin C LT-2 without 
AU-471 served as negative controls. LT-2 preplated onto the 
bottom of 60 mm culture plates with agar poured on top of 
the culture served as a LT-2 growth and viability control, 
and were scored negative.or positive for growth and viabil-
ity. AU-471 test plates and controls were scored on two oc-
casions. 
Two additional experiments were done using untreated 
LT-2 (non-mitomycin C) as "feeder" cells taking advantage of 
the fact that LT-2 will not clone in soft agar. In one ex-
periment, ten plates of 2 x 103 and 2 x 104 viable LT-2 
cells per plate (Pas. 21, 85% V.) were used as controls, 
and were also co-cultivated with AU-471 (AU-471:LT-2 at 1:1 
and 1:10 cells per plate (2 x 103 AU-471:2 x 103 LT-2 or 2 x 
103 AU-471:2 x 104 LT-2). Colonies were scored at day 14 
and 24. The other experiment used ten plates each of 2 x 
103 and 2 x 104 viable AU-471 per plate (Pas. 121, 90% V.) 
co-cultivated in soft agar with 1:5 or 1:50 ratio of AU-
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471:LT-2 per plate. Controls of ten plates of 2 x 103 and 2 
x 104 AU-471 without LT-2 and 105 LT-2 (Pas. 18, 99% V.) 
without AU-471 served as an LT-2 control. 
4. EFFECT OF AU-471 ON SOFT AGAR GROWTH OF AU-471 
Since an increase in cloning efficiency or "feeder ef-
teet" was noted in LT-2:AU-471 and also in WI-38:AU-471 co-
cultivation experiments, the effect of mitomycin C treated 
AU-471 on the cloning efficiency of untreated AU-471 was 
evaluated. The experiments were performed using 5 x 102 
(Pas. 112, 87% V.) and 2 x 103 (Pas. 126, 89% V.) AU-471 
test cells co-cultivated in soft agar with increasing con-
centrations (2 x 103 to 1 x 105 viable cells in different 
experiments) of mitomycin C treated AU-471 "feeder" cells. 
Controls consisted of untreated AU-471, mitomycin C treated 
AU-471 (no untreated cells) and pre-plated AU-471. 
5. EFFECT OF MITOMYCIN C TREATED AU-471 CO-CULTI-
VATED WITH LT-2 
The reverse experiment used five plates each of 2 x 104 
and 1 x 105 mitomycin C treated AU-471 "feeder" cells (Pas. 
122, 84% V.) with a comparable number of untreated LT-2 
cells (Pas. 28, 78% V.). Controls consisted of five plates 
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each of 2 x 104 and 1 x 105 LT-2 without AU-471 and 2 x 104 
and 1 x 105 mitomycin C treated (100.,u.g/ml CM for 40 minutes 
at 37oc with shaking) AU-471. 
6. EFFECT OF WI-38 ON 'l'HE SOFT AGAR GROW'fH AND 
CLONING OF AU-471 
A similar "feeder" experiment was done in order to 
determine the stimulatory or inhibitory effect of 
co-cultivation of varying concentrations of "normal" cells 
on the soft agar cloning efficiency of AU-471, to serve as 
a "normal" control. Five plates each of WI-38 (Pas. 26, 95% 
v.) with cell concentration of 2 x 104 and 1 x 105 viable 
WI-38 cells per plate were co-cultivated with 2 x 103 viable 
AU-471 (Pas. 121, 84% V.) in soft agar. Colonies were 
scored on days 14 and 22. Cloning efficiency was compared 
to ten plates of 2 x 103 control AU-471 per plate. Five 
plates each of WI-38 at 2 x 104 and 1 x 105 without AU-471 
served as controls. 
7. FIELD COUNT EXPERIMENTS ANO THE EFFECT OF 
MITOMYCIN C AND CYTOCH-AL-AS-{N- B- ON -L'f=--2GROWTH AND 
---------~ -- ·---- ····-- - . CLONISG IN SOFT AGAR 
Since LT-2 had been noted during time-lapse 
cinematography to be highly motile in tissue culture, 
experiments were performed to determine whether LT-2 was 
dividing in agar (or agarose), and the daughter cells 
moving apart forming single c~lls rather than developing 
into clones. To test this hypothesis, LT-2 was plated in 
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agar suspension (or agarose), and the number of cells per 
high power microscopic field (150x) were scored for five 
random fields in each of five agar culture plates. Similar 
"field counts" were repeated on two additional occasions one 
and two weeks later. 
One experiment consisted of five plates of 4 x 104 
viable LT-2 and five control plates of 100~g mitomycin C/ml 
with field counts on days 1, 8 and 23. Additional 
experiments were done to evaluate the effects of 
cytochalasin B on soft agar growth and cloning of LT-2. 
Cytochalasin B is known to inhibit cell movement, 
phagocytosis, and under appropriate conditions may produce 
cell enucleation. The probable mechanism of action is 
through disruption of microfilaments (198). Cytochalasin B 
was used at concentrations nE 1..)-l!J/ml and 5 _,4-<gjml CM and 
compared with similar field counts of the same plates at 
different time periods and/or to control plates of untreated 
or mitomycin-treated ( 100 ).J.g mitomycin C) LT-2 agar plates. 
Five ~g cytochalasin B has been shown to cause cell 
cytoplasmic retraction of spread cells with cell rounding 
. 
and inhibition of cell movement (199). 
8. THE EFFECT OF NEGATIVE AND POSITIVE 
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CHARGED IONS 
ON THE CLONING EFFICIENCY OF LT-2 
Heparin and other highly negatively charged molecules 
have been reported to reduce cloning efficiency in soft 
agar. Cell membranes are negatively charged and contact be-
tween normal cells generally results in contact inhibition 
of cell division. That ions in contact with the cell mem-
. 
brane in soft agar might result in a form of "contact inhi-
bition" preventing cell division was considered. This hy-
pothesis was evaluated using agarose. Agarose is a purified 
form of agar with many of the negatively charged ions re-
moved. Diethylaminoethy~ dextran which complexes with posi-
tively charged ions was also used to evaluate the effects of 
decreased positively charged ions. 
The concentration of the agar is important in evaluat-
ing anchorage independence since even "normal" fibroblasts 
will sometimes produce colonies in agar when the concentra-
tion of the agar is increased. Agar concentrations of 
0.33% give a semi-solid consistency. Apparently, cell 
growth and colony formation results from giving the cells a 
more solid surrounding for contact with the cell membrane. 
The consistency of pure agarose was noted to be some-
what different from that of agar (0.33% agar has a 
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semi-liquid consistency, but .033% agarose has a more solid 
consistency). Dilutions of agarose were made and their 
consistency (solid to semi-solid to'liquid) determined at 
various concentrations of agarose. A consistency of 
agarose of about 0.275% was chosen for the top agar with a 
feeder layer of 0.300% agarose giving a consisten~y similar 
to 0.3%/0.5% agar. Other experiments used 0.33% top agarose 
with 0.5% feeder agarose giving a more solid consistency 
similar to experiments with 1% DIFCO agar, or 0.1% top 
agarose with 0.15% bottom agarose giving a much more fluid 
agarose than the standard 0.33% "soft agar." 
The effect of cloning LT-2 in "soft agarose" was 
evaluated by plating five 60 mm TC plates with 1 x 105 
viable LT-2 cells per plate (Pas. 29, 80% V.) in 1.5 ml of 
0.275% agarose with 5 ml of 0.3% bottom or feeder agar. 
Five comparable control plates were preplated and overlayed 
with ag arose. 
One arm of the experiment combined both agarose and 
DEAE and consisted of three 60 mm TC with 1 x 105 viable 
LT-2 cells per plate (Pas. 31, 44% V.) with 22~g DEAE per 
ml top agar in agarose. 
A "hard agarose" experiment consisted of five 60 mm TC 
plates with 2 x 104 viable LT-2 per plate (Pas. 31, 44% V.) 
in 0.33% top agarose with 0.5% bottom agarose. Two 
additional 60 mm TC plates were plated with 1 x 105 viable 
LT-2 as above. 
A "softer" agarose experiment used 0.10% top agarose 
with 0.15% bottom agarose. Four 60 mm TC plates were each 
plated with 0.7 x 10S viable LT-2 (pooled flasks, 27% V.). 
comparable preplated viability controls were overlaid with 
agarose. 
Two experiments were done to evaluate the effect of 
oEAE on the soft agar cloning efficiency of LT-2. These 
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experiments consisted of five 60 mm TC plates each with 1 x 
10S viable LT-2 cells (Pas. 30, 38% V.) and (Pas, 23, 60% 
v.) plated with 30~g DEAE per ml soft agar as test plates 
with five comparable untreated control plates. In addition 
five plates were preplated with LT-2 as viability controls. 
9. EFFECT OF HEPES BUFFER ON LT-2 GROWTH IN SOFT 
AGAR 
The effect of HEPES buffer in cloning efficiency of 
LT-2 was evaluated using five 60 mm TC plates each with 1 x 
105 viable LT-2 (Pap. 31, 53% V.) with 30 mm HEPES with 
scoring for colony formation on days 16 and 23. 
10. EFFECTS OF CYCLIC GMP ON LT-2 GROWTH IN SOFT 
AGAR 
The effects of cyclic dibutyryl GMP (cGMP) on cloning 
of LT-2 in soft agar was evaluated using five 60 rnm TC 
Plates each with 1 x 105 viable LT-2 per plate (Pas. 32, 62% 
V.) with concentrations of cGMP of 10-9M, 1o-10M, 1o-11M 
With scoring for colonies on days 16 and 23. 
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11. THE EFFECT OF· ENZYME TREATMENT OF LT-2 ON CLONING 
IN SOFT AGAR 
The effect of digestive enzyme treatment of membrane 
molecules of LT-2 on the cloning efficiency using 
neuraminidase trypsin and a variety of carbohydrases was 
evaluated. 
a. NEURAMINIDASE 
A monolayer culture of LT-2 was harvested, (T/E), 
washed with PBS and the cells resuspended in 4 ml of PBS 
without Ca++ and Mg++ (4.35 x 106 cells; Pas. 31, 85% V). 
Two milliliter aliquots were placed in separate tubes, 
centrifuged and resuspended in 0.2 ml of PBS or PBS with 60 
units neuraminidase/ml and incubated with shaking for 60 
minutes at 37oc. Two 60 mm culture flasks with 1 x 105 
viable non-treated LT-2 (44% v. post-incubation) in soft 
agar served as controls. Three cultures contained .91 x 
105 neuraminidase treated LT-2 (53% V. post-incubation) and 
three additional soft agar cultures contained .91 x 105 
viable LT-2 treated with neuraminidase as above, but with 
the addition of 0.22fog DEAE per/ml of soft agar. All 
neuraminidase cultures also contained 50 units neuraminidase 
per/ml of soft agar. 
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b. CARBOHYDRASES 
A soft agar experiment was performed in order to deter-
mine the effect of a variety of enzymes specific for carbo-
hydrate substrates on anchorage independent growth. LT-2 
was harvested (T/E), neutralized with CM, centrifuged, 
counted (Pas. 24, 71.4% V.) and resuspended in 2 ml of PBS 
(without ca++ or Mg++), passed through a 50 ~mesh, counted 
on a hemocytometer with trypan blue and resuspended at 5 x 
106 viable cells per ml. Fifty microliter aliquots (2.5 x 
105 viable cells) were incubated at 37°C for one hour with 
0.2 ml of either: 0.6 or 6 mg B-glucosidase, 0.55 mgc<-D-
glucosidase, 0.75 and 0.075 mg chitinase, 1.25 units (2.75 
mg/ml) 0(-L-Fucosidase, 3 units (18 units per mg)o<D-mannosi-
dase or a mixture of all of the above enzymes. The incu-
bated mixtures were plated in soft agar. Final concentra-
tions in top agar were 1 ~g glucosidase, and 10~g B glu-
cosidase, 1 and 10~g chitinase, 0.25~g L Fucosidase; 1 ~ 
mannosidase per ml; and l~g of a mixture of all of the 
above per ml top agar. 
12. LT-2:AU-471 CO-CUL1'IVATION: EFFECT OF CELL CON-
TACT AND CELL LYSIS OF MITOMYCIN C AND UNTREATED 
LT-2 C£LLS 
The effect of LT-2:AU-471 cell contact or LT-2 cell 
lysis was compared in mitomycin C treated and untreated LT-
2 feeder cells. Six plates of AU-471 with 2 x 103 
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viable cells per plate were used as a control to determine 
cloning efficiency. Three plates were each co-cultured 
with: 2 x 103 viable AU-471 and 103 or 105 untreated or 
mitomycin C treated LT-2 (100~g/ml incubated for 40 min. at 
370C); 103 or 105 untreated or mitomycin C treated LT-2 
pelleted with AU-471 responder cells and then incubated for 
60 min. at 37oc in 5% C02; 103 or 105 untreated or mitomycin 
c treated LT-2 lysed by freeze thawing (zero percent 
viability as checked by trypan blue exclusion). Two prelate 
controls consisted of 10S v. LT-2 or 1.2 x 103 V. AU-471 
overlaid with 1.5 ml of 0.33% soft agar. A growth control 
for LT-2 consisted of 10S LT-2 plated alone in soft agar 
without AU-471. 
A repeat experiment was done as above except 104 and 
10S LT-2 cells were used instead of 103 and 10S in each of 
the arms of the experiment as described above. 
13. CONDITIONED MEDIA 
Filtered (0.2~ Nalgene) conditioned media taken from 
partial confluent monolayer cultures of LT-2 and AU-471 at 
24 hours and from MS at six days was used as "feeder" media. 
Five cultures of 1 x 103 viable AU-471 (Pas. 125, 83% V.) 
without conditioned media served as controls. Five plates 
each with 30% of .15% conditioned media from AU-471 (Pas. 
125), LT-2 (Pas. 50), and MS (Pas. 6) were substituted for 
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fresh media and were added.to 1 x 103 viable AU-471 cells in 
soft agar. Concentrations of tryptose phosphate broth, 
fetal calf serum and total media content (RPMI-1640) were 
kept constant. Two preplate controls of 1 x 103 viable 
AU-471 without conditioned media or with 30% conditioned 
media from AU-471, LT-2 or MS were also done. A total of 
43, 60 mm soft agar cultures were done. 
14. PROTEIN EXTRACT FROM AN ANCHORAGE INDEPENDENT 
CELL LINE 
Monolayer cultures of AU-471 were treated with 10 ml 
of 3M KCl for 10 minutes at 37°C; the flask content 
decanted into 50 ml tubes and rocked overnight at 4°C; 
centrifuged at 25,000 x g. for 90 min. at 4°C. The two 
supernatants were pooled and concentrated using an Amicon 
PM-10 membrane, the retentate dialyzed with normal saline x 
3, centrifuged at 1500 x g. at 4°C for 120 min. and filtered 
using 0.2 Nalgene f~lters. Protein content was estimated 
using the Wadell method. Three plates each with 1 x 10 
viable LT-2 (Pas. 43, 84% V.) were mixed with 20, 310 and 
1,000~g per plate of the protein extract with 12% PBS. 
Two AU-471 plates of untreated LT-2 controls and two 
preplate cultures were also done. A comparable set of 
cultures (13 plates) were done without FCS. 
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15. CELL CLUMPS IN SOFT AGAR 
L'r-2 had been noted to be relatively sensitive to 
plating at low cell densities. Therefore, studies were done 
in order to determine if cell-cell contact was necessary to 
initiate or stimulate anchorage independent growth in soft 
agar. Five separate experiments were performed consisting 
of 30 cultures and 8 preplate controls to evaluate cell 
viability. Two culture plates contained no cells to insure 
that as the agar dried that precipitants did not form 
visible clumps in agar. 105 viable LT-2 cells were plated 
in each culture as previously described, except that cells 
were not passed through 100 micron mesh filters to 
eliminate clumps. Small clumps of cells noted in the agar 
were circled and photographed serially. Photos were then 
compared to evaluate for enlargement of cell clumps 
indicating growth in soft agar. 
16. FIBRONECTIN 
The effect of fibronectin (FBN) and antifibronectin on 
anchorage independent (soft agar) cell growth and cloning 
was evaluated. The cancer cell lines AU-471 (clones in 
soft agar) and LT-2 (no clones in soft agar) were used. 
Three "normal" cell 1ines were also used: BHK-21 (clones 
in soft agar), WI-38 and MS (no clones in soft agar). 
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AU-471 was used to evaluate the effects of FBN on the 
cloning efficiency of a malignant tumor cell line that 
demonstrates anchorage independent growth. Four 
experiments were done. AU-471 (Pas. 121, 126, 127) 
monolayer cultures were harvested, washed, passed through 
an 80~nylon mesh and counted. Cells were divided into two 
aliquots and incubated for 30 minutes at 37°C with 100~g 
per ml FBN or PBS control in 2 ml volumes. The cells were 
then centrifuged, resuspended in PBS and four cultures were 
each plated with 2 x 103 v. AU-471 in 100 g/ml FBN or PBS 
per ml soft agar. One or two preplate cultures with or 
without FBN were also used as cell viability controls. 
Colonies were scored twice, generally at 2 and 4 weeks. 
The effect of FBN on soft agar cloning of LT-2 was 
cloned as an example of a malignant cell line (defined by 
tumor production in nude mice) that does not demonstrate 
anchorage independent cloning. Three experiments were dorie 
using LT-2 (Pas. 49', 41 , 61 ) • Monolayer cultures were 
harvested, washed, passed through 80 A. nylon mesh cultures, 
counted and incubated for 30 minutes at 37°C with 100~g of 
FBN or PBS in 2 ml volumes. The cells were centrifuged, 
resuspended in PBS and four plates each were seeded with 
x 104 v. cells in 100~g per ml FBN or PBS of soft agar. 
One or two preplates were also done and cultures scored as 
above. 
The effect of FBN on soft agar cloning of BHK-21 was 
done using BHK-21 as an example of a "benign" cell line 
that does demonstrate anchorage independent growth. The 
experiments were done using BHK-21 as described above. 
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The effects of FBN on soft agar cloning of WI-38 and 
MS were done using these cell lines as examples o~ "benign" 
cell lines that do not demonstrate anchorage independent 
growth. The experiments were done as described above. 
Heat inactivated (57oc for 60 minutes) Goat 
antifibronectin sera (GAFS} was used to determine the effect 
on anchorage independent growth and cloning of AU-471 and 
BHK-21. AU-471 (Pas. 123) and BHK-21 cells were harvested, 
washed, passed through an 80 M.... nylon mesh, counted and 
scored for viability, and 4 plates each with 2 x 103 v. 
AU-471 or BHK-21 were seeded in soft agar with GAFS or 
normal goat sera (heat inactivated as above} at the same 
protein concentration (9.0 mg protein per culture). 
Additional controls consisted of four plates each of AU-471 
and BHK-21 in soft agar without treatment and six preplate 
controls seeded at 8 x 105 v. cells for cell viability (one 
preplate without treatment, one with FBN and one with NGS 
each for AU-471 and BHK-21}. Cultures were scored for 
colonies at 14 days a'nd 27 days. · 
17. CELL SUBSTRATUM ADHERENCE AND ANCHORAGE 
INDEPENDENCE 
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Monolayer cultures of AU-471 show piling up of cells 
(lack of contact inhibition} that results in high cell 
saturation densities (cell/cm2} in confluent cultures. Many 
cells can be found floating in the media even in cultures 
of cells that grow as strict monolayers without piling up of 
cells (low saturation density}. Evaluation of the cloning 
efficiencies of floating cells, loosely attached cells and 
firmly adherent cells of an anchorage independent cell line 
(AU-471} was done. 
Media was decanted from culture flasks and constituted 
the "floater" fraction. The flasks were gently washed once 
with PBS, then 20 ml of PBS was added and the flasks shaken 
to obtain loosely attached cells. The flasks were washed 
again with PBS and the remaining cells harvested (T/E). 
Cell number and viability were determined for each fraction. 
Four cultures of each of the three AU-471 fractions were 
plated in soft agar at both 2 x 103 v. and 2 x 104 v. cells 
per culture. 
The number and viability of "floaters", loosely 
attached and firmly attached LT-2 cells were also 
determined. Since LT-2 had been shown not to clone in soft 
agar in over 1000 cultures, and since the floater and 
loosely attached fraction represented a minor fraction of 
dead cells they were not plated in soft agar (see Results}. 
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F. NUDE MOUSE GROW1'H 
1. GROWTH OF TUMOR CELL SUSPENSIONS IN NUDE MICE 
Four nude (nu/nu) mice were kindly provided by Doctor 
oonald Rowley, LaRabida Children's Hospital, Chicago, IL, 
and 18 additional nude mice were obtained from Northwestern 
university Animal Care Facilities, Chicago, IL. The mice 
were maintained in sterilized filter top cages in a laminar 
flow hood. All food, H20 and bedding were sterilized, and 
the water was adjusted to a pH of 2.5 with HCl. Two mice 
were injected subcutaneously (s.c.) with 4 x 106 viable 
LT-2 cells in 0.1 ml PBS into the upper dorsal thoracic 
area. (Pooled passages 21, 22, 23, 24, 26 and 27 with 
viability of 89-95%). Four mice received 8 x 106 LT-2 cells 
s.c. (pooled passages 91% V.) and four animals received 10 x 
106 viable LT-2 (Pas. pooled 26-29, 81-100% V.). Ten 
animals were injected intravenously with LT-2 via the dorsal 
tail vein; three with 5 x 106 viable cells in 0.1 ml PBS 
and three with 1 x 106 cells (Pas. pooled 21-27, 89-95% 
V.), and four additional animals received 1 x 106 viable 
LT-2 in 0.05 ml intravenously (Pas. 22, 95-99% V.). 1wo 
additional animals were injected with 2 x 106 viable AU-471 
cells in 0.05 ml PBS intravenously (Pas. 119, 79% V.). 
Subcutaneously injected cells that resulted in nodule 
formation were harvested at 3 months, 4-1/2 and 7 months. 
Nodules were cut into four small pieces. One portion was 
frozen in O.C.T., one was fixed in paraformaldehyde, and 
one portion was fixed in formalin and imbedded in parafin 
blocks, cut and stained with hematoxalin and eosin. The 
last piece was chopped into small fragments and placed in 
culture. 
2. INTRAVENOUS INJECTED NUDE MICE 
One animal convulsed apparently suffering a pulmonary 
embolus from injection of tumor cells. The remaining 
animals (twelve) survived and were sacrificed or died from 
day 33 to day 200 post-injecti~n. The animals were 
autopsied, and no tumor tissue was noted in the peritoneal 
or pleural cavity. Lungs, spleen and livers were fixed in 
formalin and processed for hematoxylin and eosin staining. 
3. NUDE MOUSE CULTURES 
84 
Nude mouse nodules were maintained in culture as noted 
above until partial confluent flasks were obtained. Two 
nude mouse nodule cultures (NMNC) were successfully 
propagated in tissue cultures. Nude mouse nodule cells and 
nude mouse skin fibroblasts were karyotyped using the 
procedure described above. The two successfully propagated 
nude mouse nodule· cultures (NMNC) were later cultured in 
soft agar to determine if successful passage through nude 
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mice would alter their anchorage independent culture 
properties. 
4. SOFT AGAR EXPcHIME~TS WITH NUDE MOUSE NODULES IN 
CULTURE 
Five 60 mm culture plates were seeded with 1 x 105 
viable (58% V.) LT-2, (NMNC culture No. 5) in soft agar, 
and five additional cultures with 1 x 105 viable LT-2 
overlaid with agar (controls). Another soft agar 
experiment compared NMNC No. 5 and NMNC No. 7. Each were 
cultured in five 60 mm culture plates with 1 x 105 viable 
LT-2 cells per plate in soft agar. There r,vere five 
"preplate controls" with agar poured over the cells for 
both NMNC 5 and 7. 
5. KARYOTYPE OF NUDE MOUSE CELLS 
Cells from nude mouse nodules that were aJain 
established in vi tr.o were karyotyped as describ\:d above. 
CHAPTER IV 
RESUL'rS 
A. CELL CULTURES 
1. GROWTH AND HISTOLOGY OF LT-2 IN TISSUE CULTURE 
LT-2, a vulvar carcinoma cell line has been 
successfully maintained in tissue culture for 4 years 
through 50 passages, probably representing between 100-200 
generations considering a plating efficiency estimated at 
40% (Section 2: Plating Efficiency). The plating 
efficiency has improved during the four years of 
observation. Viability of freeze-thawed LT-2 cells was 
generally good (average 87.1% V.). This is the third 
vulvar cancer established in tissue culture. Cell 
rnonolayers, grown on cover slips in Leighton tubes, and 
also single cell suspensions evaluated by Papanicolaou 
staining were both cytologically malignant. Cells are 
predominately mononuclear with multiple prominent nucleoli, 
weakly basophilic cytoplasm, and a large nuclear/cytoplasm 
ratio (Figure 1). Both cells and nuclei are pleomorphic 
with occasional giant forms. Fre'quent mitoses are noted. 
During the four years of observation, LT-2 has continued to 
grow as a very strict monolayer with no piling up of cells 
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Figure 1. LT-2 monolayer from Leighton tube culture, fixed 
in absolute ethanol. (Giemsa stain x 300.) 
as frequently noted in other tumor cells in tissue culture 
(Figure 2). Electron micrographs show both dense and 
fibrous nucleoli and numerous mitochondria, rough 
endoplasmic reticulum, light-staining vacuoles, and 
tonofibrils characteristic of epithelial cells. No viral 
particles were noted. Using aceto-orcein staining of 
Leighton tube cover slip monolayers, no mycoplasma were 
noted. 
2. PLATING EFFICIENCY 
Following plating, LT-2 cells attached to the plastic 
substrate of the culture flask and began to "spread". One 
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difficulty in determining plating efficiency was that cells 
continued to attach to the substratum over a period of time 
after plating. If cells were counted too early, before all 
potential plating cells attached, an inaccurately low value 
might be obtained. Likewise, if plating efficiency was not 
determined soon after plating, cell division might give an 
inaccurately high value. The use of both mitomycin C 
treated cells and untreated cells helped determine a more 
accurate plating efficiency. Plating efficiencies 
No. cells harvested 
No. cells plated x 100 varied between 11.3 and 36% at 2 
hours and cell attachment leveled off between 2 and 4 hours. 
Mitomycin C treated cells showed a 20.5% attachment 
efficiency at 2 hours which leveled off to 40.6% by 4 
Figure 2. Comparison of cell growth in vitro: top, LT-2, 
note the strict monolayer growth; bottom, AU-471, note the 
piling up of cells. 
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hours. No further increase in cell attachment to the sub-
stratum was noted after 4 hours. By 12 hours, a considera-
ble variation in the number of cells harvested was noted be-
tween the mitomycin C treated and untreated cultures with 
plating efficiency increasing to 61.8% in the untreated cul-
tures indicating cell growth in culture. These experiments 
indicate an average plating efficiency for LT-2 of about 
40% with cell attachment plateauing between 2 and 4 hours. 
Cell division was noted shortly after plating (Figure 3). 
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B. TUMOR-HOST INTERACTIONS IN VITRO 
1. LYMPHOCYTES 
Total white blood count (WBC) was consistently 
elevated (10-30,000 WBC per mm3) during the 15 months of 
observation, yet the total peripheral blood lymphocytes 
(PBL) percentages and absolute numbers were depressed. 
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Total and active T-RFC percentages and absolute numbers were 
also depressed. An increase in PBL, total and active T-RFC 
% and absolute numbers occurred following BCG immunization; 
confirming a bone marrow sparing effect of this form of 
therapy. B-RFC percentages were also depressed below 
normal levels, and also increased following BCG therapy. 
All values returned to their previously repressed values 
over a period of several months despite continued BCG 
injections (Figure 4). 
2. CYTOTOXICITY 
Chromium release cytotoxicity assays were done on two 
occasions using patient and control lymphocytes versus 
autologous tumor or an unrelated malignant cell line 
(AT-264). Cytotoxicity was assayed separately in autologous 
and control plasma. 
The first assay (Exp. 1) revealed no patient lymphocyte 
cytotoxicity against her own tumor in autologous or in 
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control plasma or against the lung carcinoma cell line 
(AT-264). Control lymphocytes also showed no specific 
cytotoxicity although some "spontaneous or natural" 
cytotoxicity was noted against control target cells in both 
control and patient (M.L.) plasma (9.12 & 10.07% LMC). 
Control LMC against LT-2 cells was more varied showing only 
0.63% cytotoxicity in patient plasmas and 11.73% LMC in 
control plasma. (Although no statistically significant 
conclusions can be drawn from this variation because of the 
large standard deviations of samples in control plasma). 
The patient's "natural" cytotoxicity was depressed against 
both her own autologous tumor and AT-264 cells in 
autologous plasma, although some (4.70 ± 1.56% LMC) 
spontaneous cytotoxicity was noted against AT-264 in 
control plasma. 
During the first and second cytotoxicity assays and 
until the patient's death two months later her general 
health and nutritional status continued to deteriorate. 
All skin tests, including skin tests to autologous tumor 
extracts, were negative at that time. DNCB skin testing 
was negative, and total PBL, T-RFC, active T-RFC and B-RFC 
percentages and absolute numbers were depressed. Yet, 
despite her general state of anergy, and her considerable 
tumor burden at that time, a significant degree of specific 
cytotoxicity (P< 0.001) was noted in both autologous and 
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control plasma (15.93 & 11.44% LMC, respectively) a~ainst 
her autologous tumor. Also a small increase in "natural" 
cytotoxicity (4.64 & 6.37% LMC) was noted against AT-264 in 
both control and autologous serum. Control lymphocytes 
again showed the expected degree of "natural" cytotoxicity 
(8.09 & 9.40% LMC) against AT-264 similar to the first 
experiment. Again no natural cytotoxicity was noted 
against LT-2 using control lymphocytes, but a very large 
variation in standard deviation in cytotoxicity was noted in 
control plasma (S.D. ±22.38). 
This increase in cytotoxicity with patient's 
lymphocytes against her own tumor occurred 2 days following 
several blood transfusions. It is interesting to speculate 
that this increase in cytotoxicity was an example of the 
"allogenic effect" or a more remote possibility is that it 
occurred because of immune reactivity of viable transfused 
lymphoid cells. 
The patient's sister's lymphocytes were also assayed 
for cytotoxicity against LT-2 in control plasma and none 
was noted. (Table 1.) 
3. LYMPHOBLAST TRANSFORMATION 
PHA induced blastogenesis was assayed on four 
occasions and remained markedly depressed throughout the 
perjod of observation. No increased response was noted 
TABLE 1 
LYMPHOCYTE - MEDIATED CYTOTOXICITY: CHROMIUM RELEASE ASSAY 
Lymphocytes Targets % LMC ± S.D. No. Plasma 
Experiment 1 
Control AT-264 9.12 3.00 4 Control 
Control AT-264 10.07 2.09 4 M.L. 
M.L. 
i 
AT-264 4.70 1. 56 4 Control 
M.L. AT-264 0 3.49 4 M.L. 
Control LT-2 11.73 17.81 4 Control 
Control LT-2 0.63 2.03 4 M.L. 
M.L. LT-2 1. 79 1. 22 3 Control 
M.L. LT-2 0 1. 38 4 M.L. 
Experiment 2 
Control AT-264 8.09 2.35 3 Control 
Control AT-264 9.40 0.32 3 M.L. 
M.L. AT-264 4.64 1. 66 4 Control 
M.L. AT-264 6.37 1. 88 4 M.L. 
Control LT-2 0 22.38 3 Control 
Control LT-2 0 2.84 3 M.L. 
M.L. LT-2 15.39 0.57 4 Control 
M.L. LT-2 11.44 2.58 4 M.L. 
Sister LT-2 0 5.92 3 Control 
1.0 
(J'I 
97 despite the increase in PBL, T-RFC and active T-RFC 
following BCG. Also no increase in blastogenesis was noted 
following blood transfusions similar to the increase in LMC 
noted above. Blast transformation to KCl extracts of LT-2 
cells ( 1 .M-9 or 10 .M.9 protein) showed no antigenic 
recognition by the patient, or by a close household contact 
(the patient's sister), or by a non-tumor control patient's 
lymphocytes. No blast transformation was noted to KCL 
extracts with mitomycin C treated patient, sister or control 
lymphocytes (control for non-specific thymidine uptake) or 
using a KCl extract of a normal human fibroblast cell line 
(control for non-specific lymphocyte stimulation). (Table 
2.) 
TABLE 2 
LYMPHOBLAST TRANSFORMATION 
Stimulation 
Lymphocytes Antigen Index ± S.D. 
M.L. PBS 1. 00 0.15 
PHA 6.8o* 1. 01 
PHA 1/10 14.39* 0.97 
LT-2 KC1 (10A.<g) 1.14 0.38 
LT-2 KC1 ( 1_p.g) 1.28 0.24 
LT-2 + me 1.04 0.29 
LT-2 + me 1. 36 0.10 
(M. L. plasma) 
LT-4 KC1 1.87 1. 01 
Control PBS 1.00 0.07 
PHA 67.06 22.49 
PHA 1/10 74.52+ 12.49 
LT-2 KC1 (lO.M.g) 1.21 0.18 
LT-2 KCl ( 1_)Ag) 1. 08 0.25 
LT-2 + me 1.05 0.10 
LT-2 + me 1.12 0.24 
(M. L. plasma) 
LT-4 KCl 1.05 0.14 
Sister PBS 1. 00 0.29 
PHA 56.15 22.49 
PHA 1/10 93.74+ 13.45 
LT-2 KCl (10 A.g) 1.43 0.20 
LT-2 KCl ( 1~g) 1.10 0.33 
LT-2 + me 1.16 0.15 
LT-2 + me 0.90 0.06 
(M. L. plasma) 
LT-4 KCl 0.99 0.03 
~ ~ignificantly lower than PHA stimulation of control 
lymphocytes (P < 0. 01) 
+ Not significantly different from normal population 
(S.I.=116±26; P)0.1) 
PBS: 0.01 ml phosphate buffered saline 
PHA: Phytohemagglutinin (Difco PHA-P), undiluted or 
diluted 1:10 · 
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LT-2 KCl: KCl extract or cultured LT-2 cells (l~g or 
10 g protein in 0.1 ml PBS) 
LT-2 +me: 104 mitomycin C - treated Lt-2 cells in 0.1 ml 
PBS 
LT-4 KCl: KCl extract of normal human fibroblasts (10~g 
protein in 0.1 ml PBS) 
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C. TUMOR-HOST INTERACTION: IN VIVO 
. 1. SKIN TESTS 
Initially, the patient (M.L.) responded to only one of 
the five recall bacterial skin test antigens 
(dermatophytin-0). She was anergic to all other skin test 
antigens including PPD. No response was noted to DNCB. 
The patient received BCG intralesional immunotherapy (see 
below), and was again skin tested. At that time, she 
responded to PPD, but was now anergic to dermatophytin-0. 
Two months later, she was again re-tested, and she was then 
totally anergic to all recall skin test antigens including 
PPD despite the fact that she had received three BCG 
immunizations and was previously PPD skin test positive. 
Still no response was noted to DNCB. She remained totally 
anergic when again re-tested six weeks later. The patient 
was also anergic to skin testing with autologous KCl tumor 
extracts. 
2. BCG 
Following the first BCG intralesional immunization, the 
patient became hyperthermic for 2 days. No decrease in the 
size of the right inguinal lesion was noted, and by the 
time of the third ·intralesional injection the mass had 
doubled in size (3 months). No beneficial clinical response 
was noted to BCG injections, aithough an increase in PBL's 
occurred as noted above. 
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D. CELL CHARACTERIZATION AND TUMOR PROPERTIES 
1. ELECTRON MICROSCOPY 
As pointed out by Bernhard, the ultrastructural 
differences between normal and malignant cells are 
quantitative rather than qualitative. Well differentiated 
cancer cells generally resemble the tissue of origin and 
contain organelles characteristic of differentiation. 
There is no universal ultrastructural pattern characteristic 
of cancer (200). Electron micrographs of LT-2 revealed 
numerous pinocytotic vacuole and lysosomes with prominent 
tonofilaments. The presence of tonofilaments is 
characteristic of epithelial cells or undifferentiated tumor 
cells (201). No keratonyalin was noted. Mitochondria 
appeared normal in numbers and appearance. The nucleus 
showed large prominent nucleoli. No virus particles were 
noted. 
2. KARYOTYPING 
Karyotyping of 38 cells revealed marked aneuploid 
variation with chromosome numbers varying from 47 to 81 
with no single modal number, although a tendency toward a 
triploid hypertriploiu modal range was noted. Abnormal 
marker chromosomes and ring chromosomes were noted. 
Karyotyping four years later still revealed aneuploidy with 
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marked variations in chromosome numbers. (Table 3 and 
Figure 5). 
3. GENERATION TIME 
The doubling time was determined using the 
relationship log N = 0 ·~~lt + log No and was calculated to 
be 32 hours, during the initial log phase of growth from 27 
to 72 hours in culture (Figure 6). Pirt has noted that the 
validity of such calculations are based on the assumption 
of constant exponential growth as noted with procaryotes and 
constant environment conditions (202). Fractions of 
non-growing cells resulting from cell differentiation, 
production of inhibitors, etc., would invalidate the 
assumption of exponential growth. Cell generation time 
calculated by time-lapse cinematography (see below) was 
highly varied with one multinucleated cell dividing twice in 
only 88.5 minutes (from one cell division to another) while 
other cells did not divide at all. 
4. TIME-LAPSE CINEMATOGRAPHY 
The doubling time of individual cells (cell cycle time) 
was calculated by observing the interval between two 
consecutive cell divisions and counting the number of frames 
during that interval and dividing by the number of frames 
per minute (2 frames per minute). The interval between 
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TABLE 3 
FREQUENCY OF LT-2 CHROMOSOME 
DISTRIBUTION OF 38 CELLS 
Cells: 1 1 2 1 1 1 1 
--Chromosomes: 47 48 50 51 52 54 55 
Cells: 1 1 1 1 1 2 1 
Chromosomes: 56 57 58 60 62 63 64 
Cells: 2 1 1 5 3 4 3 
Chromosomes: 65 65 68 69 72 73 74 
Cells: 1 1 1 
Chromosomes: 75 78 81 
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Figure 6. Doubling time of LT-2 in culture. Initial plating at 0.85 x 
106 cells per culture. 0 ~ 
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divisions was noted to vary considerably between cells with 
some cells dividing twice while other cells within the same 
colony did not divide at all. 
Cell division did not necessarily appear to correlate 
with cell size. Some small cells were noted to divide while 
much larger cells with abundant cytoplasm did not divide. 
Also cell division did not necessarily occur with equal 
division of the cytoplasm. As noted above, the interval 
between two cell divisions of one multinucleated cell was 
only 88.5 minutes. Some other cells within the same colony 
did not divide at all during the period of observation -
about 4 days. Considerable movement or membrane ruffling 
was noted by many cells. Individual cells were noted to 
move in and out of the photographic field, and one small 
colony consisting of about 10 cells was also noted to move 
as a group, demonstrating a total lack of cell to cell 
contact inhibition of cell movement-topoinhibition (Figure 
7) • 
Cell to cell adherence was demonstrated in one film. 
As a cell moved away from a small colony, a long 
cytoplasmic stream attached to an adjoining cell was "left 
behind" pulling out the membrane of the stationary cell. 
When the cells finally separated, both cells rapidly 
recoiled in a fashion similar to a rubber band that had 
been stretched out and then released - suggesting rather 
firm cell to cell contact (Figure 8). 
Figure 7. Time lapse 
whole colony. Cell a. 
cinematography showing movement 
moving away from colony. 
of 
106 
a 
8. Time lapse 
with cell b. 
Figure 
adhesion 
cinematography showing cell 
moving away from colony. 
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5. SATURATION DENSITY 
AU-471 reached confluent growth with a maximum satura-
tion density of 10.4 x 105 cells/cm2 at 11 days in culture 
(average 8.68 x 105 cells/cm2 with a range from 7.76 to 
1.04 x 105 cells/cm2 from day 9-14). LT-2 reached a maximum 
saturation density of 1.20 x 105 cells/cm2 at 14 days in 
culture (average of 1.10 cell/cm2 with a range from 1.02 to 
1.20 x 105 cells/cm2 from day 10-16). WI-38 reached a maxi-
mum saturation density of 0.074 x 105 cells/cm2 at day 29 
in culture (average 0.0639 x 105 cells/cm2 with a range from 
0.0522 to 0.074 x 105 cell/cm2 from day 15 to 35). Even 
after 35 days, WI-38 cultures were not totally confluent. 
AU-471 which grew with "heaped-up" colonies reached a 
maximum saturation density about 8.6 times higher than LT-2 
and 140 times greater than WI-38. Saturation density for 
LT-2 was 16 times greater than WI-38. Both LT-2 and WI-38 
grow as a strict moholayer without "heaped-up" cells as 
noted with AU-471, and both have a much lower saturation 
density (Table 4). 
TABLE 4 
SATURATION DENSITY OF LT-2, AU-471 AND WI-38 CELLS IN VITRO 
LT-2 AU-471 WI-38 
--Saturation Saturation Saturation 
Tiiile In Density Time In Density Time In Density 
Culture No. cells/ Culture No. cells/ Culture No. cells/ 
Days cm2 x 105* Days cm2 x 105* Days cm2 x 105* 
10 1. 02 8 3.86 15 .0662 
11 1. 09 9 7.76 17 .0552 
14 1. 20 10 8.81 21 .0721 
15 1.17 11 10.4 24 .0522 
16 1. 06 14 7.66 29 .0741 
15 5.22 32 .0652 
35 .0622 
* Average of three cultures 
..... 
0 
\0 
1 1 0 
6. DENSITY DEPENDENT INHIBITION OF CELL DIVISION 
·Review of stained Leighton tube cover slips of LT-2 
revealed mitotic figures both in the center of large colo-
nies with cell contact on all sides of dividing cells and 
on the periphery of the colonies (Figure 9). AU-471 also 
demonstrate cell division throughout large colonies (Figure 
10). WI-38 did not form discrete colonies. Instead, cel~s 
were noted to form anastomosing columns with individual 
cells and small groups spread over the slide. Fewer cell 
divisions were noted compared to LT-2 or AU-471 cultures 
and only rare cell divisions in the center of large colonies 
were noted by cells compietely.surrounded and in contact on 
all sides with other cells (Figure 11). 
7. SURFACE ANTIGENS: ABH 
Agglutination of LT-2 was noted using anti-A. Since 
the patient (M.L) was known to be blood type A, this normal 
cell marker has remained invariant in her tumor. No agglu-
tination was noted with anti-Rho or anti-RhC (patient was 
Rh positive, but the Rho antigen is generally expressed 
only on red blood cells). No agglutination occurred with 
anti-B, anti-H substance or PBS. LT-2 agglutinated in the 
presence of normal rabbit serum. Heterophile positive hu-
man serum (from a patient with infectious mononucleosis) did 
not agglutinate LT-2, but did agglutinate SRBC's. Normal 
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Figure 9. Colonies of LT-2 demonstrating cell division (ar-
rows) by cells in the center of a colony with cell contact 
on all sides. 
Figure 10. Colonies of AU-471 demonstrating cell division 
(arrows) by cells in the center of a colony with cell con-
tact on all sides. 
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Figure 11. WI-38 with cell division (arrows) by cells 
separated from other cells. Cell division was uncommon com-
pared to LT-2 or AU-471 cultures. Only rare cell division 
was noted by a cell in the center of a large colony. 
1 1 4 
human control serum did not agglutinate SRBC's or LT-2. 
Infectious mononucleosis positive serum did not agglutinate 
AU-471 nor was a heterophile-like antigen noted since no 
agglutination with normal rabbit serum occurred (Table 5). 
8. FETAL ANTIGENS: CEA, hCG 
Spent media from cultured LT-2 cells concentrated 14.5 
times as described in the section on Materials and Methods 
was found to contain 21 ng~/ml CEA per milliliter at pas-
sage No. 3, corresponding to 0.877 ng. per 106 cells per 
day. Fetal calf serum used in cell cultivation was also 
found to contain CEA immunoactivity corresponding to 6.15 
±0.83 ng. CEA per milliliter fetal calf serum or 0.922 
±0.124 ng. CEA per milliliter complete medium or 13.4 ng. 
CEA per milliliter of 14.5 times concentrated medium. Thus, 
in vitro production of CEA by LT-2 was significantly ele-
vated above levels expected in concentrated complete media 
with 15 percent fetal calf serum (P < 0.001 ). CEA activity 
attributable to LT-2 production decreased with continued 
culture and was undetectable at passage No. 11. Spent me-
dia was also found to contain 179 I.U. ~-hCG per liter, 
corresponding to an output of approximately 20 mi.U. (4 
ng.) per 106 cells per day. Immunoreactive hCG (cross-reac-
tive with LH) in this concentrated medium was found to be 
only 9 I.U. per liter, at the lower level of sensitivity of 
TABLE 5 
DEMONSTRATION OF HETEROPHILE ANTIGEN ON LT-2 
AND DIFFERENTIATION FROM INFECTIOUS MONONUCLEOSUS HETEROPHILE 
ANTIGEN 
*NRS 
**Im+ 
***Im-
Sheep RBC 
+ 
+ 
*NRS = Normal Rabbit Serum 
LT-2 
+ 
AU-471 
**Im+ = Infectious Mononucleosus Positive Antisera 
***Im- - Infectious Mononucleosus Negative Antisera 
Human Blood Type A RBC 
+ 
V1 
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the radioimmunossay, and did not increase when the medium 
was concentrated (immunoreactive~-hCG did increase in the 
medium with concentration), indicating prefecential secre-
tion of the beta subunit of hCG by LT-2 cells. 
9. SERUM DEPENDENCE 
LT-2 was plated at 5 x 104 cells per well in 10%, 1%, 
0.1%, .01% and 0 serum and was harvested at 4 days, result-
ing in recovery of 4 x 104 cells from 10% serum, 2.3 x 104 
cells from 1% and progressively fewer cells in less serum, 
but some cells survived even when cultured in 0 serum (1.7 
x 104 cells at 4 days). Plating LT-2 in 15% serum and 
changing to lower serum concentrations as noted above after 
24 hours, did not consistently produce incceased growth. 
In a repeat experiment, LT-2 was plated at higher con-
centrations (1.5 x 105 cells per well) and harvested later 
(6 days). High yields were noted with 10% and 1% serum 
(2.5 and 3.6 x 105 cells per well), indicating growth in 
10% and 1% serum, but lower cell yields were noted with 
0.1, 0.01 and 0 serum (1.2, 0.8, 1.2 x 105 cells per well) 
indicating cell survival in limited serum, but not growth. 
These data indicate serum growth dependence by LT-2. In 
contrast, AU-471 dem~nstrated ser~m independence with growth 
at both 10% and 0 serum, but much greater growth at the 
higher serum levels (1.5 x 105 cells per well plated with 
117 
yields of 20.5, 12.2, 5.1, 2.6, 2.6 in 10%, 1%, 0.1%, 0.01% 
and 0 serum, respectively). Plating in 15% serum for 24 
hours prior to feeding with various serum concentrations re-
sulted in much better growth in all cultures compared to 
cultures initially plated in lower serum concentrations. 
These data indicate serum independence but also response to 
serum, suggesting retention of receptors for growth stimu-
lating factors in serum by AU-471. Interestingly, WI-38, a 
"normal diploid" cell line also demonstrated serum indepen-
dence when harvested at 4 days but with better growth when 
plated in higher serum concentration. 
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E. GROWTH IN SOFT AGAR: ANCHORAGE INDEPENDENT GROWTH 
1. SOLUBLE STIMULANTS & INHIBITORS: CO-CULTIVATION 
EXPERIMENTS, LT-2:AU-471 
Preliminary studies revealed that LT-2 did not clone in 
soft agar. This lack of anchorage independent growth by 
LT-2 was of particular interest since most turnors·in tissue 
culture clone in soft agar (Figure 12). In fact, soft agar 
anchorage independent growth is currently the most reliable 
assay of in vitro malignancy. Although Marshall has 
reported a human malignant bladder carcinoma that did not 
clone in soft agar, but was tumorogenic in the nude mouse 
(203). Smith and Temin had demonstrated that serum 
independence by tumors results from production by the tumor 
of growth stimulating factors that can replace serum (204). 
The possibility that a soluble inhibitor or stimulant was 
responsible for anchorage dependent or independent growth 
was considered. Experiments were done to determine whether 
anchorage independence was a function of a soluble product 
produced by cells capable of growth in soft agar and/or 
whether non-cloning cells produced a soluble inhibitor. 
Two co-cultivation experiments using untreated LT-2 
cells cultured with AU-471 showed an increase in soft agar 
plating efficiency of AU-471 when colonies were scored at 
about two weeks. One experiment showed a dose response 
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Figure 12. Clones of AU-471 growing in soft agar. 
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increase (1:10>1:1) in plating efficiency (control mean 
55.0 ±10.87; 77.3 ±11.69 co-cultured with 2 x 103 LT-2 
giving an LT-2:AU-471 ratio of 1:1; and 129.2 ±26. 16 with 2 
x 104 LT-2 giving an LT-2:AU-471 ratio of 1:10) (P<0.001). 
After 24 days, no significant increase in cloning efficiency 
was noted at the lower (1:1) feeder to response cell ratios, 
but a significant (P<0.001) response was still noted at the 
higher (1:10) cell ratios (Table 6.) This gloss" of feeder 
effect by 24 days in the 1:1 co-cultivation may have 
resulted from the much greater increase in cloning 
efficiencies occurring in control plates (3.32 x increase) 
from day 14 to day 24 compared to test plates (2.52 x for 
1:1 and 2.22 x for 1:10). Similar results were seen in 
other experiments using AU-471 co-cultivated with mitomycin 
AU-471 (see below). 
Another experiment used low and high cell ratios of 
responder and feeder cells. {1 :5 and 1:50 AU-471 :LT-2 
ratios with 2 x 103 "responder" AU-471 as above, but also 
with 2 x 104 responder cells). Significant (P<.001) 
increases in cloning efficiency were noted when cultures 
were scored at both 15 days and 26 days, and at both low 
and high AU-471:LT-2 ratios and with low and high numbers of 
responder AU-471 cell's {Table 7).· Plating efficiency of 
control AU-471 was greater with 2 x 104 AU-471 (4.97%) 
compared to 2 x 103 AU-471 (2.36%) suggesting a self-feeder 
effect. 
TABLE 6 
ENHANCEMENT OF AU-47la GROWTH IN SOFT AGAR BY LT-2 
LT-2d No. of Colonies (Mean± S.D.) Increase In Da:t 21 
No. X 103 Day 14 pC Day 21 pC Cloning Efficiency: Day 14 
0 55 ± 10 - 183 ± 8 - 3.3 
2 77 : 11 .001 195 :23 N.S. 2.5 
20 129 : 26b .001 295 !3ob .001 2.2 
a = 2 x io3 AU-471, 75% viable 
b = Significant increased number of colonies compared to 2 x 103 LT-2 cultures, 
p <. 001 
c = P values compare significance to cultures with 0 LT-2 cells 
d = No growth in LT-2 soft agar control cultures 
_. 
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TABLE 7 
ENHANCEMENT OF AU-471 GROWTH IN SOFT AGAR BY BOTH 
HIGH (1:50) AND LOW (1:5) AU-471:LT-2 CELL RATIOS 
AU-471 
No. X 103 
LT-2a 
No. X 103 
No. of Colonies (Mean! S.D.) 
Day 15 pC Day 26 pC 
2 
2 
20 
20 
0 
100 
0 
100 
47 ± 18 
154 ± 34 
995 ±243 
1000 
a ~ No growth in LT-2 soft agar control cultures 
129 ± 11 
.001 256 ± 30 
1700 ±428 
sig. 412ob±868 
.001 
.001 
b = Plating efficiency calculated after counting only a portion of the total plate 
c = P values compare 100 x 103 LT-2 cultures to 0 LT-2 with comparable numbers of 
Au-471 
Sig.= Obviously significant, but could not be calculated 
..... 
"" N 
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These experiments demonstrated stimulation of cloning 
efficiency or growtn of an anchorage independent cell by an 
anchorage dependent cell rather than inhibition which was 
expected. The response is dose dependent and more evident 
when cultures are scored early (2 weeks) rather than late 
( 3-4 weeks) . 
2. SOLUBLE STIMULANTS & INHIBITORS: CO-CULTIVATION, 
MITOMYCIN C TREATED LT-2:AU-471 
Three additional experiments used increasing 
concentrations of mitomycin C "feeder" LT-2 cells. 
Mitomycin "feeder" cells were used to insure that the 
increased cloning noted by AU-471 in previous experiments 
was not the result of clone formation by LT-2. One 
experiment confirmed a significant (P< .05- .01) "feeder 
effect" with cloning efficiency increasing directly with 
increasing numbers of feeder cells at day 18 (Table 8). No 
difference between test and control cultures was noted by 
day 24 except for one set of cultures with 1 x 104 feeder 
cells (P< 0.05). In another experiment no dfeeder effect" 
was noted at either 15 or 22 days, but the cloning 
efficiency of control plates was 25% by 15 days and 64% by 
22 days. This cloning efficiency of controls in this 
experiment was much higher than noted in other experiments 
in which "feeder effect" was clearly demonstrated {Table 9). 
TABLE 8 
DOSE DEPENDENT ENHANCEMENT OF AU-471 CLONING EFFICIENCY WITH VARIATIONS 
IN MITOMYCIN C TREATED LT-2 CELLS 
LT-2 No. of Colonies Mean± S.D.) 
No. X 104 Day 18 pC Day 14 pC 
0 51 ± 6 - 74 ± 15 
1 49 ± 7 N.S. 62 ± 9 N.S. 
2 59 ± 4 • 05 61 ± 6 N.S . 
5 . 63 ± 9 .05 76 ± 16 N.S. 
10 77 ± 9 .01 92 ± 6 .05 
50 74 ± 6 .01 83 ± 5 N.S. 
a = 500 AU-471 per culture, 5 cultures per group 
b = No growth of LT-2 soft agar control cultures 
c = P values compare significance to cultures with 0 LT-2 cells 
~ 
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TABLE 9 
LACK OF LT-2 FEEDER EFFECT ON AU-471 CLONING EFFICIENCY 
IN SOFT AGAR CULTURES WITH HIGH SPONTANEOUS CLONING EFFICIENCYa 
LT-2C No. Colonies (Mean~ S.D.)b 
No. X 103 Day 15 Day 22 
0 505 ± 41 1239 ± 214 
1 506 ± 49 1267 ± 295 
2 524 ± 28 1212 ± 102 
5 498 ± 25 1226 ± 197 
10 550 ± 30 1232 ± 163 
a = No significant differences noted between co-cultured and control cultures 
cloning efficiency 
b ~ Cloning efficiency 25% 
c = No growth in LT-2 soft agar control cultures 
"" U1 
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The last experiment showed no "feeder effect" (Table 10). 
rn fact, inhibition of soft agar cloning efficiency was 
noted with 5 and 10 x 105 feeder LT-2 cells. This experi-
ment had a very low viability of mitomycin C treated LT-2 
feeder cells (35%) which may have accounted for the inhibi-
tion (Table 10). These experiments using mitomycin C 
treated LT-2 demonstrated "feeder effect", but generally 
only when colonies were scored early (usually 2 weeks) in 
the experiment and when the cloning efficiency of control 
cultures was low (generally less than 20%). The last ex-
periment suggested that large numbers of dead mitomycin C 
treated feeder cells might decrease cloning efficiency. 
3. SOLUBLE STIMULANTS & INHIBITORS: CO-CULTIVATION, 
AU-471 FEEDING AU-471 
Experiments were done to determine whether AU-471 
could stimulate its own cloning efficiency in soft agar us-
ing mitomycin AU-471 "feeder cells". In two co-cultivation 
experiments using mitomycin C treated AU-471 cells as feeder 
cells and untreated AU-471 responder cells, a significant 
increase (P<.05- 0.01) in AU-471 soft agar cloning effi-
ciency was noted when cultures were scored at about two 
weeks, and the efficiency increased directly with the number 
of feeder cells (Table 11 and Table 12). Evaluation of 
cloning efficiency at 4 weeks was more variable with one ex-
TABLE 10 
INHIBITORY EFFECT OF HIGH NUMBERS OF CO-CULTIVATED LT-2 CELLS 
ON THE CLONING EFFICIENCY OF AU-471 
LT-2b No. of Colonies (Mean~ S.D.) 
No. X 103 Day 17 pC Day 25 
0 297a ± 39 - 473 ± 48 
10 315 ± 23 N.S. 494 ± 59 
20 276 ± 37 N.S. 427 ± 45 
50 242 ± 34 .05 360 :!: 16 
100 80 :!: 29 .005 110 :!: 26 
a ~ Cloning efficiency 15% 
b ~ No growth in LT-2 soft agar control cultures 
c = P values compare significance to cultures with 0 LT-2 cells 
pC 
N.S. 
N.S. 
.05 
.005 
..... 
N 
-..J 
TABLE 11 
DOSE RESPONSE INCREASED CLONING EFFICIENCY OF AU-471 CO-CULTURED 
WITH MITOMYCIN C TREATED AU-471a 
AU-471 No. of Colonies (Mean± S.D.) 
No. Cells x 103 Day 14 pb Day 23 pb 
0 46 ± 6 <. 01 128 ± 12 N.S. 
2 72 ± 8 (;01 130 ± 13 N.S. 
5 88 ± 9 <· 01 143 ± 17 N.S. 
10 92 ± 3 <.01 182 ± 10 <. 01 
50 87 ± 7 <.01 210 ± 40 <.01 
100 104 ±12 <· 01 181 ± 20 <. 01 
a = 500 viable AU-471 per culture, 89% viable 
b • significant increased number of colonies compared to 0 LT-2, P(.Ol 
1\,) 
(X) 
TABLE 12 
DOSE RESPONSE INCREASED CLONING EFFICIENCY OF AU-471 CO-CULTURED 
WITH HIGH NUMBERS OF MITOMYCIN C TREATED AU-47la 
AU-47lb No. of Colonies + (Mean- S.D.) 
No. Cells x 103 Day 16 pC Day 28 pc 
0 339 ± 51 - 612 ± 44 
10 398 ± 58 N.S. 608 ± 61 N.S. 
20 430 ± 37 .01 592 ± 41 N.S. 
50 474 ±1os .05 622 ±135 N.S. 
100 564 ± 57 .01 660 ± 53 N.S. 
500 624 ± 37 .01 668 ± 49 N.S. 
a ~ 2000 viable Au-471 per culture, 87% viable 
b ~ 72% viable, no colony formation in control mitomycin C treated cultures 
c = P values compare significance to cultures with 0 mitomycin C treated AU-471 
cultures 
... 
tv 
\0 
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periment showing no signif'icant difference between feeder 
cultures and controls, and the other experiment showing sig-
nificant differences (P>O.Ol) only with higher numbers of 
feeder cells (10, 50 and 100 x 103 feeder cells), but not at 
lower feeder cell proportions (2 and 5 x 103 feeder cells). 
similar results were noted (see above) in some LT-2:AU-471 
feeder experiments suggesting that the "feeder effect" in-
creases cell cloning efficiency early in experiments re-
sulting in more recognizable (scorable) clones, but when 
cultures are scored later (3-4 weeks) non-feeder cultures 
had a greater proportional increase in cloning efficiency 
often eliminating any noticeable "feeder effect" on cloning 
efficiency. Control cultures (Table 12) increased by 1.8 x 
~ile "feeder cultures" demonstrated a small increase in the 
number of scorable colonies (l.Sx, 1.1x 1.4x 1.2x, 1.1). 
4. SOLUBLE STIMULANTS & INHIBITORS: CO-CULTIVATION, 
WI-38:AU-471 
Experiments were done using a "normal" near diploid 
cell strain that does not clone in soft agar as "feeder" 
cells to determine if cloning stimulating efficiency was 
specific for tumor lines or was also produced by "normal 
cells". Co-cultivation of WI-38 with AU-471 also demon-
strated a "feeder effect" with significantly increased col-
ony formation at both 14 and 22 days with AU-471J WI-38 
1 3 1 
cell ratios of 1:10 and 1:50 (P<.OOOS) (Table 13). No colo-
nies were noted with 2 or 100 x 103 WI-38 cells plated alone 
in soft agar (controls). Cloning efficiencies of control 
cultures were 1.6% at 14 days and 6.39% at 22 days indicat-
ing a 3.97 x increase while feeder cultures nad only a 3.50 
x and 1.76 x increase. 
A larger increase in cloning efficiency occurred in the 
control cultures between day 14 and 22 than in "feeder" cul-
tures with the smallest percent increase occurring in the 
group with the highest number of feeder cells. Similar re-
sults were seen in other experiments and suggest "self 
feeding" with increased time in culture of control plates 
with resulting stimulation of growth of controls later in 
experiments (after 2 weeks). Similar results were noted in 
previous experiments (see above). 
5. SOLUBLE STIMULANTS & INHIBITORS: CO-CULTIVATION, 
LT-2 WITH MITOMYCIN C TREATED AU-471 
No significant stimulation of soft agar growth by solu-
ble products from AU-471 was noted in co-cultivation experi-
ments using mitomycin C treated AU-471 to "feed" untreated 
LT-2 (Table 14). 
TABLE 13 
ENHANCEMENT OF AU-471a CLONING EFFICIENCY BY CO-CULTIVATION 
· WITH A "NORMAL DIPLOID" CELL LINE WI-38 
INCREASE IN CLONING 
No. of ~olonies (Mean ±S.D.) EFFICIENCY: WI-38 Day 22 
No. X 104 Day 14 pb Day 21 pb Day 14 
0 32 ± 9 - 128 ± 30 - 3.97 
2 68 ±1o .0005 239 ± 20 .0005 3.50 
10 230 ±2o .0005 405 ± 14 .0005 1. 76 
a ~ 2 x 103 viable AU-471, 84% viable 
b = P value compares significance with cultures with 0 WI-38 cells 
w 
N 
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TABLE 14 
LACK OF ANCHORAGE INDEPENDENT GROWTH STIMULATION 
OF CO-CULTIVATION WITH MITOMYCIN C TREATMENT 
LT-2 AU-471 
No. X 103 No. X 103 
0 100 
0 20 
100 0 
20 0 
100 100 
20 20 
Results: No colony formation in all cultures on day 
14 or day 21 
... 
w 
w 
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6. MITOMYCIN C TREATED AND UNTREATED LYSED CELLS 
Since mitomycin was being used to treat "feeder" cells, 
an experiment was designed to evaluate mitomycin C in in-
tact and lysed cells and when feeder and responder cells 
were in "close contact" following centrifugation and incu-
bation. 
Control AU-471 (no co-cultivation with LT-2) had a 
cloning efficiency in soft agar of 1.6% at 20 days (Table 
15). Feeder cultures with 1:1 untreated LT-2:AU-471 showed 
no significant stimulation or suppression of cloning. 
Feeder cultures with 105 untreated LT-2 (1 :50 ratio) re-
sulted in total inhibition of AU-471 anchorage independent 
growth. Gross speckling of culture plates was noted as the 
agar dried which microscopically represented lysed and dead 
cells, cell debris and a few 2 and 3 cell clusters (proba-
bly of LT-2 origin), but no colonies. Similarly, centrifu-
gation of LT-2:AU-471 with incubation for 60 min. at 37°C 
(cell contact) resulted in no significant change at 1:1 ra-
tios, but total inhibition of AU-471 cloning at 1:50 (105 
LT-2) ratios. Significant suppression was noted with 105, 
but not 103 lysed LT-2 cells at 20 days. 
Comparable mitomycin C treated LT-2 cells showed sig-
nificant depression (P<O.OS) of AU-471 co-cultured with 105 
~-2, but no oth~r demonstrated suppression or stimulation 
of colony formation by day 20. 
TABLE 15 
EVALUATION OF LT-2:AU-471 CELL CONTACT CELL LYSIS AND MITOMYCIN C 
ON THE CLONING EFFICIENCY OF AU-471d 
Experiment No. 1 
Mitomycin C Treatment of LT-2 
Colony Count (Mean- S.D.) 
me- me+ 
No. of LT-2 Description Day 20 Day 30 Day 20 Day 30 
0 Control 32 ± 6 164 ± 32 
103 Co-Culture 30 ± 4 143 ± 32 25 ± 6 133 ± sa 
Cell Contact 30 .± 5 158 ± 11 37 ± 4 141 ± 3a 
Lysed 23 ± 6 128 ± 6a 41 ± 7 132 ± 7a 
105 Co-Culture oa oa 20 ± 2a 117 ± sa,b 
Cell Contact oa oa 30 ±1o 183 ± 12b 
Lysed 11 ± 4a 8 ± la,c 45 ±14 158 ± 19C 
a = Significant suppression of cloning efficiency of AU-471 compared to control 
cultures, P (.Ol 
b ~Significant difference between groups labeled "b" P (.01 
c ; Significant difference between groups labeled "c", P (.005 
d = 2 x 103 viable AU-471 -w 
VI 
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Mitomycin C treated and ~ysed LT-2 showed significant 
suppression with 103 but not 103 LT-2 at 30 days. Findings 
were similar at 30 days with suppression of AU-471 soft agar 
cloning efficiency with 103 co-cultured, and cell contact 
LT-2, but in addition, 10S co-cultured LT-2 cells showed 
suppression (P<0.001) at 30 days. No suppression.was noted 
with 10S cell contact or lysed LT-2 groups at 30 days. 
Significant suppression was noted in C all mitomycin C 
treated groups except in 10S lysed and cell contact groups 
at 30 days. 
Comparison between mitomycin C and non-treated groups 
revealed significant suppression between the 10S lysed gro-
ups at 30 days, and between 10S co-cultured and cell contact 
groups at 30 days. This experiment indicates suppression of 
AU-471 soft agar cloning with high numbers of untreated and 
co-cultivated LT-2 cells at both 20 and 30 days, but not 
with low numbers of untreated LT-2 cells. Untreated lysed 
cells also inhibited AU-471 cloning. No feeder effect was 
noted in this experiment with either mitomycin C or un-
treated cells. 
A repeat experiment (Table 16) identical to the above 
was done except 1 x 104 and 1 x 10S mitomycin C treated and 
Untreated LT-2 were used instead of 1 X 103 and 1 X 10S and 
colonies were scored at 2 and 4 weeks. The ~ncrease to 104 
instead of 103 LT-2 was used to maximize the possibility of 
TABLE 16 
EVALUATION OF LT-2:AU-471 CELL CONTACT, CELL LYSIS AND MITOMYCIN C 
No. of LT-2 
0 
104 
105 
ON THE CLONING EFFICIENCY OF AU-471 
Experiment No. 2 
Mitomycin C Treatment of LT-2 
Colony Count (Mean± S.D.} 
me- me+ 
Description Day 14 Day 27 Day 15 Day 27 
Control 10 ± 3 39 ± 8 
Co-Culture 31 z 3b,c,g 302 ±64b 7 ± 2C 33 ± 16 
Cell Contact 29 ± 3b,d,h 254 ±15b,e,j 11 ± 3d 60 ± 23e 
Lysed 6 ± 1g,h 60 ±18j 5 ± 2 50 ± 24 
Co-Culture oa oa 14 ± 3 98 ± 9a 
Cell Contact oa oa 33 ±1o 165 ± 2lb,f 
Lysed 8 -:!: 3 41 :!: 7 13 ± 3 71 ± 9b,f 
a ; Total suppression of AU-471 cloning efficiency compared to control 
b = Significant enhancement of AU-471 cloning efficiency compared to controls, P(.01 
c = c,d,e,f,g,h.j.: Significant difference between groups with the same letter P(.01 
~ 
~ 
..... 
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"feeder effect", since other ~xperiments generally noted a 
greater "feeder" when larger numbers of feeder cells (up to 
1 x 10S) were used. In this experiment AU-471 cloning effi-
ciency was 0.49% at 14 days and 1.9% at 27 days (much lower 
than generally noted). A marked feeder effect was noted in 
the 10 4 non-mitomycin C treated co-cultured and contact 
groups (P<0.002), and a total suppressive effect with 10S 
co-cultured or cell contact groups at both 14 and 27 day. 
Lysed cells produced no suppressive effect in any group at 
day 14 or 27. No significant effects, suppressive or 
stimulatory were noted with mitomycin C treated cells at 
day 14. The mitomycin C treated groups showed "feeder ef-
fect" with 10S LT-2 in all three groups - co-cultured, con-
tact and lysed at 27 days, but no significant difference in 
all three groups with only 104 LT-2 at 27 days. Comparisons 
between mitomycin C and untreated and unlysed groups re-
vealed stimulation by non-mitomycin C treated LT-2 compared 
to mitomycin C treatment with 104 LT-2 at both 14 and 27 
days, and marked suppression with 10S non-mitomycin C 
treated LT-2 at both 14 and 27 days. No difference between 
mitomycin C treated and non-treated lysed cells was noted. 
These experiments indicate a complex series of growth 
stimulation and inhibition that is dependent on both feeder 
cell number, duration of cells in culture and treatment 
with mitomycin c. In both experiments 105 untreated non-
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lysed LT-2 suppressed cloning of AU-471. No effect was 
noted with 103 LT-2 and a feeder effect (increase in cloning 
efficiency) was noted with 104 LT-2~ Similar results have 
been suggested in other experiments. Low numbers of LT-2 
cells generally have no effect "feeder" or inhibitory, but 
stimulation occurs with higher numbers of cells and finally 
inhibition occurs with large numbers of feeder cells. Sup-
pression with large numbers of cells might result from com-
petition for nutrients, direct toxic effect was suggested in 
the first experiment using untreated lysed LT-2 cells, and 
was not noted with 10S mitomycin C lysed cells (Table 15). 
Direct toxic effect was also not confirmed in the second ex-
periment with either untreated or mitomycin C treated lysed 
cells. Nutrient competition might explain the marked sup-
pression in cloning with 10S untreated LT-2 cells in both 
experiments, but this "competition" is eliminated by mi-
tomycin C treatment. 
7. CONDITIONED MEDIA 
The effect of conditioned media rather than intact 
cells or lysed cells was evaluated. A cloning efficiency 
of 3.8% (32 colonies) was noted at 17 days and a final effi-
ciency of 5.9% (59 colonies) by 28 days (Table 17). No in-
crease was noted in cloning efficiency with 15 or 30% condi-
tioned or spent media (SM) from AU-471, but a significant 
TABLE 17 
DOSE DEPENDENT TRANSFER OF INCREASED CLONING 
EFFICIENCY BY CONDITIONED MEDIA FROM LT-2 AND M.s.a 
Source of Percent 
+ Conditioned Conditioned Colony Count (Mean - S.D.) 
Media Media Day 17 p Day 28 p 
0 0 32 ± 10 - 59 ± 7 
AU-471 30 31 ± 6 N.S. 55 ± 12 N.S. 
AU-471 15 26 ± 4 N.S. 53 ± 9 N.S. 
LT-.2 30 74 ± 11 .001 101 ± 14 .001 
LT-2 15 51 ± 11 .02 71 ± 15 . N. S. 
M.S. 30 81 ± 14 .001 77 ± 47 N.S. 
M.S. 15 70 ± 8 .001 100 ± 18 .005 
a = Good growth and viability of AU-471 control cultures on the bottom of culture 
plates with 30% conditioned media from all three cell lines and overlaid with 
soft agar 
.... 
.c. 
0 
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increase (P<0.001) was noted with 30% LT-2 SM at both 17 
and 28 days. A significant increase was also noted with 15% 
LT-2 SM (P<0.02) at 17 days, but not by 28 days. A signifi-
cant increase (P<.001) was also noted with both 15 and 30% 
SM from M.S. at 17 days, but only with the 15% SM by day 28. 
Good growth and colony formation was noted in all preplated 
controls showing cell viability and growth capabilities or a 
substratum. 
This experiment indicates that "feeder effect" can be 
obtained with spent media from LT-2 or M.S. Feeder effect 
was more apparent when cultures were scored early rather 
than later as noted in co-cultivation experiments, and a 
dose response increase was noted with LT-2 conditioned media 
at both day 17 and day 28. No inhibitory effect was noted. 
8. SUMMARY OF AGAR FEEDER EXPERIMENTS 
Stimulation of anchorage independent soft agar growth 
in co-cultivation experiments was noted with a variety of 
cell types both benign and malignant- AU-471, LT-2, WI-38 
and M-S. Co-cultivation stimulation could generally be 
noted by two weeks, but results by 4 weeks were more varied 
suggesting that the "feeder effect" stimulated growth 
early, but that un-fed cultures eventually caught up, per-
haps by conditioning their own media or production of 
growth stimulant factors.· Control cultures generally demon-
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strated a greater proportional increase in cloning effi-
ciency between early {2 weeks) and late {3-4 weeks) read-
ings. "Feeder effect" was not noted when control culture 
showed high cloning efficiencies {>23%) by two weeks. Ef-
fects of very low {2000 cells) numbers of co-cultivated 
cells showed no "feeder effect". High concentrat-ions of LT-
2 cells sometimes produced decreased cloning efficiency. 
Feeder effect was most consistently noted with 
10,000-50,000 feeder cells. Mitomycin C treated and lysed 
LT-2 cells were generally not inhibitory, but high numbers 
of untreated lysed LT-2 cells were inhibitory. Mitomycin C 
treated LT-2 cells were less effective as feeders and gen-
erally did not suppress. 
9. LT-2 CELL PROLIFERATION IN SOFT AGAR AND THE EF-
FECTS OF CYTOCHALASIN B 
Four experiments were done to evaluate the number of 
cells in soft agar versus time in culture and the effects 
of cytochalasin B {an inhibitor of all movement). The pe-
riod of observation was generally two to three weeks. 
Counts of the numbers of cells per 150x microscopic field 
for each of five fields in {generally) five plates were re-
corded on day one of.each experiment and repeat counts were 
recorded at approximately weekly intervals. The initial 
experiment compared untreated LT-2 cells with mitomycin C 
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treated LT-2 cells (Table 18) .• A significant increase in 
the number of cells per field (16.5 on day one to 26.1 by 
day 23 was noted (P<0.0001), but no increase in mitomycin C 
treated LT-2 controls. 
A preliminary experiment suggested cytochalasin B 
treated LT-2 cells also proliferated in soft agar~ Micro-
colonies consisting of aggregates of 8 - 12 cells were also 
noted, but cannot be attributed to the effect of cytochala-
sin B since similar microcolonies were noted in control un-
treated LT-2 plates and had on occasion been noted in other 
LT-2 soft agar experiments. Another experiment confirmed 
LT-2 proliferation (P<0.0001) in the presence of cytochala-
sin B, but no colony formation was noted {Table 19). No 
proliferation of untreated LT-2 was noted. Pre-plated con-
trol cells were noted to be healthy and proliferating on day 
1 and day 14. 
A final experiment, compared untreated, mitomycin C 
treated, and cytochalasin B treated LT-2, and showed a sig-
nificant increase in the number of cells per Hpf between day 
1 and day 8 or 18 in untreated and cytochalasin B treated 
LT-2 cells {P<0.0001), but no increase in the number of mi-
tomycin C treated {control) cells (Table 20). The increase 
. 
in cell number occurred early in the experiment (between 
day 1 and day 8) since no further increase was noted be-
tween day 8 and day 18. 
TABLE 18 
TIME-INDEPENDENT INCREASE IN THE NUMBER OF DISCRETE LT-2 CELLS 
LT-2 
Treatment 
0 
100 _.u.g + mc/ml 
IN SOFT AGAR CULTURES WITHOUT COLONY FORMATION 
Cell Countsa 
Day 1 Day 8 Day 23 
17 21 26 
19 19 19 
pb 
.0001 
N.S. 
a = Mean count of number of cells per 5 high power microscopic fields from 5 
plates (25 values) 
b = Analysis of variance by Waller-Duncan K-ratio T test 
... 
~ 
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TABLE 19 
EFFECT OF CYTOCHALASIN B ON THE GROWTH OF LT-2 CELLS IN SOFT AGAR 
Treatment 
of LT-2 
5 .AA3 CB/ml 
l...lAg CB/ml 
5 ,.u.g CB/ml 
0 
Day 1 
20 
56 
50 
54 
Cell Countsa 
Day 7 Day 16 pb 
Experiment 1 
26 30 .0001 
Experiment 2 
70 89 .0001 
75 91 .0001 
50 51 N.S. 
a = Mean count of number of cells per 5 high powered microscopic field from 5 
plates (25 values) 
b = Analysis of variance by Waller-Duncan K-ratio T test 
CB = Cytochalasin B 
N.S. = Not significant 
.... 
~ 
V1 
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TABLE 20 
EFFECT OF CYTOCHALASIN B AND MITOMYCIN C ON THE GROWTH OF 
Treatment 
of LT-2 
0 
1~ CB/ml 
100 ,.,v.g + mc/ml 
LT-2 CELLS IN SOFT AGAR 
Cell Counta 
Day 1 Day 8 Day 18 
38 61 55 
44 64 60 
44 44 43 
pb 
.0001 
.0001 
N.S. 
a = Mean count of number of cells per 5 high powered fields from 5 plates (25 values) 
b = Analysis of variance by Waller-Duncan K-ratio T test 
CB = Cytochalasin B 
+me = Mitomycin C 
N.S. = Not significant 
.... 
.. 
0'1 
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In summary, these experi~ents indicate that LT-2 may in 
fact divide early in soft agar, although only a 68.2% to 
73.0% increase in total cell number was noted. This small 
increase in cell number may only represent cell division of 
LT-2 cells already committed to cell division prior to 
plating in soft agar. Cytochalasin B did not inhibit this 
cell division, but approximately the same per cent increase 
in cell number was noted (67.1, 63.1, 55.1%). No colonies 
were noted with cytochalasin B treatment. 
10. SOLUBLE PRODUCTS: PROTEIN EXTRACT FROM AU-471 
Experiments were done to evaluate protein extracts of 
AU-471 on soft agar cloning of LT-2. 
No LT-2 soft agar colonies were noted when cultured 
with 20, 310 and 1000- g per culture of KC1 protein ex-
tracts from AU-471 with and without FCS. Preplate controls 
showed good viability with an estimated 75% of cells at-
tached to the surface with 50% of cells spreading on the 
substratum. A few small 4-6 cell colonies were noted indi-
eating cell growth in the FCS(+) plates. Preplates without 
FCS(-) showed good viability and attachment, and only 10% 
of cells flattened out on the surface. No toxic effect was 
. 
noted from the AU-471 protein extract, but no soft agar 
colonies were noted. 
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11. CELL CLUMPS IN SOFT AGAR 
Attempts were made to determine if small aggregates of 
LT-2 cells, could proliferate in agar using the cell clump 
as a point of anchorage. The possibility that a small ag-
gregate of cells might "condition" the media in the local 
microenvironment of the clump was also considered. 
Review of serial photographs of small clumps of cells 
in soft agar showed no change in size indicating any addi-
tional significant growth in soft agar when plated in cell 
clumps (see Figure 13, 14, and 15.). 
12. ENZYME TREATMENT: CARBOHYDRASES, NEURAMINIDASE 
Many cell functions are controlled by membrane glyco-
proteins. Enzyme treatments were used to alter the membrane 
surface glycoproteins. Experiments were done to determine 
the effect of such enzyme treatments on anchorage indepen-
dent growth. 
Preplate controls overlaid with agar showed some col-
ony formation indicating cell viability and growth cap-
abilities following enzyme treatment. Light "speckling" 
consisting of microcolonies generally in the range of 10-15 
cells per colony were noted in control untreated plates and 
also in treated plates. A few microcolonies consisting of 
10-15 cells were noted in both~ andj3 glucosidase plates. 
Sp~ckling was frequently noted even in untreated culture 
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Figure 13. Cell clump of LT-2 plated in soft agar and se-
rially photographed. Top Day 1; Middle Day 7; Bottom Day 
14. 
Figure 14. Cell clump of LT-2 plated in soft agar and se-
rially photographed. Top Day 1; Middle Day 7; Bottom Day 
1 4 • 
15 0 
Figure 15. Cell clump of LT-2 plated in soft agar and se-
rially photographed. Top Day 1; Middle Day 7; Bottom Day 
1 4 • 
1 5 1 
r 
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plates after 4 weeks when seeded with 105 LT-2 cells. This 
speckling generally consisted of dead cells and cell debris 
noted when the agar began to dry, making interpretation 
difficult. The microcolonies noted did not appear to cons-
ist of healthy or viable cells. 
No anchorage independent colony formation was noted 
following incubation and plating of LT-2 with neuramini-
dase. No definite conclusions can be drawn from these ex-
periments since several possible explanations exist includ-
ing the possibility that important membrane glycoproteins 
receptors are important in anchorage independent growth, 
but are buried in the cell membrane or some manner protected 
from the actions of the enzymes used. 
13. EFFECTS OF cGMP AND HEPES BUFFER 
No anchorage independent growth of LT-2 was noted in 
separate experiments using cGMP or Hepes buffer. 
14. EFFECTS OF AGAROSE AND/OR DEAE 
No colonies (25 cells/colony) were noted with LT-2 
cells plated in agarose or with DEAE. Small clusters (mi-
crocolonies) consisting of 5-15 cells were noted in both 
test and control plates of agarose and DEAE experiments, 
and no enhancement of anchorage independent growth could be 
attributed to elimination of negatively charged ions. The 
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presence of some "microcolonies" was frequently noted where 
LT-2 was plated in high concentration. (1 x 105 cells per 
60 min. soft agar plate.) 
Agar contains contaminating negatively charged ions 
which might inhibit anchorage independent growth. Increased 
cloning efficiency has been reported using agarose (205). 
No effect was noted using agarose. No clones were noted us-
ing the chelating agent DEAE. Heparin (negatively charged 
molecule) has been reported to decrease cloning efficiency 
in soft agar (206). 
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F. FIBRONECTIN 
Fibronectin has been noted to restore normal cellular 
behavior and morphology of in vitro tumors. Experiments 
were designed to evaluate the effect of fibronectin on 
anchorage independent growth (Table 21). Fibronectin 
significantly increased (P<0.01) the cloning efficiency of 
AU-471 in soft agar. A more pronounced effect was noted 
when cultures were scored early in ~xperiments (2, 5, 6, and 
7 fold increases) compared to later (0, 1.9, 2 and 3.1 fold 
increases). 
Increased cloning efficiency following FBN treatment 
was also noted with BHK-21, but again the increase was noted 
only early in experiments similar to results obtained with 
"feeder" experiments (Table 22). 
No clones were noted with FBN treatment with cell 
lines that do not clone in soft agar (LT-2, WI-38, M.S.). 
Antifibronetin treatment of AU-471 resulted in complete 
suppression of soft agar colony formation. No toxicity was 
noted in preplate controls plated with antifibronectin and 
cell attachment was noted. Normal goat serum added in 
comparable concentrations was not statistically 
significantly different from control plates without NGS 
(Table 23). 
Antifibronectin treatment of BHK-21 resulted in 
TABLE 21 
ENHANCED CLONING EFFICIENCY OF A MALIGNANT 
CELL LINE - AU-471 BY FIBRONECTIN 
Treatmentb 
Colony Count (Mean± S.D.) 
Experiment Day 16 pa Day 28 pa 
1 0 12 ± 2 - 108 ± 17 
+FBN 84 ± 20 .03 200 ± 8 .007 
Day 13 p Day 31 p 
2 0 12 ± 3 - 91 ± 4 
+FBN 61 ± 6 .001 284 ± 17 .001 
Day 14 p Day 31 p 
3 0 41 2" 8 - 272 ± 18 
+FBN 83 2" 5 .008 264 2" 16 N.S. 
Day 13 p Day 30 p 
4 0 12 2" 1 - 168 :1: 6 
+FBN 71 ± 9 .008 335 ± 19 .004 
a = P values compare significance to cultures with 0 FBN 
b = Good growth was noted by untreated and +FBN cells plated on the bottom of 
_. 
culture plates and overlaid with agar V'l 
V'l 
Treatment 
0 
+FBN 
0 
+FBN 
TABLE 22 
ENHANCED CLONING EFFICIENCY OF AN ANCHORAGE INDEPENDENT 
"NORMAL" CELL LINE - BHK-21 BY FIBRONECTIN 
Experiment 1 
Colony Count 
Day 14 pa 
146 ± 5 
191 :!: 8 .004 
Experiment 2 
Day+13 
412 - 21 
881 :!: 20 
pa 
.0001 
+ (Mean- S.D.) 
Day 31 
169 ± 4 
215 :!: 9 
Day+30 
434 - 11 
864 :!: 24 
pa 
.01 
pa 
.0001 
a = P values compare 0 FBN with +FBN cultures 
-U1 
0\ 
TABLE 23 
SUPPRESSION OF SOFT AGAR CLONING EFFICIENCY OF AU-471 
Treatmentd 
0 
Anti-FBNa 
NGSb 
a = Anti-FBN - antifibronectin 
b = NGS = normal goat serum 
BY ANTIFIBRONECTIN 
+ Colony Count (Mean - S.D.) 
Day 14 Day 26 
7 ± 2 
0 
Colonies too small 
to score 
46C ± 8 
0 
29C ± 4 
c = No statistical significant difference between control cultures with PBS 
or NGS 
d = All cells demonstrated good viability when incubated with PBS, Anti-FBN or 
NGS and plated on the bottom of culture dishes and overlayed with soft agar 
... 
1.1'1 
..... 
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significant suppression of cl9ning efficiency at 14 days 
p = 0.0008) and day 26 ( = .007), but normal goat serum 
also produced significant suppression (P = 0.009 at day 14, 
p = .008 at day 26). There was no statistical significance 
between antifibronectin treated and normal goat serum 
treated. The reason for clone suppression by normal goat 
serum was not evident. (Table 24). 
TABLE 24 
SUPPRESSION OF SOFT AGAR CLONING EFFICIENCY 
OF BHK-21 BY ANTIFIBRONECTIN 
Colony Count (Mean± S.D.) 
pf Day 26 pf Treatmente Day 14 
0 198 ± 4 - 215 ± 9 
NGsa 138 ± 19C .009 133 ± 23d .008 
Anti-FBNb 129 ± 8C .0008 153 ± 15d .007 
a = NGS = normal goat serum 
b = Anti-FBN = antifibronectin 
c = No statistical significant difference between Anti-FBN and NGS at day 14 
d = No statistical difference between Anti-FBN or NGS at day 26 
e = All cells demonstrated good viability when incubated with PBS, Anti-FBN 
or NGS and plated on the bottom of culture dishes and overlayed with soft 
agar 
f = P values compare significance to 0 treatment control groups 
~ 
VI 
1.0 
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G. CELL SU3STRATUM AND ANCHORAGE INDEPENDENCE 
AU-471 grows as heaped up or piled up cells, 
indicating lack of contact inhibition and has a high 
saturation density. Cells harvested from flasks indicate 
that floating cells composed 8% of the total AU-471 cells, 
and were 85.2% viable. Loosly attached cells composed 74% 
of total cells and were 91.0% viable. Substratum attached 
cells accounted for only 18% of the total cell population 
and were 88.2% viable. 
These findings were in marked contrast with LT-2 which 
grows as a strict monolayer where floating cells composed 
5% of the total with only 7.3% viable. Loosely attached 
cells composed only 1.28% of total cells and were all dead. 
Substratum attached cells constituted 93.7% of total cells 
and were 62.2% viable. 
Soft agar plating of floaters, loosely attached and 
substratum attached· AU-471 cells at 2 x 103 cells per plate 
revealed a significant difference in cloning efficiency at 
14 days of floaters compared to loosely attached (P = .0002) 
and substratum attached cells (P = .0001). There was no 
difference between loosely attached and substratum attached 
cells (Table 25). 
Similar results were noted at 26 days, with 20 x 103 
cells per culture significant differences were also noted 
Type 
Cells 
F.L. 
L.A. 
S.A. 
F.L. 
L.A. 
S.A. 
TABLE 25 
SOFT AGAR CLONING EFFICIENCY OF FLOATING, LOOSELY ATTACHED 
AND SUBSTRATUM ATTACHED AU-471 CELLS 
Number Viable 
Cells x 103 
Colony Count (Mean± S.D.) 
Day 14 p Day 26 p 
2 59 ± 2 - 177 ± 2 
2 5aa± 3 .0002 86b± 9 .002 
2 11a± 2 .0001 83b± 5 .0001 
20 1400 ± 50 - 2603 ± 45 
20 598C ± 16 .0006 2057d± 82 .004 
20 43QC ± 2 .0001 1072d± 5 .0001 
F.L. = Floating cells a= N.S. (No significance)between groups 
lettered "a" 
L.A. = Loosely attached cells 
S.A. = Substratum attached cells 
b = N.S. {No significance) between groups 
lettered "b" 
c = N.S. (No significance) between groups 
lettered "c" 
d = Significant at P = .0002 between groups 
lettered "d" 
.... 
0'1 
.... 
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between floaters and loosely attached cells (P = .0006) and 
substratum attached (P = .0001) and similar findings were 
noted at 26 days. No differences w~re noted between 
loosely attached and substratum attached cells at 14 days, 
but a significant difference was apparent by day 20 (P = 
.0002). 
·I 
H. NUDE MICE 
The ultimate test of tumorgenecity of an in vitro 
cultured cell line is growth and tumor production in an 
appropriate animal host like the nude mouse. Experiments 
were done to evaluate LT-2 tumorgenecity in nude mice. 
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Tumor nodules were noted in one of two nude mice 
injected s.c. with 4 x 106 v. LT-2 (Table 26). This nodule 
was harvested after seven months observation. One of two 
animals receiving 8 x 166 v. LT-2 cells s.c. developed two 
nodules which were harvested at three months and were 3 x 4 
mm and 2.5 x 2.5 mm respectively. Three of four animals 
inoculated with 10 x 106 v. cells s.c. were sacrificed after 
four and one half months with nodules measuring 4 mm, 3mm 
and 2 mm (Figure 16.). The exact interval from injection to 
first appearnace was difficult to evaluate. In one animal 
receiving 10 x 106 v. LT-2 cells, the s.c. "bleb" produced 
by injection never fully disappeared before enlargement 
began. Once a visible lesion was definitely discernable 1/2 
- 1 mm, growth was very slow. No metastasis was noted in 
animals receiving s.c. injections that developed tumor 
nodules. Histologic section revealed a relatively 
well-differentiated epithelial tumor (Figure 17) compared to 
the original tumor (Figure 18). Injected cell suspensions 
had organized themselves into a well recognizable 
TABLE 26 
NUDE MICE 
No. Cell Route of Date Date 
No. Mice Cells Type Injection Injected Harvested 
2 4x1o6 LT-2 S.C. 4/28/78 11/29/78 
4 8x1o6 LT-2 s.c. 8/05/78 10/11/78 
4 10x1o6 LT-2 s.c. 7/17/78 11/29/78 
3 5x1o6 LT-2 I. v. 4/28/78 6/20/78 
7/06/78 
. 
3 1x1o6 LT-2 I. v. 4/28/78 7/26/78 
8/8/78 
4 1x1o6 LT-2 I. v .. 5/12/78 11/28/78 
2 2x1o6 AU-471 I. V. 5/02/78 6/20/78 
7/06/78 
*Two separate nodules noted in one mouse. First noted at 7 weeks. 
Duration Nodule 
7 months 1/2 
approx. 2 mos. 2/4* 
approx.4-1/2 3/4 
mos. 
Metastasis 
33 days 0 
49 days 
89 days 0 
102 days 0 
200 days 0 
49 days 0 
65 days 0 
0'1 
~ 
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Figure 16. Nude mouse showing growth of tumor nodule. 
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Figure 17. Histology of nude mouse nodule showing organiza-
tion into an epithelium with differentiation reflected by 
keratini toward the center of the nodule. (Hematoxylin and 
eosin.) 
Figure 
node. 
18. Patient 
(Hematoxylin 
M.L. biopsy 
and eosin x 
of right 
1 2 5. } 
16 7 
inguinal lymph 
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epithelium. All nude mouse nodules demonstrated central 
keratinization with cells becoming flattened and hyalinized 
as they progressed toward the center of the nodule 
indicating cell differentiation as they progressed inward 
in the tumor nodule (Figure 19). Some cells demonstrated 
bi-or-tri-polar mitotic plates. Some mononuclear. 
inflammatory cells were noted to surround some nodules 
suggesting a host (nude mouse) immune reaction. 
Two nude mice tumor nodules were successfully cultured 
in vitro. Cell morphology remained similar to LT-2 with 
strict monolayer growth and no piling or heaping up of 
cells. No change in growth characteristics or morphology 
could be noted. 
Subsequent soft agar cultures of the two in vitro 
cultured nude mouse nodules showed no anchorage independent 
growth. Karyotyping of these cells indicated that they were 
of human origin with metacentric, submetacentric and 
acrocentric chromosomes present. The cells were aneuploid 
with considerable variation in chromosomal number similar 
to karyotyping of LT-2 prior to nude mouse injections 
(Table 27). Control nude mouse skin cells were also placed 
in culture and revealed only telocentric chromosomes 
characteristic of mouse cells. 
No metastasis to liver, spleen, kidney or other 
peritoneal cavity was noted in 10 mice injected 
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Figure 19. Cross section and high-power magnification of 
nude mouse nodule showing epithelial formation with keratin-
ization. 
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TABLE 27 
LNM 7 (NUDE MOUSE LINE-7) CHROMOSOME FREQUENCY 
DISTRIBUTION OF 18 CELLS 
Cells: 2 2 1 1 2 1 1 
Chromosomes:57----=s9----61----~62----~63----~64----~65 ____ _ 
Cells: 2 2 1 1 2 Chromosomes:67----=69----7o----=71----=73 ________________ _ 
intravenously with 1 x 106 or 5 x 106 v. LT-2 cells or in 
the mice injected with 2 x 106 v. AU-471. Duration of 
observation ranged from 33 days to 200 days. 
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CHAPTER V 
DISCUSSION 
Vulvar carcinomas comprise 3-4% of gynecologic malig-
nancies (207). These squamous cell carcinomas dlffer from 
other skin cancers arising elsewhere in the body in that 
they are particularly malignant with an overall five year 
survival rate of only 60-70%, even with very aggressive 
therapy. Isolation of LT-2 in tissue culture afforded a 
good opportunity to study in detail an uncommon malignancy. 
Such studies have revealed some particularly interesting 
properties. 
The only absolute test of malignancy for an in vitro 
cell line is its biological behavior in the autologous 
host. Because such testing is impossible, a variety of al-
ternate test systems and criteria have been developed to 
evaluate the malignant potential of cultured cells. 
Based on extensive study of the growth properties of 
human embryonic and adult lung fibroblasts, Hayflick (208) 
postulated the following criteria for malignancy in vitro: 
1. Heteroploidy 
2. Morphology (histologic 'criteria of malignancy) 
3. Indefinite growth (ability to be propagated con-
tinually in culture). 
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Other criteria of malignancy include growth in an immu-
node!icient test animal (nude mouse) and/or anchorage inde-
pendent growth in soft agar (209, 210, 211, 212). These 
criteria have been accepted and confirmed to some extent by 
many investigators, but some apparently "normal" cells have 
also been established in continual cell culture. Although 
most normal human cells in tissue culture undergo senescence 
and will not proliferate past 50-70 generations, occasional 
normal cells undergo an "immortality event", generally with 
a change in cell growth kinetics resulting in a continuous 
proliferating cell line (213, 214). Although initially di-
ploid these cells generally convert to a heteroploid kary-
otype in tissue culture. "Normal" diploid cells in culture 
can also mimic the morphologic appearance of malignant 
cells. While mimicking some of the properties of malignant 
cells, these immortal or established presumably non-malig-
nant cell lines have not been found to produce clones when 
cultured in soft agar, and do not produce tumors in 8-10 
weeks when injected into an appropriate animal model like 
the nude mouse (215). 
Therefore, the definitive criteria of malignancy remain 
1. the ability of the cells in question to proliferate into 
progressively growing tumors in syngeneic, immunosup-
pressed, or immuriodeficient animals, and 2. anchorage-inde-
pendent cell growth, such as in soft agar suspension. 
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Cultured LT-2 cells amply satisfy Hayflick's criteria 
of malignancy in vitro, with a heteroploid chromosome 
complement, abnormal cytology, and continued growth in cul-
ture beyond 70 generations. Most important, LT-2 cells sat-
isfy the criteria of Shin et al (216) for tumorigenicity in 
the nude mouse, consisting of the appearance of a palpable 
nodule at the site of injection within 10 weeks, and colony 
formation in soft agar suspension. Although such criteria 
are the most stringent currently available, they are not 
infallible. For instance, malignant tumor cells taken di-
rectly from a cancer may not grow in a nude mouse because of 
metabolic considerations. Unfortunately, no single cellu-
lar property has been found which adequately defines the 
malignant state. The present criteria of malignancy of in 
vitro cells are based on a variety of parameters which in-
clude the heterogeneous properties of cancer cells, but ex-
clude normal cells. 
Concern has been expressed regarding the use of cul-
tured cells as models of malignancy, because of possible 
selective pressures occurring in vitro with resulting al-
terations in antigenicity or metabolism compared to the 
original tumor. Such concerns are valid and alteration in 
any given parameter may occur in vitro within the limits im-
posed by the genetic information of the cells. On the other 
hand, many cell lines maintained in culture for long peri-
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ods have continued to express properties of the original 
tumor type. For example, the BeWo cell line (a choriocar-
cinoma) has continued to secrete hCG despite 11 years in 
tissue culture (217). Isoenzyme phenotypes in cultured 
cells nave also been found to remain stable, even in the 
face of karyotype instability, treatment with mutagens, and 
malignant transformation (218, 219). In studies of kary-. 
otype stability in long-term cultures, Fraccaro (220) noted 
that abnormal karyotypes do not necessarily predispose to 
instability, and long-term cultures may accurately reflect 
the tissue of origin. The RPM! 2650 cell line was reported 
to show very little change in karyotype over a period of 
one year in culture. (221). 
Other studies of cell lines have noted a numerical 
drift in chromosome complement in culture (222). Analogous 
exceptions to the stability of other malignant cell prop-
erties during continual culture have also been reported 
(223). Consequently, interpretation of observations using 
any cultured tumor cell line must be made in view of al-
terations that may result from continual cell propagation in 
vitro. 
However, alterations in cell properties may not be li-
mited only to malignant cells in vitro. Altered subclones 
may also occur in vivo in any large tumor cell population 
as a result of spontaneous mutations or selective pressures 
176 
occurring in the expanding tumor cell population. Even a 
one centimeter tumor represents nearly 30 cell doublings and 
more than one billion cells, giving ample opportunity for 
development of subclones. In fact, Baumal and Scharff (224) 
noted subclones of MOPC 173 myeloma cells produced by in 
vivo passage, as judged by their immunoglobin secretory pro-
ducts. In vivo development of subclones is also indicated 
by non-CEA producing primary tumors with CEA producing meta-
stases. Harvey et al (225) demonstrated heterogeneity of 
immunoreactive CEA extracted from various tumors, showing 
differences in carbohydrate composition and molecular 
weight. No immunoreacti~e CE~ was found in breast carcino-
mas (an epithelial tumor), but CEA activity was found in 
metastases in the liver, verifying subclonal variation of 
tumors in vivo. Similarly, a CEA producing tumor recurring 
following treatment may no longer express CEA activity. 
Thus, alteration in karyotype or phenotypic expression in 
malignancies may occur both in vivo and in vitro. 
Interestingly, after 4 years in tissue culture and 
after passage through nude mice and reculiuring in vitro, 
the karyotype of LT-2 still revealed a wide separation in 
chromosome numbers with no modal number (variations from 57 
to 73 chromosomes in 18 karyotypes). Despite the presence 
of many subclones and markedly variable chromosomal number 
and continued growth and subcultivation in tissue culture, 
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LT-2 was still capable of some degree of differentiation as 
noted in the nude mouse tumor nodule. A single cell suspen-
sion was injected subcutaneously on the back of nude mice, 
resulting in the formation of a tumor nodule. This nodule 
was not a mass of unorganized cells or tissue, but instead 
formed into a recognizable skin with cells further differen-
tiating towards the center of the nodule forming keratin. 
This remarkable cell differentiation would appear to be 
ploidy-independent, since the cells injected and recovered 
consisted of many subclones with variable chromosomal num-
bers and morphology. 
Similarly, over the years of observation with close to 
one thousand soft agar cultures using LT-2, no anchorage 
independent growth could be demonstrated. (Small clusters 
of cells were frequently noted, but no colonies over 25 
cells.) LT-2 also continued to grow as a strict monolayer 
with minimal heaping-up of cells as noted with most malig-
nant cells grown in culture. The stability of these cell 
phenotypes despite the wide karyotypic variability suggested 
that these phenotypes may also be ploidy-independent. Al-
though there may be a variety of explanations, the work of 
Jacob and Monod regarding control of gene expression would 
appear to be pertinent (226). St"udies of the induction of 
the a-galactosidase (lac) gene in bacteria revealed a re-
pressor gene product wnich controlled expression of 8-ga-
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lactosidase. Mutations in the regulator gene resulted in 
constitutive expression. There are only about 10 soluble 
repressor molecules for the lac gene in Escherichia-coli 
(227). The balance between the availability of repressors 
and binding sites on the structural gene operon (operator) 
is critical. If a similar repressor control system is pre-
sent and operational in eukaryotic cells, it is not unre-
asonable to expect the ratio of repressor molecules to op-
erator binding sites to be important. Variations in chro-
mosomal number may result in disturbances of such a deli-
cate ratio when the repressor and operator are physically 
located on different chromosomes. Repression or derepres-
sion of gene function might consequently result from varia-
tion in chromosomal number. 
Cancer cells with karyotypic variations might therefore 
result in variations in expression of ploidy-independent 
phenotypes, while ploidy-independent phenotypes and func-
tions would remain inviolate. Obviously all genes have a 
degree of ploidy-independence in that the total lack of a 
gene results in an absence of expression. Yet, much of the 
cell metabolism and basic housekeeping functions of cells in 
culture can occur despite considerable variation in kary-
otype and even some degree of differentiation, as clearly 
demonstrated by LT-2. These basic cell functions for all 
intent and purpose, would appear to be ploidy-independent. 
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on the other hand, consistent cell regulation and control 
as evident in normal cells in the total organism would ap-
pear to be much more sensitive to variations in chromosomal 
number. Most embryos with abnormal karyotypes are aborted 
and one has only to consider the many problems of the 
Down's Syndrome child born with 3 No. 21 chromosomes, to ap-
·preciate the effects of even small changes in the delicate 
balance of gene dose. 
A definition of an in vitro ploidy-independent pheno-
type could be the following: a consistent expression of a 
phenotype or function despite considerable karyotypic varia-
tion in a large number of cells. Also important in such 
consideration is the stability of the karyotypic varia-
tions. If cell chromosomal sorting at the time of mitosis 
is highly variable, the potential of a whole spectrum of 
cells with wide karyotypic variation and consequently 
ploidy-independent phenotypes would be realized. Ploidy-
independence arising from karyotypic variation might require 
repressor and operator genes to reside on different chromo-
somes or at least different loci on translocated chromo-
somes. Undoubtedly large tumor populations could poten-
tially express new (derepressed) genes, secondary to loss of 
environmental controls (soluble regulators) or from mutation 
of repressor genes on the same chromosome with selection 
for such positive cells. 
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The patient M.L., discussed in this report, was found 
to have a serum CEA concentration of 9.8 ng/ml, despite the 
epithelial origin of her vulvar tumor. Subsequently, cul-
tured cells LT-2 derived from a lymph node metastasis of 
this tumor were found to produce .877 ng CEA/106 cells/day 
(above fetal calf serum CEA levels). The presence of CEA 
activity noted both in vivo and in vitro and subsequent l?SS 
with passage in culture reflect the dynamic state of tumor 
cells which may occur both in the test tube or in the pa-
tient. These vagaries are the realities which must be con-
sidered by both cancer researchers and therapists. 
Sensitization to CEA in s?me cancer patients has been 
reported. Gold (228) noted circulating antibodies against 
CEA, and Costanza et al (229) noted CEA antibody complexes 
in a patient with nephrotic syndrome and colon cancer. The 
secretion of CEA by cells in tissue culture may explain some 
cases of specific lymphocyte mediated cytotoxicity or lym-
phoblast transformation in CEA sensitized patients. Fetal 
calf serum (FCS) should not be used in either test (LMC or 
lymphoblast transformation) since sensitized patient lym-
phocytes could potentially respond to the CEA in FCS. 
An intriguing line of investigation suggested by pro-
perties of the LT-2 line is the apparent relationship be-
tween human malignancy and cellular production of the beta 
subunit of human chorionic gonadotropin (~-hCG). McManus et 
181 
al (230) have demonstrated,~-hCG on the cell surfaces of 25 
or 28 different tumors using peroxidase-labelled antibody 
staining. Active tumor cell production of B-hCG in vitro 
has also been noted, not only in this study of LT-2 which 
secretes about 4 ng/106 cells/day (0.1% of thefi-hCG pro-
duction noted in the choriocarcinoma cell line BeWo), but 
also by the cervical carcinoma cell line CaSki (231) and an 
ovarian carcinoma cell line (232). 
The only non-malignant source of biologically active 
hCG known is trophoblastic tissue, which actively invades 
the uterine endometrium during early pregnancy. Serum con-
centration of hCG begins to decline during gestation at 
about the same time that active endometrial invasion by 
trophoblasts ceases (233). (A recent report suggests low-
level hCG production by liver and colon of normal individu-
als, but this hCG is apparently non-functional) (234). 
LT-2, a relatively well-differentiated cell line de-
rived from a metastatic lesion also produces and secretes 
the beta subunit of hCG. Further research will be needed to 
determine whether the expression of/.1-hCG by such a wide va-
riety of tumors as noted by McManus et al is integrally in-
volved in the cancer process or simply the random expres-
sion of a normally repressed gene. (235). 
LT-2 retained its original ABH blood group type. Many 
tumors have been reported to change their blood group types 
(236). 
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Despite some of the malignant properties of LT-2 like 
continued growth in culture, abnormal karyotype, lectin ag-
glutination, production of fetal antigens like CEA, -hCG 
and most importantly growth in vivo in the nude mouse, LT-2 
has retained some normal cell phenotypes. LT-2 grows as a 
very strict monolayer in culture and this is ref~ected by 
the relatively low saturation density compared to AU-471 at 
the same serum concentrations. Low saturation density and 
monolayer growth are frequently used criteria for contact 
inhibition. Yet, frequent cell division can be noted within 
large colonies of cells despite cell contact on all sides. 
Time lapse cinematography has clearly confirmed a lack of 
contact inhibition of both cell division and locomotion by 
LT-2. Abercrombie has suggested that contact inhibition 
can result from the devlopment of strong lateral adhesions 
to adjacent cells during cell-cell collisions or the inabil-
ity of the dorsal surface of one cell to provide an ade-
quate substratum for locomotion for another cell. (237) 
Studies by Middelton (238) in which cells were plated on 
confluent monolayers suggest that the latter phenomenon is 
more important. Time lapse studies by Steinberg also sug-
gest avoidance of overlapping as the main mechanism for 
monolayer growth (239). Both mechanisms might apply to 
monolayering by LT-2. Our time lapse studies have demon-
strated the formation of strong lateral adhesions resulting 
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from cell-cell collision, although these lateral adhesions 
were not sufficient to prevent a colliding cell from moving 
away from a cell colony. Avoidance of overlapping was also 
noted. LT-2's low saturation density would therefore ap-
pear to result not from contact inhibition per se, but from 
a strong tendency to monolayer growth, and may therefore 
result from either the formation of strong lateral adhesions 
and/or the inability to use the dorsal surface of another 
cell for adhesions. A preferential strong adhesion poten-
tial for the plastic substratum rather than another cell 
might also be a possible explanation. 
Holley has noted th.at the. phenotype of contact inhibi-
tion is serum dependence (240). Cell growth continues with 
an increase in saturation density when fresh serum is added 
to contact inhibited monolayer cell cultures. Holley iso-
lated a factor from serum, and Temin (241) isolated a growth 
promoting factor from contact inhibited media of a cell 
line that demonstrated such serum independence. Lipkin 
(242) has also reported a factor produced by contact inhi-
bited cells that restores contact inhibition to malignant 
melanocytes. LT-2 requires growth factors found in serum 
for stimulation of growth, but not for metabolism and cell 
survival as demonstrated by a lack of cell division in the 
absence of serum, but good cell survival. The necessity 
for an additional factor (not in serum) produced by LT-2 for 
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stimulation of cell division is suggested by the inability 
to clone LT-2 in small wells in Cuprak dishes even with 
conditioned media, and the requirement for as many as 
500-1000 cells per well in a 96 well cluster dish to obtain 
colonies and cell growth. The presence of some types of 
growth stimulation is also suggested in the soft agar 
feeder experiments in which LT-2 increased anchorage inde-
pendent cloning efficiency of AU-471. WI-38 also increased 
cloning efficiency of AU-471 in soft agar and is known to 
produce a growth factor unin vitro (243). Since neither 
cell (LT-2 nor WI-38) clones in soft agar, this growth pro-
moting factor would appear to stimulate cell division, but 
not anchorage independent growth per se. Conditioned media 
could also transfer the growth stimulation. Anchorage in-
dependence could not be produced by co-cultiviation of AU-
471 with LT-2, suggesting that these phenotypes are either 
not controlled by a soluble mediator or the mediator is in 
such low concentration or so labile that it is not efficient 
in stimulation of anchorage independent growth by LT-2. 
Spandidos and Siminovitch were able to transfer an-
chorage independent growth by means of metaphase chromo-
somes (244). 
Field count experiments showed a small increase in the 
number of LT-2 in soft agar cultures suggesting that a few 
cells were able to divide in soft agar. These may be cells 
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already committed to cell division before plating in the 
soft·agar. Such anchorage independent growth suggests that 
cell division can occur in an anchoiage independent environ-
ment even by a cell that will not normally clone without 
dnshcrage, and the absence of cell division under the con-
ditions of anchorage independence results from the control 
of the initiation of cell division rather than the inhibi~ 
tion of the division process itself. Stanbridge (245) has 
noted a separation of in vitro transformation phenotypes 
like absence of contact inhibition and lack of density-de-
pendent inhibition of growth, lectin agglutination, serum 
independence, and anchorage independence from malignancy in 
vitro using HeLa and normal fibroblast hybrids. BeLa-fi-
broblast hybrids retained the in vitro transformation 
phenotypes, but lost their in vitro malignancy potential. 
LT-2 also clearly demonstrates that these phenotypes are in-
dependent, but in contrast, LT-2 grows in nude mice demon-
strating its malignant potential, but retains many normal in 
vitro phenotypes that are usually regarded as associated 
with malignancy. 
Fibronectin increased cloning efficiency in soft agar 
of AU-471, but had no effect on LT-2 or WI-38. Anti-fibro-
nectin had a marked inhibitory effect on anchorage indepen-
dent growth of AU-471, but not BHK-21. These experiments 
suggest that fibronectin is necessary but not sufficient for 
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anchorage independent growth. These findings were surpris-
ing since fibronectin has been associated with restoration 
of normal phenotypes and monolayer growth in transformed 
cells. 
Although tumor nodules could be repeatedly produced by 
subcutaneous injection of LT-2, no tumors were produced fol-
lowing intravenous injection of either LT-2 or AU-471. Var-
iation in tumor formation with route of injection is well 
recognized (246}, and might result from differences and lo-
cal microenvironmental conditions or from an active process 
of cell destruction by macrophages or other cells in the 
nude mouse. Interestingly metastases are uncommon even for 
massive subcutaneous tumors in the nude mouse, suggesting 
some controlling mechanism. 
The patient M.L.'s lack of specific tumor antigen rec-
ognition, ascertained by lymphocyte-mediated cytotoxicity, 
lymphoblast transf~rmation and in vivo autologous tumor an-
tigen skin test response, may reflect a lack of antigenic-
ity of her tumor cells or a specific suppression of immune 
response to tumor antigens. However, the absence of general 
immune responses to both microbial recall skin test antigens 
and DNCB is more consistent with a state of total immune 
suppression. Lymphocyte numbers, total T-cell, active T-
cell, and B-cell fractions, and mitogen stimulation of lym-
phocytes are also consistent with a total suppression of 
187 
the patient's immune system. A spontaneous (nonspecific) 
LMC of the patient's lymphocytes versus unrelated malignant 
cells significantly lower than normal lymphocytes is con-
sistent with recent observations that spontaneous LMC is de-
pressed in cancer patients. (247, 248). 
The repeated re-evaluation of both in vivo and in vi-
tro immuno-competency over a 15 month period of observation 
clearly demonstrates the dynamic interaction of the host 
with its tumor and disease process. The presence of a posi-
tive DTH to a bacterial recall skin test antigen (derma-
tophytin-0) which became negative a little over a month la-
ter at the same time that the patient converted from a 
negative to a positive PPD skin test demonstrates the rapid 
development of anergy while retaining the ability to respond 
to a primary immunization with PPD. The response to PPD im-
munization occurred despite the fact that the patient did 
not respond to a primary immunization with another antigen 
- DNCB. Likewise, the marked suppression in cytotoxicity 
discussed above which increased to a statistically signifi-
cant degree shortly before the patient's death also testi-
fies to the dynamic equilibrium between energy and immune 
responsiveness in the cancer patient. It suggests caution 
in interpretation of'studies of immunocompetency in cancer 
patients where observations are made at only a single point 
in time. The variations in responsiveness to PPD and DNCB 
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are another example of the vagaries of the immune systems in 
cancer patients. 
Any immune responses on the part of a tumor host to 
its autochthonous tumor require either the presence of a 
"foreign" or "new antigen" expressed by the tumor or a 
breakdown in the patient's normal tolerance recognition 
system with a resulting response to self antigens expressed 
by the tumor. Both types of responses have been reported in 
tumor patients. No immune responsiveness was noted in this 
study as evaluated by in vivo skin testing with autologous 
tumor extracts and in vitro by lymphocyte blast transforma-
tion in the presence of extracts of the tumor (LT-2). The 
15% specific cytotoxicity noted shortly before the pa-
tient's death suggests that a tumor antigen might be pre-
sent on LT-2. In vitro studies have demonstrated that the 
tumor has retained its original blood group type with no ex-
pression of Rh antigens (normally restricted to red blood 
cells and not seen on epithelial cells), but did express CEA 
which is unusual for an epithelial tumor. The expression 
of fi-hCG (which is normally expressed only by trophoblastic 
cells), and lectin binding (indicating changes in carbohy-
drate composition of the cell membrane which are generally 
noted in tumor cells but not in normal cells), and reactiv-
ity with normal rabbit serum also suggest the presence of a 
"new antigen". All of these findings indicate an "abnormal 
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or unusual" antigen expressed on LT-2 which could have been 
responsible for the cytotoxicity noted. 
Lev in, et al, ( 249) have reported responses of house-
hold contacts of cancer patients to allogenic tumors using 
a cytotoxicity assay. No such antigen exposure of the pa-
tient's sister could be demonstrated using the sister's lym-
phocytes in a blast transformation assay to LT-2 tumor ex-
tracts in this study. 
The cytotoxicity assay used in this study involved the 
use of an in vitro cultured autologous tumor. Most studies 
in the past have involved the use of allogeneic tumor cells 
or on occasion, fresh tumor tissue. The rationale for the 
use of allogeneic tumor is based upon the concept of a 
shared tumor antigen between histologically similar tumor 
types. Unfortunately, the same studies which are used for 
supporting the concept that histologically similar tumors 
share the same common tumor antigen are used as proof of 
cytotoxicity to tumor cells. Proof of a shared "tumor an-
tigen" in most histologically similar tumors in humans is 
poor at best. Dodson and Menon (250) have recently re-
viewed the subject of "tumor antigens", and their possible 
mechanism of production and have emphasized the vagaries of 
antigen expression between different tumors and even be-
tween cells of the same tumor and note that except for vi-
ral antigens, most "tumor antigens" are a reflection of the 
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karyotype and metabolic vagaries of the tumor cell. Al-
though such "tumor antigens" have been amply demonstrated in 
viral induced tumors in experimental animals, and have been 
suggested in humans in Burkitt's Lymphoma and possible ma-
lignant melanoma, their presence in most human tumors is 
questionable. 
The great bulk of tumor cytotoxicity studies are also 
questionable because of the recent observation by Zinkerna-
gel and Daugherty {251) regarding the major histocompat-
ibility restrictions between the cytotoxic effector cell 
and the target cell. In order for cytotoxic T-cells to kill 
virus infected cells expressing new (viral) antigens, the 
lymphocyte and infected cell must share the same histocom-
patibility antigens. This cytotoxicity system - killing 
self cells expressing new antigens (viral in the case of in-
fected cells) would appear to be a similar system to that 
proposed for immune.surveillance in which cancerous self 
cells expressing new antigens are destroyed. Allogeneic 
cells with viral antigens are not killed in this system. 
Undoubtedly, the body contains a mechanism for rejecting 
foreign tissue as demonstrated by graft rejection, but it 
would not appear to be the same cytotoxicity system that 
checks self cells for new antigens since allogeneic cells 
are not affected in the system illustrated by Zinkernagel 
and.Daugherty. A lack of a tumor antigen in histologically 
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similar tumors, and a lack of histocompatability between 
target and effected cells in allogeneic cytotoxicity sys-
tems results in serious questions regarding the great major-
ity of such tumor studies currently in the literature. 
The use of fresh tumor avoids the problem noted above, 
and may give some significant data, but it also raises other 
questions. The general method of processing tumors in-
volves mincing the tissue into small pieces and sometimes 
treatment with enzymes to disperse the cells. Such a pro-
cess results in the presence of many fibroblasts. As a con-
sequence, it is difficult to compare values since a low cy-
totoxicity score may simply reflect a high percentage of 
fibroblasts rather than a lack of cytotoxicity between lym-
phocyte and target cells. Enzymes may modify or destroy 
surface antigens, also raising questions regarding cytotox-
icity data when tissue is processed in this manner. 
Undoubtedly, the use of culture cells can also be 
criticized on the basis that cells may change their pheno-
type, karyotype or other properties while in tissue culture. 
Although such changes may occur in vitro, they may also oc-
cur in the tumor mass in vivo. 
These questions of techniques are not simply academic. 
Cytotoxicity studies have suggested that tumors possess new 
"tumor antigens", and that the immune system is capable of 
destroying tumor cells. Yet the data are in conflict with 
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common clinical observations -that tumor progression is com-
mon and immunological tumor regression is exceptionally 
rare. Enthusiasts of immune surveillance suggest that tu-
mors are common, and that it is the immune system that 
kills most of these tumors very early, before they are 
clinically evident. Unfortunately, the theory has been 
difficult to test clinically, and cytotoxicity data which 
has been used to support the concept of immune surveillance 
is questionable for the reasons discussed above. Perhaps 
there is an immune surveillance system with cytotoxic lym-
phocytes despite the problems with experimental design of 
many cytotoxicity studies previously published. Additional 
research will be needed to answer this question, but should 
be done with autologous tumors and lymphoctyes if relevant 
data are to be obtained. 
A particularly interesting finding in this study is the 
dissociation of the phenotypes of in vivo malignancy and 
anchorage independent growth by LT-2. Only a few tumors 
have been reported that fulfill the stringent criteria of 
tumor formation in the nude mouse, but that will not clone 
in soft agar. The studies and experiments presented here 
raise serious questions regarding the use of anchorage inde-
pendent growth as the ultimate in vitro criterion of malig-
nancy. 
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LT-2 is capable of cell division in an anchorage inde-
pendent environment as revealed by field count experiments 
in this work, but colony formation does not occur. The con-
trol of soft agar cloning would therefore appear to involve 
initiation of cell division rather than a limitation of the 
capacity for mitosis. This is not surprising since even 
cells growing in monolayers "round-up" during cell division 
and are already "rounded" in shape when plated in soft agar. 
Fibronectin increases anchorage independent growth of 
malignant cell lines, but does not initiate soft agar 
growth by LT-2. Anti-fibronectin decreases anchorage inde-
pendent growth. Therefore, fibronectin is necessary but 
not sufficient for anchorage independent growth. No solu-
ble stimulants released by an anchorage independent cell 
line could be demonstrated, but LT-2 was capable of both 
stimulation and suppression of colony formation by an an-
chorage independent cell line depending on dose and time in 
culture. These effects were less apparent when LT-2 was 
treated with mitomycin C, suggesting that limitation of cell 
division was an important factor in both processes. 
Single cell suspensions of LT-2, injected into nude 
mice, were capable of aggregating and forming an easily re-
. . 
cognizable skin with differentiation as reflected by kera-
tin formation. These findings suggest that LT-2 retains re-
ceptors for cell aggregation and the capacity for differen-
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tiation despite its malignant nature and markedly variable 
and aneuploid karyotype. Cells re-cultured in vitro from 
such nude mice also demonstrate markedly variable aneuploid 
karyotype indicating that some capabilities of LT-2 to or-
ganize into an epithelium and differentiate and form keratin 
are ploidy independent. Soft agar cultures of such cells 
again demonstrated a lack of anchorage independent growth 
confirming the separation of the phenotypes of anchorage in-
dependence and nude mouse growth even in cells passed 
through nude mice. 
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